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iAbstract 
 
4'-substituted-2,2':6',2"-terpyridine ligands which all contain a terminal 
alkyne functionality are synthesised and discussed in Chapter 2. These 
ligands have been designed with potential coupling to platinum(II) or gold(I) 
through the alkyne in mind and have varying degrees of flexibility built in. 
Ligands are intended to favour either polymer or macrocycle formation 
according to their flexibility and the various ways of achieving this are also 
discussed in Chapter 2. 
 
The coupling of these ligands with platinum(II) and gold(I) are 
discussed separately in Chapters 3 and 4, respectively. The combination of 
the ligand flexibility with the coordination geometry at the metal centre is 
carefully considered in order to form building blocks of a specific shape which 
can then be reacted further at the pendant terpyridine moiety. The ligands 
have been fully characterised, some crystallographically. Luminescence 
spectra of these building blocks are measured. 31P NMR spectroscopy is a 
particularly useful tool for characterisation of these molecules, especially in 
the case of the platinum(II) complexes, since this provides a means of 
determining the configuration of the phosphine ligands at the platinum(II) 
centre. Again, X-ray crystal data provide some invaluable information as to 
the arrangement of the molecules in the solid state, including interactions 
between metal atoms in the case of Au(I). 
 
The final step in the formation of polymers or macrocycles is discussed 
in Chapter 5 where the platinum(II) and gold(I) containing building blocks are  
assembled into supramolecular structures by coordination of the pendant 
terpyridine moiety with iron(II). The resulting structures are fully characterised, 
and electrospray ionisation mass spectrometry is important in determining the 
size of the macrocycles formed. Pulsed-field gradient spin-echo NMR 
experiments help to determine the size of the products formed and X-ray 
crystal data for one structure have been obtained and are discussed. 
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General Experimental 
 
1H, 13C, 31P and 195Pt NMR spectra were recorded on Bruker DRX400 
and 500 spectrometers. Chemical shifts for 1H and 13C spectra were 
referenced with respect to residual solvent peaks and TMS = δ 0ppm. 31P was 
referenced with respect to 85% aqueous H3PO4 (δ 0ppm) (sometimes also 
with an internal reference of [PF6]-) and 195Pt with respect to Na2PtCl4 (δ 
0ppm). Compound labelling schemes are shown in each chapter. 
 IR spectra were recorded on a Shimadzu FTIR-8400S 
spectrophotometer with samples as solids using a Golden Gate ATR 
accessory. 
 ESI mass spectra were recorded using a Finnigan MAT LCQ 
spectrometer, and MALDI mass spectra were recorded using a PerSeptive 
Biosystems Voyager instrument. 
 Electronic absorption spectra were recorded on a Varian-Cary 5000 
spectrophotometer and fluorescence spectra were recorded using a 
Shimadzu RF-5301 PC spectrofluorophotometer. 
 TGA experiments were carried out on a Mettler Toledo TGA/SDTA851e 
machine. 
 Liquid crystals were examined under a Leica DMLP polarising 
microscope. 
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Chapter 1 Introduction 
 
1.1 Supramolecular Chemistry 
 
 The field of supramolecular chemistry has grown in importance over 
the last couple of decades. In 1987 Jean-Marie Lehn won the Nobel Prize for 
Chemistry with his work in this area of research. But what exactly is 
supramolecular chemistry? There are many definitions of the phrase. Lehn 
himself describes supramolecular chemistry as “chemistry beyond the 
molecule”,1 where the molecules concerned are components of complex 
chemical systems and are held together by non-covalent intermolecular 
forces.2 This type of system is often found in natural biological systems, 
though at the research level the field of supramolecular chemistry is entirely 
unnatural in character. 
 
Unfortunately things are not as straightforward as they might first 
seem. Normally, non-covalent intermolecular forces are weak (often less than 
10 % of the intramolecular bond energies) and the “bonds” are long, often 
much longer than the intramolecular distances. This in itself is not a problem. 
However, in the last few years there has been a great increase in the amount 
of supramolecular systems constructed by using the principles of coordination 
chemistry. A problem arises in the fact that the metal-ligand bonds are not 
long and the energies involved are significantly greater than traditional non-
covalent forces such as van der Waals forces, π-stacking, or hydrogen bonds. 
Thus, there is some contradiction surrounding the definition of supramolecular 
chemistry.3  
 
 The growing amount of research into this field of chemistry has come 
about due to the greater need for smaller and smaller devices for applications 
in  nanotechnology, defined as “the understanding and control of matter at 
dimensions of roughly 1 to 100 nanometers, where unique phenomena enable 
novel applications”4 according to the National Nanotechnology Initiative in the 
USA.  The creation of devices at this scale requires great precision and 
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control, and traditional organic synthesis is severely limited in terms of what it 
can deliver in this respect.5 Not only do chemists have to develop the 
molecular technology, but they also have to develop the means of allowing 
these devices to communicate with the outside world as well as the 
appropriate structures to contain and service the devices.6 The use of metals 
in forming coordination complexes is one way of achieving this control and 
order. 
  
1.2 Metallosupramolecular Chemistry 
 
Metallosupramolecular chemistry involves “the use of transition metal 
centres to control the assembly of novel supramolecular architectures.”7 
There is a wide variety of transition metals, and each of these has a preferred 
coordination geometry as well as a preference for certain types of donor 
ligand.8 The choice of a specific metal for coordination in supramolecular 
assembly therefore allows the design of building blocks based around these 
coordination geometries.  
 
The use of a chelating ligand, such as a terpyridine, gives control and 
stability to any resulting supramolecular structure. Complexes of 2,2':6',2"-
terpyridine ligands can be formed with various different metals in different 
oxidation states, bringing in a certain degree of versatility to these systems. 
The three nitrogen donors on each tpy form strong interactions with the metal 
ion and if the ligand is 4'- substituted, there is no chirality arising from the MN6 
core, unlike in systems where monosubstituted bpy ligands are used. This 
means the resulting structure is predictable, one of the most important 
qualities of this type of synthesis. Figure 1.1 shows the 2,2':6',2"-terpyridine 
ligand with ring atom numbering.  
 
 
Figure 1.1: 2,2':6',2"-Terpyridine ligand showing ring atom numbering scheme. 
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If supramolecular compounds are to be useful as functional 
microporous materials they need to have several features. They should be 
cyclic with suitable cavities which can be accessed by smaller molecules. This 
means that there should be no catenation between different molecules and no 
counter ions which might take up valuable space inside the cavity. They 
should also be stable enough to resist removal of solvent or any other small 
molecules which fill the cavity on a temporary basis. Most of the compounds 
under investigation as potential molecular materials are supramolecular 
squares with Re(CO)3X as corner units where X = Cl or Br, two examples of 
these can be seen in figure 1.2.11 
 
 
 
Figure 1.2: X-ray crystal structures of supramolecular compounds investigated as potential 
microporous materials clearly showing the square structure and the large empty cavities 
capable of hosting smaller molecules.11 
 
The different metals available to the coordination chemist also bring 
unusual and interesting properties to a supramolecular structure. There is 
significant literature available on the use of metals in supramolecular 
assemblies for their luminescent and photophysical properties, such as 
ruthenium(II), iridium(III), osmium(II) and platinum(II)9. Yam has carried out 
significant research into the use of metal alkynyls as luminescent materials,10 
and there are also reports in the literature of supramolecular materials as 
molecular sieves, chemical sensors and catalysts.11 
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1.3 Molecular Self Assembly 
 
Molecular self assembly involves the use of diverse interactions 
between molecules to construct nanoscale structures with a wide variety of 
functions. This is a phenomenon which is widely present in nature, for 
example, the formation of the DNA double helix, shown in figure 1.3 and the 
growth of the Tobacco Mosaic Virus.6  
 
Figure 1.3: Probably the most important natural example of supramolecular self assembly 
in nature- the formation of the double helix of the DNA molecule. Base pairs are held together 
by hydrogen bonds. 
 
Up until recently, the use of organic synthesis to produce large 
structures has been the only method available. However, although some 
relatively large molecules have been synthesised, such as vitamin B12, it is 
clear that to synthesise any molecule on a nanometre scale would involve an 
incredible effort in terms of manpower, time and of course money. Lessons 
have to be learnt from nature, and nature has taught us that the most efficient 
way to produce large nanometre scale structures is to self assemble these 
from smaller subunits. It is highly important to understand the nature of the 
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interactions which are responsible for the self assembly6 and this is where the 
field of coordination chemistry plays an important part. 
 
1.4 2,2':6',2"-Terpyridine Ligands 
 
 The molecule 2,2':6',2"-terpyridine (tpy) has been known since 1932 
when Morgan and Burstall heated pyridine and anhydrous iron(III) chloride in 
an autoclave.12 Terpyridine was one of 20 products of this reaction, and since 
then the synthesis has been developed to give more specific results and 
better yields.  
 
 Terpyridine ligands have many applications apart from that in the field 
of supramolecular chemistry.  The use of aryl substituents in the 4'- position 
gives a molecule which can be used in the colorimetric determination of 
iron(II) as well as having the potential for use in clinical chemistry. There are 
examples of the use of terpyridine ligands in the preparation of luminescent 
materials and these have potential as luminescent protein labels. 13 
 
 
Figure 1.4: The original Kröhnke 2,2':4',3"-terpyridine synthesis. 
 
These days there are many different synthetic routes to form 
substituted terpyridines. These are generally based on two different methods, 
ring closure and ring coupling. An example of the ring closure method is the 
Kröhnke synthesis,14 shown in figure 1.4. This method is described by 
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Kröhnke in the literature for the synthesis of 2,2':4',3"-terpyridine. The other 
method is the direct coupling of the pyridine rings. This method is inefficient, 
producing on average less than 10 % yield of terpyridine.13  
 
A useful method for directly forming a hydroxy-substituted terpyridine 
uses acetone and 2-acetylpyridine as reactants to generate 4'-hydroxy-
2,2':6',2"-terpyridine (HO-tpy).15 This can then be used as the starting point for 
further functionalisation of the terpyridine ligand. This method is possibly more 
useful for synthesis of building blocks for supramolecular self assembly since 
the product here has the nitrogen atoms positioned in a way which is suitable 
for coordination to an octahedral metal ion. In the original Kröhnke synthesis 
the donor atoms are positioned so that it is impossible for all three of them to 
coordinate simultaneously to the metal ion.  Figure 1.5 shows ring closure to 
form 4'-substituted tpy directly. 
 
 
 
Figure 1.5: Formation of hydroxy-substituted terpyridine by the ring closure method.15 
 
 The hydroxyl group is a particularly useful functional group to include 
since it provides a means for attaching all sorts of other functionalities to the 
terpyridine ligand itself. The use of a base creates a nucleophile which can 
undergo substitution reactions and there are many examples in the literature 
of this.16,17,18  
 
The use of substituted terpyridine ligands has now become widespread 
as a building block in supramolecular chemistry since these ligands readily 
coordinate to a wide variety of transition metal ions and can be substituted 
with many different functionalities. 4'-Substituted tpy when coordinated to an 
octahedral metal centre produces a rigid linear moiety which can produce 
molecular wires and rods.  Figure 1.6 shows how substituents on 4'-
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substituted tpy ligands are arranged linearly as part of an octahedral metal 
complex.  
 
 
Figure 1.6: Octahedral metal complex of 4'-substituted 2,2':6',2"-terpyridine showing the 
overall linear arrangement of substituents, X. 
 
There are many examples in the literature of 4'-substituted terpyridine 
ligands being used as precursors for large supramolecular architectures. The 
synthesis of terpyridine ligands bearing pendant naphthalene units was 
designed in order to provide a method for the self assembly of ligands and/or 
complexes in the solid state by use of π-stacking interactions of the 
naphthalene groups.19 Terpyridine ligands have also been used in the core of 
metallodendrimers as a means to investigate the novel properties associated 
with a metal ion, such as iron(II) and cobalt(II), being embedded in the centre 
of a large macromolecular structure.20 Terpyridines can also be found on the 
outside of dendrimers, providing a means of using the coordination of metal 
ions to assemble further generations of the dendrimer structure as shown in 
figure 1.7.21 
 
The addition of an alkyne substituent onto a terpyridine in the 4'- 
position is useful for achieving further coordination or functionality. There are 
various methods in which this can be achieved, namely the direct attachment 
onto the terpyridine22 or the use of a spacer of varying lengths to separate the 
alkyne from the terpyridine.16,18,23 The alkyne functionality is useful as a 
means for the insertion of cobalt clusters24,25,26 as well as reaction with square 
planar  platinum complexes27,28 to give a bis-tpy building block.  
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Figure 1.7: The use of the 4'-substituted 2,2':6',2"-terpyridine ligand as a functional group on 
the outside of a dendrimer.21 
 
1.5 Iron(II) and Ruthenium(II) Terpyridine Complexes 
 
There are several possible metals which can be complexed with 
terpyridine ligands. However we will concentrate on iron(II) and ruthenium(II) 
here. Both ruthenium(II) and iron(II) have the electron configuration d6. In the 
case of ruthenium(II), complexes are always diamagnetic in a low spin 
electron configuration. Crystal field theory can be used to explain why this 
occurs since the electrons surrounding the metal centre are located in the d 
orbitals of the metal and there is electrostatic repulsion between these 
electrons and the electrons of the ligands. Both the metal electrons and the 
ligand electrons are dealt with as point charges for the purposes of crystal 
field theory. If we now consider the ligands arranged in an octahedral fashion 
around the metal, the electrons in the dz2 and dx2-y2 orbitals will point directly 
at the ligands and will therefore experience higher repulsion energy. The 
remaining d orbitals (dxy, dxz and dyz) point between the ligands and 
experience less repulsion. This leads to a splitting of the d orbitals, called 
crystal field splitting. Depending on the metal centre and the ligand field, this 
splitting can be large or small resulting in higher or lower stabilisation effects. 
Each orbital can hold a maximum of two electrons and energy is required to 
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pair these electrons up in the orbitals. When there is a choice of orbitals for 
the electrons to occupy, the orbital occupation depends on whether a lower 
energy can be achieved by pairing the electron or promoting it to the higher 
level. Thus a lower crystal field splitting means that less energy is needed to 
promote the electron to the higher orbital than is needed to pair the electron 
and thus the complex is high spin. In the case of iron(II), complexes can be 
either low or high spin depending on the position of the ligands in the 
spectrochemical series, though the use of the terpyridine ligand means there 
is a strong crystal field splitting and therefore the complex is in a low spin 
configuration.29,30 Figure 1.8 shows low spin and high spin configuration for a 
d6 metal such as Fe(II). 
 
 
Figure 1.8: High and low spin electron configurations for a d6 metal centre. 
 
Both iron(II) and ruthenium(II) display octahedral coordination and 
readily form complexes with chelating nitrogen donor ligands such as tpy, bpy 
or phen. Two tpy ligands are coordinated to one metal ion compared to three 
bpy or phen ligands. The tpy ligand is symmetrical when monosubstituted in 
the 4'- position, whereas monosubstitution in bpy and phen leads to 
asymmetrical ligands. All three ligands can be seen in figure 1.9. 
 10
 
 
 
Figure 1.9: Symmetry of 4'-monosubstituted tpy compared to asymmetry of monosubstituted 
bpy and phen ligands. 
 
 When tpy is unsubstituted there are no isomers of an M(tpy)2 unit and 
the product is symmetrical. However, the use of unsubstituted bpy or phen 
produces two enantiomers of an ML3 unit. When the symmetrical 4'-
substituted terpyridine ligand is coordinated to a metal ion, once again it 
allows for only one product with no isomers. This is a significant advantage 
over bpy or phen which, if monosubstituted, are asymmetrical. This 
asymmetry of monosubstituted bpy and phen means that on complexation 
with an octahedral metal ion, fac and mer isomerism occurs as shown in 
figure 1.10. Because of this, there is a significant advantage in using 4'-
substituted tpy over substituted bpy and phen31 for supramolecular self 
assembly as tpy complexes have highly predictable structures whereas bpy 
and phen complexes will produce a statistical mixture of different isomers 
which is not something which is sought after in this type of synthesis. 
 
The main difference between iron(II) and ruthenium(II) is the way in 
which they can be used in the synthesis of self-assembled structures. The 
formation of iron-tpy complexes is done in one step at room temperature 
starting from two equivalents of the tpy ligand and an iron(II) salt. Usually the 
reaction is complete in a very short space of time. This gives a symmetrical 
complex in which both the terpyridine ligands are the same.  The reaction 
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proceeds to give a deep purple coloured solution which is indicative of the 
formation of the bis-tpy complex.  
 
 
Figure 1.10: Enantiomers of octahedral bpy and phen complexes compared to the achiral tpy 
complex.  
 
 
 
Figure 1.11: The possibility of fac and mer isomerism with monosubstituted bpy and phen 
complexes, but the formation of one species for 4'-monosubstituted tpy. 
 
The reaction between iron(II) and terpyridine ligands has been used as 
a means to form molecular triangles in the group of Hogyu Han. The synthesis 
was reported as occurring simply by adding Fe(II) to an aqueous solution of 
the DNA-functionalised terpyridine ligands. This work, shown in figure 1.12, is 
a nice example of the use of two types of intermolecular forces in 
supramolecular self assembly, the hydrogen bonding between the base pairs 
in the complimentary DNA strands as well as coordination bonds between the 
transition metal and the nitrogen donors of the terpyridine ligand.32  
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In contrast, there are a few different methods for the formation of 
ruthenium-tpy complexes. An advantage of ruthenium over iron is that the 
reaction can be carried out in two steps, enabling an asymmetrical complex to 
be synthesised using two different substituted terpyridine ligands. In the first 
step RuCl3.xH2O is reacted with one equivalent of terpyridine to form the 
insoluble ruthenium(III) complex Ru(tpy)Cl3. This is then reduced to 
ruthenium(II) in the second step using a reducing agent such as N-ethyl 
morpholine while the second equivalent of the terpyridine ligand is added.33 
An alternative to this second step is to remove the chlorides from the mono 
complex using silver tetrafluoroborate34 followed by addition of the second 
equivalent of the tpy ligand.  
 
 
Figure 1.12: The formation of DNA triangles using iron(II) terpyridine complexes to form 
corner units.32 
 
For a symmetrical complex, two equivalents of ligand can be used, with 
N-ethylmorpholine as above in a one-pot method. This also involves heating 
to reflux, usually for several hours, and so another method has been 
developed whereby the one-pot reaction mixture is heated in the microwave 
for very short times giving the desired symmetrical product in high yield.35 
Unfortunately the disadvantage of both of these methods is that a large 
amount of energy is put into the system. Having said that, the microwave 
method has significantly lower reaction times than the traditional thermal 
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method (several minutes compared to several hours) and therefore this 
method is an improvement on the thermal method. In both cases the large 
amount of energy needed can lead to decomposition of some less stable 
ligands during the reaction.  
 
There are many examples in the literature of the use of terpyridine 
metal complexes in the construction of molecular cycles and polymers. The 
first reported examples of these were cycles based on bis-terpyridines with 
rigid spacers linking them together. The spacers were either linear or had a 
built in angle to them. The choice of angle predetermined the size of the 
macrocycle, and the use of alkynyl spacers played an important part in the 
synthesis of these rigid building blocks. Even with this seemingly rigid 
phenanthroline spacer it was reported that there was formation of both the 
tricyclic and tetracyclic compound, shown in figure 1.13. 36 
 
 
Figure 1.13: Formation of tricyclic and tetracyclic macrocycles using terpyridine complexes 
connected by a “rigid” spacer.9 
 
Things become even more complicated when the spacer used is 
flexible. This type of system allows for the formation of various macrocycles 
and polymers, and indeed this is what has been observed in the majority of 
cases cited in the literature. In order to push the equilibrium to favour ring 
formation it is often necessary to perform these reactions at low 
concentration. In order to form a monocycle the spacer has to be sufficiently 
long enough so that the two terpyridine ligands can come together to form a 
 14
complex. Use of a spacer containing a naphthalene unit gives sufficient space 
to form a monocycle when the two tpy moieties are complexed with iron(II).37 
The formation of this complex is interesting because although the spacer is 
long enough for the complex to form, it is not long enough to allow free 
movement of the naphthalene ring. Therefore the conformation of the 
monocycle is locked, with the naphthalene occupying a cleft between the two 
terpyridine ligands. Since the naphthalene sits over one of the two tpy ligands, 
the tpy ligands are non-equivalent and the whole structure is therefore chiral. 
This arrangement can be seen in figure 1.14. 
 
 
 
Figure 1.14: A conformationally locked chiral monocyclic iron(II) tpy complex with a 
naphthalene containing spacer, as well as a cartoon representation of its chirality.37  
 
 An example of terpyridine ligands connected with a flexible spacer 
shows how, on complexation of the terpyridine moieties with iron(II), two 
different macrocycles are formed, along with a small amount of polymeric 
material. In this case the length of the spacer is too short to allow a mono-
cycle, and mass spectrometric evidence suggests the formation of a tri- and 
tetra-cycle.38 Both these products are illustrated in figure 1.15.  
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As we have seen, choice of spacer is important in the design of 
supramolecular macrocycles and polymers. The use of alkyne spacers has 
been a popular choice in the literature, and these are also well known to form 
complexes with platinum and gold. This therefore begs the question “what 
properties could be added to a macrocycle by the use of alkynyl complexes as 
spacers in macrocycles such as the ones above?” 
 
 
Figure 1.15: Formation of tri- and tetra-cycles with flexible spacers.38  
 
1.6 Platinum(II) Alkynyl Complexes 
  
Platinum is a transition metal commonly found in oxidation states +2 or 
+4.  For the purposes of this thesis we will concentrate on the +2 state which 
has an electron configuration of d8 at the platinum(II) centre. Platinum(II) 
complexes have a coordination number of 4. In theory, 4-coordinate d8 
platinum(II) complexes could have either a tetrahedral or square planar 
geometry, but in practice they are almost always square planar. This can be 
explained by crystal field theory.29  
 
As described previously in the chapter, crystal field theory is a model 
where the ligand electrons create a field around the metal centre. This field is 
not spherical, due to the fact that electrons are found only in the d orbitals of 
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the metal which are arranged around the metal centre in an octahedral 
fashion. These orbitals are not equal in energy since two (dz2 and dx2-y2)   
point directly at the ligands, therefore having a greater repulsion, while three 
(dxy, dxz and dyz) point between the ligands and have a lower repulsion.  The 
orbital diagram for a square planar complex is derived from the octahedral 
one by simple removal of the axial ligands, thus lowering the repulsive 
energies of those orbitals with a z component (z is taken to be the vertical 
axis) and meaning that the two orbitals with highest energy are those with no 
z component, the dx2-y2 and the dxy. In contrast, the tetrahedral crystal field 
does not have the ligands pointing directly at the d orbitals of the metal. 
However, some point nearer than others and there is still an inequality in the 
orbitals. Figure 1.16 shows the crystal field splitting for the three geometries.  
 
 
Figure 1.16: Crystal field splitting for octahedral, square planar and tetrahedral geometries. 
 
 Orbitals are filled with up to two electrons. This means that in the case 
of the d8 metal centre, a square planar species would be diamagnetic, with all 
eight electrons paired up, and a tetrahedral species would be paramagnetic, 
with two unpaired electrons. When electrons are paired they require energy 
which can be offset by the energy gained by the stabilisation of the orbitals. 
Thus, a large crystal field splitting, and therefore a large stabilisation of the 
orbitals provides better compensation for the energy needed in pairing 
electrons than a smaller splitting. The crystal field splitting is affected by the 
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metal ion. Platinum(II) has a high crystal field splitting and when considering 
the stabilisation of the orbitals versus the energy saved by not pairing 
electrons as would be the case for a tetrahedral geometry, the square planar 
geometry is of lower energy and is therefore the geometry seen in virtually all 
d8 platinum(II) complexes.  
 
The synthesis of platinum(II) alkynyl complexes can be achieved by 
several methods. Firstly there is the use of organometallic reagents such as 
Grignard reagents, organolithium or organosodium reagents. An example of 
this is the way Chisholm uses propyne and BuLi to form the complex trans-
Pt(C≡CMe)2(PMe2Ph)2.39 A second method involves transfer of the alkynyl 
group from less reactive species such as alkynyl tin, mercury and gold. 
Wrackemeyer40 uses the alkylstannane method in his synthesis of trans-
(alkynyl)chloro-bis(triethylphosphine)platinum(II) and Cross41  uses the rather 
toxic alkynylmercury transfer method in his synthesis of trans-
chlorobis(methyldiphenylphosphine)(phenylethynyl)platinum(II). A third, and 
probably the most common method uses copper iodide42 as a catalyst with 
the most likely intermediate being a copper alkynyl complex. There is also the 
oxidative addition to platinum(0) and HX elimination from halogenoalkynyl 
complexes.41 In all of these cases, the starting platinum complex has easily 
displaced ligands (such as halides) which are replaced by the nucleophilic 
alkynyl ligand on reaction. The above methods generate mostly the trans 
isomer if used with a monodentate ligand such as a phosphine, although the 
use of a chelating ligand, for example dppe, on the platinum(II) centre is a 
useful way to force the geometry to form the cis isomer, a popular corner unit 
for the formation of supramolecular squares. Figure 1.17 shows how the use 
of dppe forces the complex into a cis configuration compared to a non-
chelating ligand where the complex is free to adopt a trans configuration. Use 
of the chelating phosphine dppe is exemplified in the work of Bruce.43 
 
Platinum(II) alkynyl complexes have been shown to exhibit interesting 
luminescent properties which are unique to the presence of the alkynyl 
ligands.10 The increasing demands over the past few years for new materials 
for use in the electronics industry has led to the investigation of this class of 
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compounds as potential molecular wires, sensors and other electronic 
materials. Studies have shown that the alkynyl ligand is a good σ- and π-
donor although a poor π-acceptor.44  
 
 
Figure 1.17: The use of chelating phosphine dppe forces the complex into a cis configuration 
(left) compared to the non-chelating phosphine (right) in which the complex is free to adopt 
the trans configuration. 
  
Early work on the use of platinum polyynes as luminescent materials 
was done in the group of Hagihara.45,46 However, the fact that these materials 
are polymers means that they are difficult to study and there are problems 
associated with molecular weight distribution, reproducibility and confirmation 
of the exact structure. This led Yam’s group to study the design and synthesis 
of soluble metal alkynyls with luminescent properties which can potentially 
form building blocks for the supramolecular self assembly of luminescent 
organometallic oligomers, functional materials and molecular sensors.10  
 
 
Figure 1.18: Coordination of different metals modifies the luminescence of this platinum 
complex which can act as a metal sensor.47  
 
A recent example of the way platinum alkynyl complexes can be used 
as molecular sensors comes again from the work of Yam. Two square planar 
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platinum centres are linked via the use of a chelating phosphine ligand in a 
face to face arrangement. Studies have been done on the luminescence 
properties of this molecule and it has been shown that the further coordination 
of a second metal such as copper or silver to the alkynes modifies the 
luminescence and therefore the complex can act as a sensor for these 
metals.47 Figure 1.18 shows the coordination of this second metal to the 
alkynes of the platinum complex. 
 
 
Figure 1.19: Colour changes of [Pt(tpy)C≡CC≡CH]OTf in solution with increasing diethyl ether 
content and its UV/VIS spectrum in MeCN (a), and emission spectrum in acetone (b).48  
 
 Alternatively, a simple linear platinum complex, [Pt(tpy)C≡CC≡CH]OTf 
has been shown to exist in two polymorphic forms, and solutions of either of 
these polymorphs have been shown to have varying luminescence properties 
depending on the composition of the solvent mixture. By increasing the 
amount of diethyl ether while keeping the concentration of the complex the 
same, the colour of the solution changes from yellow to green and finally to 
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blue and there are significant changes in the UV/VIS spectrum, shown in 
figure 1.19. This type of complex may eventually go on to act as a probe or 
reporter of environmental changes and may have other applications in 
materials science and sensor technology.48,49 
 
 The choice of the alkynyl ligand is also important in the design of 
supramolecular assemblies. It is a linear and rigid molecule which makes it a 
useful building block in the formation of large structures. It is well suited to 
forming the edge unit of squares and triangles and in combination with the 
right choice of metal centre it is a useful tool for the supramolecular chemist. 
 
 
 
Figure 1.20: Stang’s use of the platinum bis-alkyne unit to form the edges of triangles 
(above)50 and the corners of molecular squares (below).51 
 
Some examples of how the platinum(II) coordination geometry can be 
used in combination with the alkyne ligand include those in which Stang uses 
the square planar geometry of a bis-alkyne complex in a trans arrangement 
as a rigid linear building block in the self assembly of supramolecular 
triangles50 as well as the use of a similar platinum complex, forced into the cis 
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configuration by use of a chelating phosphine ligand to form molecular 
squares which have the potential to form host-guest complexes.51 Both of 
these are shown in figure 1.20 
 
Bruce43 makes use of a polyyne “edge” to give a greater cavity size for 
his molecular square, below in figure 1.21.  
 
 
Figure 1.21: Bruce’s molecular square. The use of the poly-alkyne chain for the edge units 
gives a larger cavity than using large aromatic systems.43 
 
 
Figure 1.22: Ziessel’s use of polypyridine ligands as precursors to molecular squares.52,53  
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In his work, Ziessel52,53 starts to incorporate bipyridine and terpyridine 
ligands into his corner and edge units shown in figure 1.22 which have the 
potential to form complexes with other transition metals, closing up the square 
in the process.  
 
Platinum is not the only metal which can be used in conjunction with 
alkynes to form large supramolecular architectures with interesting 
luminescence properties. Gold(I) alkynyl complexes are also commonly found 
in the literature and some of these are discussed in Section 1.7. 
 
1.7 Gold(I) Alkynyl Complexes  
 
In a similar way to platinum(II), gold forms alkynyl complexes. 
However, unlike platinum, gold is mainly found in the +1 and +3 oxidation 
states. Here we will concentrate on the +1 state, and this means that gold(I) 
alkynyl complexes are mostly linear54 with a coordination number of two rather 
than 4-coordinate square planar like their platinum(II) analogues.  This also 
means that in order to form a neutral complex as with platinum(II) analogues, 
one of the ligands must be neutral, for example a phosphine, since the alkynyl 
ligand is anionic (i.e. RC≡C-).  
 
There are two methods commonly used in the literature for the 
synthesis of phosphino-gold(I) alkynyl complexes which involve either the 
reaction of a gold alkynyl polymer with a suitable phosphine, or the reaction of 
a terminal alkyne with a phosphino-gold halide in the presence of a base, the 
most common one being the latter. By choosing a chelating phosphine, larger 
structures can be synthesised. 
 
One important feature of gold complexes is the presence of Au…Au 
interactions. These are relatively weak but comparable in strength to 
hydrogen bonds and therefore an important factor in the supramolecular 
assembly of gold complexes in the solid state.55 It is also thought that the 
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presence of these interactions gives rise to the luminescence often exhibited 
by these complexes.56 Luminescence occurs when the interactions are short, 
around 3 Å. When the interactions are longer than this, no luminescence is 
observed. The choice of spacers used to link gold centres together can play 
an important part in the luminescent properties: gold centres can be held 
together or forced apart in order to switch luminescence on or off. Since the 
gold interactions also play an important part in the solubility of these 
complexes, by choosing linking groups which hinder interactions, solubility 
can be improved.55 
 
In the group of Laguna, gold(I) complexes of the chelating phosphine 
bis(2-diphenylphosphinoethyl)phenylphosphine (triphos) have been 
synthesised, illustrated in figure 1.23, and their luminescent properties 
studied. This work has shown that in the case of gold(I) complexes, 
luminescence depends heavily on the ligand. In the cases of X = Cl, C6F5 and 
Fmes (2,4,6-tris(trifluoromethyl)phenyl) there is no luminescence, whereas in 
the case of X = Br and I there is luminescence. Thus the choice of a suitable 
ligand is important if synthesis of a luminescent gold complex is to be 
achieved.57 
 
 
Figure 1.23: Synthesis of some luminescent gold(I) complexes.57  
 
A nice example of the use of a chelating phosphine ligand in 
conjunction with an alkynyl ligand to form supramolecular structures 
containing gold centres is from the group of Puddephatt. Two gold centres are 
connected using a long organic spacer. The two gold centres are then 
connected at their other coordination site to close the ring using a chelating 
phosphine of varying lengths. Depending on the nature of the phosphine, 
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different supramolecular architectures can be formed resulting in either a 
single ring or a catenane as shown in figure 1.24.58 
 
 
 
Figure 1.24: Formation of either a ring or a catenane containing gold centres in a linear 
arrangement (E = spacer).58 
 
 In later work done in the same group,59 luminescence spectra were 
recorded for similar compounds where the chelating phosphines were the 
same as before and the alkyl spacer was varied. In the solid state two rings 
associate to form a pair and the Au…Au interactions can be clearly seen 
between the two rings in the pair, shown in figure 1.25. When the phosphine 
is shorter as in the case of dppm and dppe there is a short distance between 
the two gold centres of the same ring. This eliminates the need for pairing of 
rings since stabilisation due to Au…Au interactions is achieved in one ring. All 
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of the series of these compounds displayed luminescence, due to either 
Au…Au interactions in the same ring, or in a pair of rings, thus providing 
evidence that luminescence occurs as a result of these interactions. 
 
 
Figure 1.25: Crystal structure showing the presence of Au…Au interactions between the two 
rings.59  
 
As with platinum(II) complexes, gold(I) complexes can potentially also 
have applications as molecular sensors. Yam’s group has recently 
synthesised a series of gold(I) complexes functionalised with crown ethers. 
These molecules have been shown to exhibit a change in luminescence 
properties when binding of a metal cation occurs at the crown ether site. The 
complexes alone have been shown by X-ray crystallography (figure 1.26) to 
have the crown ether groups far apart. Therefore the gold centres are also far 
apart, far enough that there are no Au…Au interactions present. On binding of 
the metal cation, the crown ether groups come together to form a sandwich 
with the metal cation in the centre, thus bringing the two gold centres close 
enough together so that they can interact and therefore change the 
luminescence of the complex.60 
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Both gold(I) and platinum(II) alkynyl complexes have been shown to 
exhibit interesting luminescent properties, and these in combination with the 
structural properties of terpyridine complexes should, in theory, make for 
some potentially interesting supramolecular structures. 
 
 
 
Figure 1.26: Two different examples of gold-containing molecular sensors; above [Au2(μ-1,1-
dicyanoethylene-2,2-dithiolate)Ph2P-benzo-15-crown-5)2] without a bound metal cation, and 
below, [{Au2(μ-diethyldithiocarbamate)(Ph2P- benzo-15-crown-5)2}.Na](PF6)2 showing the 
bound sodium cation and the presence of Au…Au interactions.60  
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1.8 Aims 
 
The aim of this thesis is the synthesis of 4'-substituted-2,2':6',2"-
terpyridine ligands, all containing a terminal alkyne functionality. Coupling of 
these ligands at the alkyne site with platinum(II) and gold(I) is envisaged and 
the spectroscopic and structural properties of the resulting complexes will be 
investigated. The suitability of these complexes for the assembly of 
macrocycles or coordination polymers via further complexation at the 
terpyridine moiety will also be investigated. 
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Chapter 2 2,2':6',2"-Terpyridine Ligands 
 
2.1 2,2':6',2"-Terpyridine Ligands 
 
4'-Substituted 2,2':6',2"-terpyridine ligands are well known in the 
literature1 as building blocks for supramolecular self assembly. The use of an 
alkyne-functionalised tpy ligand is particularly useful in this type of self 
assembly since it can be reacted with other species, giving further opportunity 
for functionalisation, for example, addition of a carbaborane2 or a cobalt 
cluster.3 The alkyne functional group can also be reacted with a platinum(II) or 
gold(I) centre to form homoditopic ligands, leaving the tpy moiety free for 
coordination.  
 
This chapter describes the synthesis and characterisation of several 
alkyne-functionalised tpy ligands. These are grouped into two types: the first 
being ligands having a flexible alkyl spacer between the tpy moiety and the 
alkyne, and being prepared from 4'-hydroxy-2,2':6',2"-terpyridine, and the 
second type being ligands with a rigid C6H4-spacer and synthesised from 4'-
(n-bromophenyl)-2,2':6'2"-terpyridine. The rigid ligands have a predetermined 
angle built into them, achieved by the choice of placing the alkyne in either the 
meta or para positions. Figure 2.1 shows the different terpyridine ligands 
discussed in this chapter and the nomenclature used for describing them.  
 
Syntheses were based on literature methods reported for 4'-(2-propyn-
1-oxy)-2,2':6',2"-terpyridine2 and 4'-(4-ethynylphenyl)-2,2':6',2"-terpyridine.3 
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Figure 2.1: Numbering scheme for tpy ligands synthesised. Ligands 12, 44, 65,6, 73, 87  and 108 
as well as HO-tpy9 were prepared according to literature methods. 
  
2.2 Synthesis of 4'-Hydroxy-2,2':6',2"-Terpyridine  
Derivatives 
 
The ligand 4'-hydroxy-2,2':6',2"-terpyridine is a useful starting material 
for the synthesis of 4'-substituted terpyridine ligands. The synthesis of this 
starting material was reported in 1990 by Constable and Ward9 and starts with 
the formation of a triketone by a double Claisen condensation reaction 
between two equivalents of ethyl 2-pyridine carboxylate and one of acetone.10 
The triketone is then reacted with ammonium acetate to close up the middle 
ring and form 2,6-bis(2'-pyridyl)-4-pyridone. The tautomer HO-tpy can be 
purified by recrystallisation from ethanol. The reaction scheme can be seen in 
figure 2.2. 
 
 
 
Figure 2.2: Formation of HO-tpy from two equivalents of ethyl 2-pyridine carboxylate and 
acetone. 
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Reactions of HO-tpy can produce different functionalised terpyridines 
as shown in figure 2.1. By using a base to deprotonate the hydroxy group, the 
resulting nucleophile can then be reacted with other species containing a 
good leaving group such as an alkyl halide.  By choosing an alkyl halide with 
a terminal alkyne, this method can be used to generate a ligand which can go 
on to react with platinum(II) or gold(I) at a later stage.  
 
This method (figure 2.3) is based on the reported synthesis of ligand 12 
where the use of propargyl bromide attaches a short alkyl spacer to the 
oxygen atom of the HO-tpy as well as providing the terminal alkyne 
functionality. 
 
 
Figure 2.3: Synthesis of ligands 1, 2 and 3 (n = 1, 3 and 4 respectively). 
 
 First of all, HO-tpy is suspended in acetonitrile and is deprotonated at 
room temperature using potassium carbonate as the base. After an hour, the 
halogenated compound is added and the reaction is stirred for 24 hours at 60 
°C. During this time, a nucleophilic substitution reaction occurs in which the 
deprotonated HO-tpy attacks at the halogenated position of the alkyne 
compound. The bromide is a good leaving group and is eliminated as the C-O 
bond forms. The reaction mixture is then poured into water. This precipitates 
the product out of solution, as well as dissolving the excess base. Finally, the 
product is isolated by filtration as an off-white solid. Purification can be 
achieved by recrystallisation from hot ethanol. This method has proved 
successful for ligands 1, 2 and 3 where n = 1, 3 and 4 respectively. Several 
attempts were made to synthesise the n = 2 ligand in the same way but to no 
avail.  
 
 35
This reaction worked well, giving a yield of the alkyne-substituted 
ligand of between 29 % and 66 %. The products were recrystallised from hot 
ethanol in the first instance. This usually produced large crystals which, in the 
case of 3 were suitable for X-ray crystallography. In the cases of 1 and 2, X-
ray quality crystals were obtained from a layered solution of CH2Cl2 and 
hexane. A search of the Cambridge database revealed that the X-ray crystal 
structure of ligand 1 had not previously been published, and so the structure 
was determined. In the case of 3, both solvent systems produced suitable X-
ray quality crystals. It was found that these were two different polymorphs, 
neither containing any solvent molecules.11 Crystal structures of these ligands 
are discussed later in the chapter. 
 
The known ligand 4, was synthesised according to the literature 
method.4 Once again, HO-tpy was used as the starting material for this 
synthesis and was deprotonated in the same way described above using 
potassium carbonate as the base in conjunction with potassium iodide. These 
reactants were stirred in DMF for half an hour at 70 ˚C before 2-(2-
chloroethoxy)ethanol was added. As before, a nucleophilic substitution 
reaction occurs where the deprotonated HO-tpy acts as the nucleophile and 
the chloride is the leaving group. After removal of the solvent, the residue is 
suspended in CH2Cl2 and washed with NaOH followed by NaHCO3 and finally 
water. After drying of the organic layer and removal of the solvent, the product 
is isolated as an oil which solidifies on standing. 
 
Ligand 4 is then dissolved in acetonitrile. A stronger base than in the 
previous examples, in this case KOH, was used to remove the proton from the 
terminal OH group. After an hour, propargyl bromide was added and the 
reaction was stirred at 60 ˚C for 24 hours. Again the deprotonated hydroxyl 
group on the end of the spacer acts as a nucleophile in a substitution reaction 
with the propargyl bromide, the bromide acting as the leaving group. As 
before, the reaction mixture was poured into water, although this time since 
no precipitate formed, the product was extracted from solution with CH2Cl2. 
Finally the solvent was removed from the organic layer after drying over 
magnesium sulfate. Ligand 5 was isolated as a brown oil which later solidified 
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giving a good yield of around 50 %. Figure 2.4 shows the synthesis of ligand 
4, followed by reaction to form ligand 5 as the final product. 
 
 
Figure 2.4: Synthesis of ligand 4 followed by reaction to form 5. 
 
X-ray quality crystals of this ligand were obtained from a CDCl3 solution 
and the structure is discussed later in the chapter. 
 
2.3 Characterisation 
 
2.3.1  1H NMR Spectroscopy. 
 
All the above ligands were characterised by 1H NMR spectroscopy in a 
CDCl3 solution. The protons in the aromatic region of the spectra all 
correspond to signals from known terpyridine ligands as is expected. The 
aliphatic region differs between ligands with the varying numbers of CH2 
groups. The signal which corresponds to the terminal alkyne function is clearly 
distinguishable due to the presence of coupling between the alkyne proton 
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and the CH2 group nearest to it. Chemical shifts were assigned using COSY 
and NOESY experiments. 
 
 A3 A4 A5 A6 B3 a b c d e C≡CH 
1 8.67 7.91 7.39 8.75 8.16 4.99     2.61 
2 8.62 7.82 7.33 8.69 8.03 4.35 2.08 2.45   1.98 
3 8.63 7.88 7.35 8.70 8.04 4.28 2.00 1.77 2.30  1.99 
4 8.57 7.82 7.31 8.66 8.07 4.41 3.91 3.66 3.76   
5 8.59 7.84 7.32 8.68 8.03 4.40 3.89 3.73 3.78 4.21 2.44 
 
Table 2.1: Table of 1H NMR data for ligands 1-5. Chemical shifts are shown in δ/ppm. The 
signal for the OH proton in 4 was not observed. See fig. 2.1 for atom labelling. 
 
 Table 2.1 shows the different chemical shifts for the protons in each of 
the 5 ligands synthesised. Shifts of 1 and 4 compare well with those cited in 
the literature.2,4 All the signals for the terpyridine protons are comparable with 
each other, only showing slight differences from one ligand to another. In 
each of the ligands, proton a is always shifted the most down field due to its 
close proximity to the electronegative oxygen atom directly bound to the 
terpyridine unit.  
 
In the aliphatic region of the spectra the assignment of peaks is not so 
straightforward. The order in which the peaks can be seen varies according to 
the length of the alkyl spacer. The proton coupled to the alkyne proton (c in 
ligand 2, d in ligand 3) is always the next highest field after a, and after that 
come b, c and the alkyne proton, with the chemical shifts being similar in the 
different ligands.  
 
Figure 2.5 shows the 1H NMR spectrum of 3. This is typical of this 
series of ligands. The terpyridine peaks can be seen in the aromatic region 
and it is possible to see the downfield shift of a, due to its proximity to the 
terpyridine oxygen atom. 
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Figure 2.5: Representative 500 MHz 1H NMR spectrum of ligand 3 in CDCl3 (marked X).  
 
 The expansion of the aliphatic region of the spectrum is shown in figure 
2.6. It is quite clear from looking at the coupling constants which signal is d, 
since this signal appears as a triplet of doublets. The largest coupling 
constant (J = 7.2 Hz) is similar in size to that seen in b and c, and arises due 
to coupling with the adjacent CH2 group. The other smaller coupling constant 
(J = 2.4 Hz) corresponds to coupling between d and the alkyne proton. The 
coupling constant is small because coupling occurs between protons which 
are not attached to neighbouring carbons. This type of coupling pattern can 
be seen for all the flexible ligands in this series and is a useful diagnostic tool 
for the presence of the alkyne functionality. Signals for protons b and c can 
also be seen in figure 2.6. These signals are both quintuplets arising from 
coupling to 4 protons in approximately equal environments. In the case of b, 
the signal for the alkyne proton is superimposed on top, and the two signals 
therefore appear together. 
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Figure 2.6: Expansion of the aliphatic region of the 500 MHz 1H NMR spectrum of 3 in CDCl3 
showing clearly the small coupling between d and the alkyne proton. 
 
The NMR spectrum of ligand 5 is shown in figure 2.7. Due to the nature 
of the spacer it was more difficult to assign the signals. Proton a could be 
easily assigned due to the fact that it appeared as a triplet as well as being 
the most downfield shifted. Proton e was also easy to assign based on the 
coupling to the alkyne proton as described for ligands 1, 2, and 3.  
 
Information from COSY NMR experiments made it possible to assign 
proton b since cross peaks could be seen to proton a. Likewise, c and d 
showed small cross peaks between them. These assignments are shown in 
figure 2.8.  
 
It was not possible to assign c and d from the COSY alone so NOESY 
experiments were crucial in determining which peak was c and which was d. 
A very weak cross peak could be observed between b and c due to their 
proximity to each other and it was therefore possible to assign c and d based 
on this.  An expansion of the region of the NOESY spectrum in question is 
shown in figure 2.9.  
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Figure 2.7: 500 MHz 1H NMR spectrum of ligand 5 in CDCl3. Protons c and d have very 
similar chemical shifts. X = residual CHCl3, I = impurities. 
 
 
Figure 2.8: Expansion of the aliphatic region of the 500 MHz COSY spectrum of 5 in CDCl3. 
Cross peaks between a and b can be clearly seen, cross peaks between c and d appear 
together. 
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Figure 2.9: Expansion of the 500 MHz NOESY spectrum of ligand 5 in CDCl3. The cross peak 
is very weak but shows the link between b and c. Signals marked X are due to breakthrough 
or noise. 
 
2.3.2  13C NMR spectroscopy 
 
Ligands were also characterised using 13C NMR spectroscopy. All 
experiments were run with proton decoupling. This means that all signals 
appear as singlets since coupling to neighbouring protons is removed. 
Carbons were assigned using HMQC (Heteronuclear Multiple Quantum 
Coherence) and HMBC (Heteronuclear Multiple Bond Coherence) 
experiments and a table of data is shown in table 2.2. HMQC shows coupling 
between a proton and a directly bound carbon or other heteroatom, whereas 
HMBC shows longer range coupling between 1H and 13C, over a range of 
between 2 and 4 bonds. 
 
 A2 A3 A4 A5 A6 B2 B3 B4 
1 157.3/ 155.9 121.4 136.8 123.9 149.1
157.3/
155.9 107.6 165.9 
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2 157.4/ 156.4 121.8 137.4 124.3 149.3
157.4/
156.4 107.9 167.6 
3 157.0/ 156.0 121.4 136.9 123.9 149.0
157.0/
156.0 107.4 167.4 
4 156.9/ 155.9 121.3 136.8 123.8 148.9
156.9/
155.9 107.7 167.0 
5 157.5/ 156.4 121.7 137.2 124.2 149.4
157.5/
156.4 107.8 167.3 
         
 a b c d e C≡CH C≡CH  
1 55.9     77.6 76.3  
2 66.8 28.4 15.5   83.6 69.5  
3 67.6 28.0 68.8 18.1  84.0 68.8  
4 67.9 69.9 72.8 61.7     
5 69.6 69.9 68.1 71.1 58.8 80.0 75.1  
 
Table 2.2: Table of 13C NMR spectroscopic data for ligands 1-5. Chemical shifts are shown in 
δ/ppm. 
 
 There was difficulty in assigning peaks A2 and B2 despite the use of 
HMQC and HMBC techniques. Both these methods are 2D experiments and 
show cross peaks between 1H and 13C nuclei. Usually, once the 1H spectrum 
has been assigned, HMQC can be used to assign the 13C spectrum since 
cross peaks are seen between protons and the 13C nuclei they are directly 
attached to.  
 
Both A2 and B2 are quaternary carbons and have no protons directly 
attached to them, so the use of HMQC alone to assign the peaks was not 
possible. HMBC provides information on the carbons which are indirectly 
attached to protons, that is, neighbouring carbon atoms. Unfortunately this still 
could not provide enough information and peaks A2 and B2 still remain 
unambiguously unassigned. Figure 2.10 shows the 13C spectrum of ligand 5. 
Aliphatic and aromatic 13C signals appear in a diagnostic region of the 
spectrum. 
 43
 
Figure 2.10: 125 MHz 13C NMR spectrum of ligand 5 in CDCl3 (X). 
 
 
Figure 2.11: 125 MHz 13C DEPT spectrum of 5 in CDCl3. 
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Quaternary peaks can be identified by their relatively low intensity 
compared to other peaks, as well as DEPT (Distortionless Enhancement by 
Polarisation Transfer) experiments. In the DEPT spectrum, peaks assigned to 
CH3 or CH groups appear pointing up, CH2 peaks are inverted and quaternary 
carbon peaks do not appear at all. The DEPT spectrum of ligand 5 is shown in 
figure 2.11. 
 
2.3.3  MALDI Mass Spectrometry 
 
 
 
Figure 2.12: MALDI mass spectrum of ligand 2 showing M+ = 316.49. The other peaks arise 
from 2(matrix), 3(matrix) and [M + 2(matrix)]+ where the matrix is α-Cyano-4-hydroxycinnamic 
acid (Mw = 189.17). 
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MALDI mass spectroscopy, (or matrix assisted laser 
desorption/ionization) was a useful tool for confirmation of the molecular mass 
to charge ratio of the ligands. This is a technique in which a laser is used to 
ionise the molecules in question and the molecular weight of the fragments 
determines their velocities as they pass down the chamber to the detector. 
Molecular ions are generated by loss of an electron or addition of a proton, 
sodium or potassium ion. 
 
In the MALDI mass spectrum of the ligands, peaks could often be seen 
for the molecular ion as well as sometimes the molecular ion plus sodium or 
potassium. Figure 2.12 shows the MALDI mass spectrum of ligand 2 which is 
typical. The base peak corresponds to the parent ion at m/z 316. The mass 
spectra of ligands 3 and 5 are similar and show the parent ion at m/z 330 and 
377 respectively. 
 
2.4 Synthesis of 4'-Phenyl-2,2':6',2"-Terpyridine 
Derivatives 
 
A different method was used for the synthesis of the phenyl-substituted 
tpy ligands and this is shown in figure 2.13. Here the phenyl ring is directly 
connected to the terpyridine ligand with no bridging oxygen so HO-tpy was 
not used as the starting material for this synthesis. Instead, a solvent free 
method5 was used to synthesise a bromo-substituted phenyl terpyridine using 
3-bromo, 3,5-dibromo or 4-bromobenzaldehyde with 2-acetylpyridine. In this 
method the reactants are ground together with NaOH until a powder is formed 
from the liquid starting materials. After washing the powder with water the ring 
closure step is carried out by heating a mixture of the powder and ammonium 
acetate in acetic acid to reflux for 2 hours. The reaction mixture is finally 
poured into water to precipitate the product. The product is then recrystallised 
from hot ethanol.  
 
Once these bromo-substituted ligands have been synthesised, the 
bromo functionality is converted to an alkyne. Ligands 6, 8, and 10 (figure 2.1) 
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were reacted with TMS-acetylene. Ligands 6 and 8 were converted to 7 and 9 
(figure 2.1) respectively, although there were problems with the conversion of 
10 into 11 and the synthesis of 11 using this method ultimately proved to be 
unsuccessful. Instead of obtaining a solid, off-white product as was the case 
for the mono-bromo compounds, a black solid (assumed to be polymeric) was 
obtained instead. This was completely insoluble in all solvents and remains 
uncharacterised. 
 
 
 
Figure 2.13: Synthesis of bromophenyl terpyridine ligands using a solvent free grinding 
method.5 
 
 The Sonogashira coupling12,13 reactions were all catalysed by 
[(Ph3P)2PdCl2] in the presence of triphenylphosphine and copper(I) iodide. 
First of all the bromo compounds were stirred in triethylamine with the 
catalyst, phosphine and copper(I) iodide while the reaction mixture was 
heated to 60 ˚C and cooled back to 40 ˚C. The TMS-acetylene was added 
and the reaction mixture was stirred at 40 ˚C for 7 days in total. After removal 
of the solvent the crude product was purified by chromatography, and the 
product was isolated as an off-white solid.  
 
The TMS protecting group was necessary in this synthesis to prevent 
the formation of polymers by the reaction at both ends of the acetylene. The 
protecting group was removed in the final step by dissolving the product in 
methanol and THF and stirring with K2CO3. After addition of water and 
CH2Cl2, the product was extracted into the CH2Cl2 layer, dried and (after 
removal of the solvent) isolated as an off-white solid. This method is reported 
in the literature for the formation of 4'-(4-ethynylphenyl)-2,2':6',2"-terpyridine3 
and the same method was employed for all these related ligands.  
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2.5 Characterisation 
 
2.5.1  1H NMR Spectroscopy 
 
The previously unknown ligand 9 was characterised by 1H NMR 
spectroscopy.  The chemical shifts of the known ligands 6, 7 and 8 were also 
recorded experimentally and the data are shown for comparison in table 2.3. 
The NMR spectroscopic data recorded are in good agreement with those 
reported in the literature for ligands 65,6 and 7.3 There were no reported NMR 
spectroscopic data in the literature for ligand 8, so the data are reported here 
for the first time. 
 
 A3 A4 A5 A6 B3 C2 C3 C4 C5 C6 C≡CH
6 8.70 7.93 7.41 8.76 8.74 7.75     
7 8.71 7.94 7.41 8.77 8.78 7.80    3.22 
8 8.58 7.84 7.33 8.66 8.59 8.00  7.53/
7.78 
7.33 7.53/ 
7.78 
 
9 8.67 8.04 7.54 8.77 8.68 8.08  7.75/
7.94 
7.55 7.75/ 
7.94 
4.34 
 
Table 2.3: 500 MHz 1H NMR chemical shifts (δ/ppm) for phenyl-tpy based ligands, in CDCl3 
for 6-8, DMSO-d6 for 9. 
 
 Due to the poor solubility of these ligands, it was necessary to run the 
NMR spectrum for ligand 9 in DMSO rather than CDCl3 in order to obtain well 
resolved spectra. Chemical shifts were assigned using COSY and NOESY 
techniques. Unfortunately there was still not enough information to assign 
protons C4 and C6. 
 
 Comparing the chemical shifts of 6 and 7 shows there is little 
difference in chemical shifts on going from the bromo to the alkyne 
compound. The larger difference in the chemical shifts of 8 and 9 is probably 
due to the effect of changing NMR solvent. It was not possible to purify ligand 
9 due to its poor solubility and some small impurities can still be seen in the 
NMR spectrum shown in figure 2.14. It is also possible to see in this spectrum 
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how peaks C5 and A5 overlap. COSY NMR was very important in 
distinguishing between these two signals. 
 
 
 
 
Figure 2.14: Expansion of the 500 MHz 1H NMR spectrum of ligand 9 in DMSO-d6 showing 
overlap of peaks C5 and A5. 
 
2.5.2  13C NMR Spectroscopy 
 
 13C NMR spectroscopy was once again a useful tool for 
characterisation of these phenyl substituted ligands. As was the case with the 
previous ligands, HMQC and HMBC techniques were essential in assigning 
each of the signals to a particular carbon atom. A table of data for the new 
ligand 9 and its precursor 8 is shown in table 2.4. 
 
 A2 A3 A4 A5 A6 B2 B3 B4 
8 155.8/ 155.9 121.3 136. 9 123.9 149.0
155.8/ 
155.9 118.7 123.1 
9 154.7/ 155.7 120.9 137.5 124.6 149.3
154.7/ 
155.7 118.1 122.6 
         
 C1 C2 C3 C4 C5 C6 C≡CH C≡CH 
8 140.5/ 148.7 130.4 
140.5/
148.7 
126.0/
131. 9 130.2
126.0/ 
131. 9   
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9 140.0/ 148.0 129. 5 
140.0/
148.0 
126.1/
132.2 131.5
126.1/ 
132.2 82.9 81.6 
 
Table 2.4: 500 MHz 13C NMR data for ligands 8 and 9, 8 in CDCl3, 9 in DMSO-d6. 
 
 The chemical shifts of both ligands 8 and 9 are very similar. The major 
difference between the NMR spectra is the change in the order of peaks C2 
and C5. However, a different solvent was used for each ligand due to the poor 
solubility of 9 so this could explain the difference in the order of these two 
peaks which occur very close together. Figure 2.15 shows how the peaks 
were assigned using HMBC in ligand 8. Cross peaks can clearly be seen 
between protons H(C4/C6) and  carbon C(C5). 
 
 
 
Figure 2.15: Expansion of part of the 500 MHz HMBC spectrum of ligand 8 in CDCl3 showing 
cross peaks between H(C4/C6) and C(C5). 
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2.5.3  MALDI Mass Spectrometry 
 
 Ligand 9 was also characterised using MALDI mass spectrometry. A 
peak was seen at m/z 395 corresponding to [M + K + Na]+.  
 
2.6 Synthesis of Ligand 12 
 
A further alkyne-functionalised tpy ligand has also been synthesised. It 
was originally felt that this ligand would not be a suitable precursor for the self 
assembly of metallomacrocycles, however, it did have three alkyne moieties 
and was therefore deemed potentially useful in the formation of metal-alkyne 
complexes (discussed in chapter 4). 
 
The synthesis of this ligand was not entirely straightforward (figure 
2.16). The starting ligand was 4'-[1,1,1-tris(hydroxymethyl)methoxy]-2,2':6',2"-
terpyridine,14 and this has three pendant alcohol groups at which reaction to 
form the alkyne functionalised ligand can occur. A stronger base was needed 
than in the synthesis of ligand 1 from HO-tpy since the alcohol groups are 
now further removed from the tpy moiety. There were problems in obtaining 
the tris-alkyne ligand since there was always a significant amount of the 
mono- and bis- alkyne ligands produced and purification by chromatography 
on alumina using 0.5 % MeOH in CHCl3 was possible, though difficult. The 
tris-alkyne product was finally obtained, though in a low yield (23 %), by the 
use of a large excess of propargyl bromide. Use of stoichiometric quantities 
produced the mono- or bis-alkyne ligands as the major products. 
 
 
Figure 2.16: Synthesis of ligand 12. 
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 As ligand 12 was not originally intended to be used in the formation of 
metallomacrocycles, only minimal characterisation data has been obtained 
and this is reported in Chapter 6. 
 
2.7 Crystal Structures 
 
2.7.1 Ligand 1 
 
Single crystals suitable for X-ray crystallographic analysis were grown 
from a CH2Cl2 solution of 1 layered with hexane. An ORTEP representation of 
1 is shown in figure 2.17 and figure 2.18 shows the packing of the molecules. 
Crystal data are given in the appendix and selected bond lengths and angles 
are given in table 2.5. Torsion angles of the tpy ligand are also shown in table 
2.5.  
 
Like most other uncoordinated 2,2':6',2"-terpyridine ligands, ligand 1 
exists in a trans, trans conformation which minimises the interactions between 
lone pairs on each of the nitrogen atoms.15 Ligand 1 deviates slightly from 
planarity, with torsion angles between the adjacent pyridine rings (defined in 
table 2.5) of 1.0(1) and 7.8(1) ˚ respectively. The bonds linking the rings of the 
tpy compare very well with similar systems such as the unsubstituted 
2,2':6',2"-terpyridine, with C5-C6 having a length of 1.4879(16) and C10-C11 
a length of 1.4901(16) Å. Bond angles in the tpy rings are also comparable 
with those in the same unsubstituted tpy.16 
 
 Hydrogen bonds of length 2.582 Å can be seen between N3 of one 
molecule and H18 of another, so that two ligand molecules are arranged in a 
pair. There is also hydrogen bonding between H16 of one ligand molecule 
and both O1 and C17 of another ligand molecule lying above. There is π-
stacking (3.5 Å) between planes.  
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Figure 2.17: ORTEP representation of ligand 1. Hydrogen atoms are omitted for clarity. 
 
 
Figure 2.18: Molecules of ligand 1 arrange themselves into dimers held together by hydrogen 
bonds between H18 of one molecule and N3 of another. 
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Bond Distance/Å Bond Distance/Å 
N1-C5 1.3469(15)     C6-C7 1.3916(16)     
C4-C5 1.3955(16)     C10-C9 1.3961(16)     
C5-C6 1.4879(16)     C7-C8 1.3894(15)     
N3-C11 1.3433(15)     C9-C8 1.3893(16)     
C12-C11 1.3938(16)     C8-O1 1.3642 (13) 
C11-C10 1.4901(16)     O1-C16 1.4406 (14) 
N2-C6 1.3482(14)     C16-C17 1.4647 (18) 
N2-C10 1.3413(14)     C17-C18 1.1838 (19) 
    
Bonds Angle/deg. Bonds Angle/deg. 
C1-N1-C5 117.77(11)     C11-C10-N2 116.41(10)     
N1-C5-C6 116.59(10)     C7-C8-O1 115.56(10)     
C5-C6-N2 116.57(10)     C8-C9-O1 124.73(10)     
C6-N2-C10 117.37(10)     C8-O1-C16 117.79(9)     
C11-N3-C15 117.59(11)     O1-C16-C17 113.24(11)     
N3-C11-C10 116.67(10)     C16-C17-C18 176.69(14)     
    
N1-C5-C6-N12 1.0(1) N2-C10-C11-N3 7.8(1) 
 
Table 2.5: Selected bond lengths (Å), angles (˚) and torsion angles (˚) for ligand 1. 
 
2.7.2 Ligand 2 
 
Single crystals of ligand 2 which were suitable for X-ray 
crystallographic studies were grown from a solution of 2 in CH2Cl2 layered 
with hexane. An ORTEP representation is shown in figure 2.19 as well as the 
packing of the molecules in figure 2.20 and selected bond parameters are 
given in table 2.6. Crystal data are given in the appendix.  
 
Once again the tpy ligand is in a trans, trans arrangement and there 
are torsion angles (defined in table 2.6) of 2.2(1) and 14.4(1) ˚ between the 
pyridine rings. This ligand also displays bond lengths which are comparable to 
the reported structure for the free 2,2':6',2"-terpyridine.16  
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Ligand 2 differs from 1 in the way its molecules are arranged in the 
solid state. There is a hydrogen bond of 2.3 Å between N1 of one molecule 
and H20 of another, but this time the molecules are not arranged in pairs, 
rather there is a zig-zag type of arrangement between molecules. Zig-zag 
chains of ligand molecules are stacked in planes (figure 2.21) and there is π-
stacking of 3.4 Å between the least squares planes. 
 
Figure 2.19: ORTEP representation of ligand 2. Hydrogen atoms have been omitted for 
clarity. 
 
Figure 2.20: Arrangement of ligand 2 molecules in a zig-zag arrangement. This ligand does 
not arrange its molecules in dimers although hydrogen bonding does occur between H20 of 
one molecule and N1 of another. 
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Figure 2.21: Zig-zag chains of ligand 2 molecules are arranged in planes which display π-
stacking. 
 
Bond Distance/Å Bond Distance/Å 
N1-C5 1.343(2)     C6-C7 1.381(2)     
C4-C5 1.382(2)     C10-C9 1.388(2)     
C5-C6 1.492(2)     C7-C8 1.398(2)     
N3-C11 1.342(2)     C9-C8 1.385(2)     
C12-C11 1.389(2)     C8-O1 1.3560(19)     
C11-C10 1.494(2)     O1-C16 1.435(2)     
N2-C6 1.351(2)     C16-C17 1.507(2)     
N2-C10 1.338(2)     C17-C18 1.526(2)     
C18-C19 1.468(2)       
    
Bonds Angle/deg. Bonds Angle/deg. 
C1-N1-C5 116.93(16)     C11-C10-N2 115.80(14)     
N1-C5-C6 116.68(14)     C7-C8-O1 115.73(14)     
C5-C6-N2 116.68(14)     C8-C9-O1 125.14(15)     
C6-N2-C10 117.26(14)     C8-O1-C16 118.27(12)     
C11-N3-C15 117.13(15)     O1-C16-C17 106.90(12)     
N3-C11-C10 116.25(15)     C16-C17-C18 111.55(13)     
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C17-C18-C19 111.78(13)     C18-C19-C20 177.20(17)     
    
N1-C5-C6-N2 2.2(1) N2-C10-C11-N3 14.4(1) 
 
Table 2.6: Selected bond lengths (Å), angles (˚) and torsion angles (˚) for ligand 2. 
 
2.7.3 Ligand 3 
 
The crystallisation of ligand 3 was achieved using two different solvent 
systems. X-ray quality crystals were obtained from a layered solution of 
CH2Cl2/hexane (a) as well as hot EtOH (b). Two solvent-free polymorphs 
were obtained. An ORTEP representation of ligand 3a is shown in figure 2.22. 
At the molecular level, the structures of both polymorphs are very similar and 
as before, the rings of the tpy are in a trans, trans arrangement in both 
polymorphs. Bond parameters are shown in table 2.7. Crystal data for both 
polymorphs are given in the appendix. Bond lengths and angles in both a and 
b compare well with the published structure of the unsubstituted 2,2':6',2"-
terpyridine.16  
 
The major difference between the two forms is in the molecular 
packing. The crystals of 3a, grown from a solution of 3 in CH2Cl2 layered with 
hexane were colourless plates. Ligand molecules form dimers due to 
hydrogen bonding between the alkyne H atom of one molecule and one of the 
tpy nitrogens of another molecule. These dimers arrange themselves into 
layers (shown in figure 2.23) and layers are all parallel to one another, with 
the b axis of the unit cell running parallel to these layers.  
 
The crystals grown from hot EtOH, 3b, were colourless prisms and 
once again molecules are arranged in dimers with the same type of hydrogen 
bonding between molecules as in 3a. However, in this structure, the dimers 
are arranged orthogonal to one another, shown in figure 2.24. 
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Figure 2.22: An ORTEP representation of ligand 3a. Crystals here were grown from a solution 
of 3 in CH2Cl2 layered with hexane. 
 
Figure 2.23: Packing of molecules of ligand 3a. Crystals grown from a solution of 3 in CH2Cl2 
layered with hexane. Ligand molecules shown here are hydrogen bonded in dimers with all 
sets of dimers forming the same layer.  
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Figure 2.24: packing of molecules of ligand 3b. Crystals grown from hot EtOH. Once again 
molecules are arranged as dimers (top) though here dimers are arranged perpendicular to 
one another (bottom). 
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Bond Distance/Å Distance/Å Bond Distance/Å Distance/Å 
 a b  a b 
N1-C5 1.342(3)     1.338(2)     C6-C7 1.393(3)     1.389(2)     
C4-C5 1.391(3)     1.385(2) C10-C9 1.381(3)     1.379(2)     
C5-C6 1.489(3)     1.488(2)     C7-C8 1.383(3)     1.388(2)     
N3-C11 1.345(3)     1.343(2)     C9-C8 1.390(3)     1.384(2)     
C12-C11 1.378(3)     1.386(2)     C8-O1 1.356(2)     1.3532(19)   
C11-C10 1.488(3)       1.481(2)     O1-C16 1.432(3)     1.433(2)     
N2-C6 1.339(3)     1.329(2)     C16-C17 1.510(3)     1.504(2)     
N2-C10 1.349(3)     1.346(2)     C17-C18 1.520(3)     1.515(2)     
C18-C19 1.526(3)     1.522(3)     C19-C20 1.467(3)     1.462(3)     
C20-C21 1.180(3)     1.169(3)        
      
Bonds Angle/deg. Angle/deg. Bonds Angle/deg. Angle/deg. 
C1-N1-C5 117.5(2)    116.84(16)   C11-C10-N2 116.16(19)   115.20(14)   
N1-C5-C6 116.80(19)   116.48(15)   C7-C8-O1 125.2(2)     124.35(16)   
C5-C6-N2 115.76(18)   115.77(15)   C8-C9-O1 115.85(19)   116.11(14)   
C6-N2-C10 116.99(18)   117.61(14)   C8-O1-C16 118.67(17)   118.54(13)   
C11-N3-C15 116.9(2)     116.75(16)   O1-C16-C17 106.38(19)   106.62(14)   
N3-C11-C10 116.3(2)     116.97(15)   C16-C17-C18 113.70(19)   112.43(15)   
C17-C18-C19 109.91(19)   110.65(15)   C18-C19-C20 116.1(2)     113.74(17)   
C19-C20-C21 176.1(3)     179.5(2)        
      
N1-C5-C6-N2 1.2(2) 9.1(2) N2-C10-C11-N3 7.7(2) 12.7(2) 
 
Table 2.7: Selected bond lengths (Å), angles (˚) and torsion angles (˚) for both the CH2Cl2 (a) 
and EtOH (b) polymorphs of ligand 3.  
 
The thermal behaviour of the EtOH polymorph 3b was also 
investigated. On heating a sample of 3b at a rate of 2 ˚C per minute a phase 
change was seen at a temperature of 98 ˚C. Further heating of the sample up 
to a temperature of 110 ˚C resulted in no further changes. Cooling the sample 
back down, also at a rate of 2 ˚C per minute did not show any phase changes. 
If the sample was then heated once again, this time from 60 ˚C rather than 
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room temperature, a different phase change to that observed during the first 
heating cycle was seen, at a temperature of 83 ˚C. If this sample is then 
allowed to return to room temperature naturally and allowed to rest for several 
hours, the same cycle of phase changes can be observed and this is 
reproducible for each heating and cooling cycle. It is possible that this 
observation is due to the formation of a third, metastable polymorph which is 
formed on slow cooling of the sample back to 60 ˚C.17,11 The TGA curve of the 
heating and cooling cycles of 3b can be seen in figure 2.25. Temperature and 
time are shown on the x axis and two peaks can be clearly seen, one resulting 
from a phase change at 98 ˚C on the first heating cycle and the second from a 
phase change at 83 ˚C on the second heating cycle. 
 
 
 
Figure 2.25: TGA trace of 3b showing the two phase changes on heating and cooling. 
 
Crystals of 3b were observed under a polarising microscope. It was 
noted that on reaching a temperature just below 98 ˚C, the first phase change 
on the TGA trace, liquid crystalline behaviour was observed. Liquid crystals in 
which this behaviour is seen between a certain temperature range are called 
thermotropic and this type of liquid crystalline phase is a nematic one.18 
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Nematic phase liquid crystals are the most liquid-like of all the types. 
One or two molecular axes are oriented parallel to one another and this 
means that this type of phase has an orientational long range order. 
Molecules of a nematic phase are typically long and linear and have rotational 
freedom about the long molecular axis. Figure 2.26 shows the different 
phases and the degree of molecular order in each. 
 
 
Figure 2.26: Molecular order on going from solid to liquid crystal to liquid phase. 
 
Because of the parallel nature of nematic phase liquid crystals, these 
molecules possess an optical anisoptropy, or double refraction. The optical 
axis is parallel to the long molecular axis and if a polarising microscope is 
used to observe the liquid crystal behaviour, different textures can be 
observed depending on the orientation of the liquid crystal phase.  Figure 2.27 
shows a photograph of liquid crystals of 3b taken down a polarising 
microscope. The typical nematic “thread like” pattern can be clearly seen, this 
pattern being the one which originally gave rise to the term “nematic”. 
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Figure 2.27: Photograph of liquid crystals of 3b taken down a polarising microscope. 
 
2.7.4 Ligand 5 
 
X-ray quality crystals of ligand 5 were grown from a CDCl3 solution of 
5. An ORTEP representation is shown below in figure 2.28 and the packing of 
the molecules can be seen in figure 2.29 Once again, since this ligand is 
uncoordinated, the nitrogen atoms of the tpy rings are in a trans, trans 
arrangement. Again the bond lengths and angles compare well with those 
reported for the unsubstituted 2,2':6',2"-terpyridine.16 Figure 2.29 shows the 
arrangement of pairs of molecules in dimers, due to hydrogen bonds of length 
2.26 Å between H22 of one molecule and N3 of another. The presence of 
several oxygen atoms in this ligand means that there is also hydrogen 
bonding between H17 of one molecule and O3 (2.612 Å) of the other. Dimers 
are stacked on top of each other in a chair like conformation and stacks of 
chairs run perpendicular to one another. The tpy regions of the stacks are not 
in close enough proximity to one another to permit any π-stacking 
interactions. Selected bond parameters are shown in table 2.8.  
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Figure 2.28: ORTEP representation of ligand 5. Hydrogen atoms are omitted for clarity. 
 
 
 
 
Figure 2.29: Arrangement of molecules of ligand 5 in dimers due to hydrogen bonding 
between H22 of one molecule and N3 of another. Dimers are arranged perpendicular to 
one another. 
 
Bond Distance/Å Bond Distance/Å 
N1-C5 1.337(3)     C6-C7 1.371(3)     
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C4-C5 1.390(3)     C10-C9 1.388(3)     
C5-C6 1.479(3)     C7-C8 1.386(3)     
N3-C11 1.334(3)     C9-C8 1.391(3)     
C12-C11 1.383(3)     C8-O1 1.351(3)     
C11-C10 1.495(3)     O1-C16 1.422(3)     
N2-C6 1.342(3)     C16-C17 1.489(3)     
N2-C10 1.332(3)     C17-O2 1.419(3)     
C18-C19 1.500(4)     O2-C18 1.410(3)     
C19-O3 1.392(3)     O3-C20 1.415(4)     
C20-C21 1.466(4)     C21-C22 1.170(4)     
    
Bonds Angle/deg. Bonds Angle/deg. 
C1-N1-C5 116.9(2)     C11-C10-N2 115.30(19)     
N1-C5-C6 117.3(2)     C7-C8-O1 116.19(18)     
C5-C6-N2 115.51(19)     C8-C9-O1 124.5(2)     
C6-N2-C10 117.73(19)     C8-O1-C16 117.93(16)     
C11-N3-C15 117.4(2)     O1-C16-C17 108.00(18)     
N3-C11-C10 117.1(2)     C16-C17-O2 108.8(2)     
C17-O2-C18 110.6(2)     O2-C18-C19 109.6(3)     
C18-C19-O3 111.0(2)     C19-O3-C20 112.2(2)     
O3-C20-C21 112.1(3)     C20-C21-C22 177.5(3)     
    
N1-C5-C6-N2 12.5(2) N2-C10-C11-N3 6.5(2) 
 
Table 2.8: Selected bond lengths (Å), angles (˚) and torsion angles (˚) of ligand 5. 
 
2.8 Conclusion 
 
Several different tpy ligands have been synthesised and their NMR 
spectroscopic and mass spectrometric characteristics have been discussed in 
this chapter. X-ray crystal structures have been obtained for most of the 
ligands.  
 
 
 
 65
2.9 References 
 
 
1 H. Hofmeier and U. S. Schubert, Chem. Soc. Rev., 2004, 33, 373 and 
references therein. 
2 D. Armspach, E. C. Constable, C. E. Housecroft, M. Neuburger and M. 
Zehnder, J. Organomet. Chem., 1998, 550, 193. 
3 E. C. Constable, C. E. Housecroft, L. A. Johnston, D. Armspach, M. 
Neuburger and M. Zehnder, Polyhedron, 2001, 20, 483. 
4 D. Armspach, E. C. Constable, F. Diederich, C. E. Housecroft and J.-F. 
Nierengarten, Chem. Eur. J., 1998, 4, 723. 
5 G. W. Cave and C. L. Raston, J. Chem. Soc. Perkin Trans., 2001, 3258. 
6  W. Spahni and G. Calzaferri.  Helv. Chim. Acta,  1984,  67,  450. 
7 S. Bonnet, J.-P. Collin and J.-P. Sauvage, Chem. Commun., 2005, 3195. 
8 C. Patoux, J.-P. Launay, M. Beley, S. Chodorowski-Kimmes, J.-P. Collin, S. 
James and J.-P. Sauvage, J. Am. Chem. Soc., 1998, 120, 3717. 
9 E. C. Constable and M. D. Ward, J. Chem. Soc. Dalton Trans., 1990, 1405. 
10 B. G. Lohmeijer and U. S. Schubert, J. Polym. Sci. Part A. Polym. Chem., 
2003, 41, 1413. 
11 E. C. Constable, C. E. Housecroft, M. Neuburger, S. Schaffner and E. J. 
Shardlow, CrystEngComm., 2005, 7, 599. 
12 K. Sonogashira, Y. Tohda and N. Hagihara, Tetrahedron. Lett., 1975, 4467. 
13 K. Sonogashira, J. Organomet. Chem., 2002, 653, 46. 
14  E. C. Constable, C. E. Housecroft, M. Cattalini and D. Phillips, New J. 
Chem., 1998, 22, 193. 
15 A. M. W. Cargill Thompson, Coord. Chem. Rev., 1997, 160, 1. 
16 C. A. Bessel, R. F. See, M. R. Churchill and K. J. Takeuchi, J. Chem. Soc. 
Dalton Trans., 1992, 3223. 
17 B. Perrenot and G. Widmann, Thermochim. Acta, 1994, 234, 31. 
18 H. Stegemeyer, Topics in Physical Chemistry, Vol. 3: Liquid Crystals, 
Steinkopff Darmstadt, 1994. 
 66
Chapter 3 Platinahomoditopic Ligands 
 
3.1 Platinum(II) Alkynyl Complexes 
 
Platinum(II) alkynyl complexes are well studied in the literature 
because of their interesting luminescence properties. These compounds have 
more recently been investigated as potential molecular wires and sensors due 
to the increasing demands for new materials for the electronics industry.1,2,3  
 
This chapter describes the synthesis of several platinahomoditopic 
ligands from various alkyne-functionalised terpyridine ligands, the synthesis of 
these ligands having been discussed in Chapter 2. By coupling two terpyridine 
ligands to a platinum centre via their alkyne functionality, a platinahomoditopic 
ligand can be created, that is to say a platinum-containing ligand with two 
identical sets of donor atoms. All of the platinum complexes described have a 
square planar geometry and a trans configuration. They differ in the nature of 
the spacer between the alkyne and the terpyridine, some are more flexible 
than others, and some are completely rigid. Auxiliary ligands are various 
phosphines, PEt3, PnBu3 and PPh3. PiPr3 and PCy3 were also tried but with no 
success. These are varying sizes and have different Tolman cone angles.  
 
 
Figure 3.1: Representation of the Tolman cone angle, θ. The blue spheres represent the 
space taken up by an R group. 
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The cone angle is a measure of the steric bulk of the phosphine and is 
found by estimating the angle of a cone formed by taking the metal atom to be 
the apex of the cone.4 Figure 3.1 shows how the Tolman cone angle is 
derived and table 3.1 shows cone angles for the phosphine groups discussed 
in this chapter. 
 
Phosphine Tolman Cone Angle 
PEt3 132 
PnBu3 132 
PPh3 145 
PiPr3 160 
PCy3 170 
 
Table 3.1: Tolman cone angles (˚) for selected phosphine ligands. 
 
3.2 Synthesis of Platinahomoditopic Ligands 
 
As described in Chapter 1, there are a number of methods for 
synthesising platinum(II) alkynyl complexes. Most of the literature examples 
use a copper(I) iodide catalyst with a base such as triethylamine, and this is 
the method used for the synthesis of the platinahomodiopic ligands discussed 
in this chapter. Figure 3.2 shows the nomenclature and numbering scheme for 
the homoditopic ligands discussed in this chapter. 
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Figure 3.2: Numbering scheme for platinahomoditopic ligands. 
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Alkyne functionalised tpy ligands have two potential moieties for 
reaction with platinum(II). Either the reaction can take place at the alkyne as 
desired, or alternatively complexation of the tpy can occur with platinum(II), 
leaving the alkyne free. All of the reactions described later in this chapter 
produced the desired reaction at the alkyne with no evidence of coupling to 
the tpy. It is thought that this coupling reaction proceeds via the formation of a 
copper(I) alkynyl complex as an intermediate. The exact mechanism is not 
known, but figure 3.3 shows the proposed reaction scheme for the process.5 
 
 
Figure 3.3: Proposed reaction scheme5 for the CuI catalysed formation of M-alkyne 
bonds. For syntheses discussed in this chapter, M = Pt(II), X = I and HNEt2 was replaced by 
NEt3. 
 
The synthesis of the platinahomoditopic ligands described in this 
chapter can be straightforward. An excess of the alkyne functionalised tpy 
ligand along with a PtI2(PR3)2 complex and a catalytic amount of copper(I) 
iodide is stirred at room temperature for 5 days in a 50:50 mixture of CH2Cl2 
and NEt3 (figure 3.4). It is important for all the reactants to be soluble in the 
solvent chosen which is why it was necessary to add CH2Cl2 to the NEt3. If the 
reactants are not soluble enough, then the reaction does not proceed to 
completion and sometimes not at all. The use of CH2Cl2 can occasionally 
cause problems. X-ray crystal structures obtained from the reaction of 
PtI2(PCy3)2 with ligand 3 have shown that the CH2Cl2 is able to take part in a 
reaction with the starting platinum complex and results in the formation of a 
platinum bis-chloride bis-phosphine complex. Since chloride ligands are 
significantly less labile than iodide, this can prevent subsequent substitution of 
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the alkyne tpy ligand and if this is the case, the formation of the 
platinahomoditopic ligand is not observed. Other solvent systems have been 
investigated, such as a mixture of THF, DMF and NEt3, though these were 
more problematic in terms of the purification of the final product. Products 
resulting from reactions where this solvent system was used were usually oily 
due to the presence of remaining solvent which is difficult to remove and 
therefore the CH2Cl2/NEt3 mixture was the solvent system of choice for most 
of these reactions. 
 
 
Figure 3.4: The synthesis of platinahomoditopic ligands6 
 
As well as the correct choice of solvent system, around 4 or 5 
equivalents of the tpy ligand is usually necessary in order to ensure the 
reaction goes to completion. Using a stoichiometric amount of tpy sometimes 
results in the formation of a mixture of products, both the mono- and bis- 
complexes as well as some remaining unreacted bis-iodide complex. Proton 
NMR spectroscopy is a useful tool for monitoring the reaction, especially in 
the reaction of ligand 5 with PtI2(PEt3)2.7 There is a significant change in the 
chemical shift of the e protons on going from free ligand to the mono and 
finally the bis complex and if there is still a significant quantity of the mono 
complex the reaction can be left to react for a few more days. 31P NMR is also 
a useful tool for characterisation of the complexes since the presence of 
platinum satellites confirms coordination at the platinum centre. The coupling 
constants between the two satellite peaks can be used to determine the 
geometry at the metal centre since coupling of around 2300 Hz shows a trans 
geometry and coupling of around 3000 Hz shows a cis geometry. The NMR 
spectra of all the platinum complexes synthesised are discussed in more 
detail in Section 3.3.  
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Ligand 3 (figure 3.5) was used in attempts to synthesise Pt(3-
H)2(PCy3)2. This time, the phosphines are very sterically hindered due to the 
presence of the cyclohexyl groups and it was thought that by using ligand 3 
where the spacer is longer than in 1 or 2 there would still be enough distance 
between the platinum(II) centre and the bulky tpy groups for the reaction to 
occur. Unfortunately this was not the case and crystals obtained from the 
products of the reaction confirmed the formation of PtCl2(PCy3)2.8 This could 
possibly be due to the fact that the reaction between the alkyne and the 
platinum(II) either does not occur at all or occurs very slowly, leaving more 
time for the substitution of the iodide by chloride which comes from the CH2Cl2 
solvent used in the reaction. Once the chloride substitution has taken place 
there is even less chance for reaction between alkyne and platinum(II) to 
occur since, as discussed already, the chloride is much less labile than the 
iodide ligand.  
 
 
Figure 3.5: Ligand 3 was used in attempts to synthesise Pt(3-H)2(PCy3)2. 
 
Attempts to synthesise Pt(2-H)2(PEt3)2 from ligand 2 (figure 3.6) and 
PtI2(PEt3)2 were also unsuccessful. 31P NMR spectra showed the presence of 
3 P-Pt environments, one which was identified as being the starting material 
PtI2(PEt3)2. The major environment in the 31P spectrum came at δ 11.3 ppm. 
This is similar to the literature values9,10 for Pt(CCR)2(PEt3)2 (R = H and CH3) 
The presence of a signal at δ 12 ppm in the 1H NMR spectrum was 
reminiscent of the signal arising from the NH group of the tautomer of HO-tpy 
seen in the NMR spectrum of HO-tpy suggesting there had also been 
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cleavage at the ether bond of the ligand. Attempts to separate the fractions 
were unsuccessful. 
 
 
Figure 3.6: Ligand 2 was used in attempts to synthesise Pt(2-H)2(PEt3)2. 
 
When ligand 7 (figure 3.7) was first used in attempts to synthesise a 
rigid platinum complex from the reaction with PtI2(PPh3)2 the solvent used was 
NEt3 only. This ligand was much less soluble than 1 and after a while an 
orange precipitate formed in the reaction vessel. This was collected by 
filtration and found to be virtually insoluble in water as well as all common 
organic solvents. It was not possible to record an NMR spectrum due to its 
insolubility although the IR spectrum did show peaks similar to those of the 
free ligand suggesting the resulting compound was in some way related.  
 
 
Figure 3.7: Ligand 7 was used in attempts to synthesise Pt(7-H)2(PPh3)2. 
 
 
A saturated solution of the orange product in CH2Cl2 layered with 
hexane produced crystals suitable for X-ray diffraction studies and the 
structure was confirmed as a copper(I) complex11 containing two copper 
atoms coordinated to the nitrogen atoms of the tpy. The crystal structure of 
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this product is discussed later in the chapter in Section 3.4. It was interesting 
to note that there was no platinum in the product and that the 
triphenylphosphine ligands which had previously been coordinated to the 
platinum(II) had now migrated to the copper(I). The alkyne moiety remained 
uncoordinated. Figure 3.8 shows the X-ray crystal structure of the resulting 
copper(I) complex. Hydrogen atoms have been omitted for clarity. 
 
 
Figure 3.8: Structure of the cation [Cu2(PPh3)2(μ-I)(μ-7)]+ from X-ray determination of the 
iodide salt. Hydrogen atoms have been omitted for clarity. 
 
 This result was then investigated further using a stoichiometric amount 
of copper(I) iodide rather than a catalytic amount and the formation of the 
same orange precipitate was again observed. This unexpected result 
suggests that formation of copper(I) complexes is in competition with the 
formation of platinum(II) complexes and that platinum(II) complex formation 
only occurs when the tpy ligand is highly soluble. A similar platinum(II) 
complex, Pt(7-H)2(PEt3)2, was finally achieved by the use of a THF/DMF/NEt3 
solvent system, however attempts to purify the product by crystallisation from 
 74
a saturated solution of the product in CH2Cl2 layered with hexane produced 
the same insoluble orange solid seen in the original reaction and no crystals 
of the platinum(II) complex. Likewise, the use of PtI2(PnBu3)2 in the reaction 
with ligand 7 produced similar results though the product was even less 
soluble than its ethyl counterpart and attempts at purification again produced 
an insoluble orange solid. 
 
Figure 3.9: Mono and bis Pt(II) complexes formed from the reaction of ligand 5 with 
PtI2(PEt3)2 in different solvent combinations. Using a large excess of ligand 5 facilitates the 
formation of the bis complex. 
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Purification of the platinahomoditopic ligands can normally be achieved 
by column chromatography. The solid phase is alumina and a mixture of 
CH2Cl2 and acetone is used as the eluent. Usually a quantity of 1 % acetone 
is used which is sufficient to elute the excess ligand first. This can be 
recovered and can be used again. Increasing the quantity of acetone in the 
eluent to about 5 % then elutes the product. If there is any mono complex 
(PtI(L-H)(PR3)2, where L is an alkyne substituted tpy ligand) in the mixture, 
this is eluted after the free ligand but before the bis complex. All tpy containing 
fractions can be detected by spotting a small amount on an alumina covered 
TLC plate dipped in an aqueous solution of FeCl2.4H2O. If the spot appears 
purple, this confirms the presence of a tpy containing fraction. The product is 
eluted as the second or third fraction, depending on if there is any of the mono 
complex present. Once the solvent is removed from the separated fractions, 
the product is isolated as a white solid or oil in yields ranging from 38 % for 
Pt(5-H)2(PEt3)2 to 71 % for Pt(1-H)2(PEt3)2. In early trial reactions the mono 
complex PtI(5-H)(PEt3) was isolated from the reaction mixture when the 
solvent mixture used in the reaction was THF/DMF/NEt3. Figure 3.9 shows the 
mono and bis complexes formed during the reaction of ligand 5 with 
PtI2(PEt3)2.  
 
Since the goal of this work is ultimately to synthesise heterometallic 
macrocycles containing both platinum(II) and iron(II), attempts were also 
made to take an iron(II) tpy complex bearing pendant alkyne moieties and 
couple this to a platinum(II) centre using the afore-mentioned methodology. 
This was attempted using the complex [Fe(5)2][PF6]2, the synthesis and 
characterisation of this iron(II) complex is discussed in Chapter 5. On workup 
of the reaction mixture and analysis of the products it was clear to see from 
the absence of the 31P NMR signal corresponding to the PtI2(PEt3)2 starting 
material as well as loss of the diagnostic triplet signal of the alkyne proton in 
the 1H NMR that reaction of the platinum(II) centre had taken place. There 
were several different environments in the 31P NMR spectrum and, from the 
different JPtP values, it could be seen that these included products with both 
cis and trans geometries. Attempts to separate the products by 
chromatographic methods were made and the 1H NMR spectra of the 
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fractions obtained were recorded. It was suggested from analysis of the 
spectra obtained that reaction had taken place at the platinum(II) centre, 
however, only at the expense of cleavage of the polyethyleneoxy chain. The 
products observed in the 1H NMR spectra of the fractions were cleavage 
products and it was concluded therefore that this was not a viable method for 
the formation of heterometallic macrocycles.7 
 
3.3 Characterisation 
 
3.3.1  1H NMR Spectroscopy 
 
The homoditopic ligands Pt(1-H)2(PEt3)2, Pt(1-H)2(PnBu3)2, Pt(5-
H)2(PEt3)2 and Pt(7-H)2(PEt3)2 were characterised by 1H NMR spectroscopy in 
a CDCl3 solution. Pt(1-H)2(PPh3)2 was recorded in C6D6 solution due to its 
poorer solubility in chloroform. The protons in the aromatic region of the 
spectra all correspond to signals from the tpy ligands discussed in Chapter 2. 
As with the free tpy ligands, the aliphatic region differs between ligands with 
the varying numbers of CH2 groups. The signal, which in the free ligand 
corresponds to the terminal alkyne functionality, is missing since the alkyne is 
now bound to the platinum(II) centre. This is a very useful indication of Pt-C 
bond formation and any free ligand impurities can easily be seen in the 1H 
NMR spectra. Another useful indication of successful Pt-C bond formation is 
the signal corresponding to proton e. In the free ligand this appears as a 
doublet due to coupling to the alkyne proton. In the platinum complex the 
same signal now appears as a triplet as well as being shifted downfield 
slightly. Figure 3.10 shows an expansion of the aliphatic region of the proton 
NMR of Pt(5-H)2(PEt3)2. The signal for proton e can be clearly seen as well as 
a small doublet to higher field which arises from a small amount of free ligand 
still in the sample. Chemical shifts were assigned using COSY and NOESY 
experiments although with these techniques alone it was not possible to 
distinguish between protons c and d.  Table 3.2 shows the 1H chemical shifts 
for the platinahomoditopic ligands synthesised in this chapter, all recorded in 
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CDCl3 apart from Pt(1-H)2(PPh3)2 and Pt(7-H)2(PnBu3)2 which were recorded 
in C6D6. 
 
 
 
Figure 3.10: Expansion of the 500 MHz 1H NMR of Pt(5-H)2(PEt3)2 in CDCl3 showing the 
aliphatic region. The peak for the e protons can be clearly seen to be a triplet rather than a 
doublet as in the free ligand. An impurity arising from the uncoordinated ligand 5 is marked I. 
 
 A3 A4 A5 A6 B3     
Pt(1-H)2(PEt3)2 8.58 7.82 7.30 8.65 8.06     
Pt(1-H)2(PnBu3)2 8.58 7.82 7.30 8.65 8.05     
Pt(1-H)2(PPh3)2 8.74 7.30 6.70 8.38 8.33     
PtI(5-H)(PEt3)2 8.66 7.89 7.37 8.72 8.08     
Pt(5-H)2(PEt3)2 8.52 7.84 7.33 8.67 8.03     
Pt(7-H)2(PEt3)2 8.73 7.88 7.38 8.67 8.73     
Pt(7-H)2(PnBu3)2 8.77 7.34 6.79 8.61 9.18     
          
 a b c d e w x y z 
Pt(1-H)2(PEt3)2 4.96       1.83 0.88
Pt(1-H)2(PnBu3)2 4.94     1.85 1.33 1.25 0.77
Pt(1-H)2(PPh3)2 4.18      6.95 
PtI(5-H)(PEt3)2 4.44 3.98 3.77 3.73 4.29   2.18 1.15
Pt(5-H)2(PEt3)2 4.39 3.93 3.74 4.26   2.03 1.10
          
 C2 C3    w x y z 
 78
Pt(7-H)2(PEt3)2 7.41/ 
7.81 
7.41/
7.81 
     2.23 1.28
Pt(7-H)2(PnBu3)2 7.65/ 
7.57 
7.65/
7.57 
   2.19 1.73 1.48 0.96
 
Table 3.2: 1H Chemical shifts (δ/ppm) of platinahomoditopic ligands synthesised in this 
chapter. Spectra were recorded at 500 MHz in CDCl3 with the exception of Pt(1-H)2(PPh3)2 
and Pt(7-H)2(PnBu3)2 which were recorded in C6D6. 
 
3.3.2  13C NMR Spectroscopy 
 
 Platinum(II) complexes were also characterised using 13C NMR 
spectroscopy. Peaks were assigned (see experimental, chapter 6) using 
HMQC and HMBC techniques. Figure 3.11 shows the HMBC spectrum of 
Pt(5-H)2(PEt3)2 which enables the distinction between protons c and d which 
was not possible using COSY and NOESY alone. A cross peak can clearly be 
seen in the HMBC spectrum between proton b and carbon c, and in turn, 
between carbon c and proton d. 
 
 
Figure 3.11: Expansion of the aliphatic region of the 500 MHz HMBC spectrum of Pt(5-
H)2(PEt3)2 in CDCl3. 
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For the free ligands, as well as the platinum(II) complexes, 13C NMR 
spectra were proton-decoupled. This means that in the free ligand, most 
signals appeared as singlets apart from those associated with the phosphine 
groups. However, in the platinum(II) complexes, one of the alkyne signals 
appears as a triplet in the 13C spectrum with coupling of around 14 Hz. This is 
characteristic of the formation of the complex since the coupling arises from 
coupling of the carbon to the two identical phosphorus atoms and is good 
evidence that the complex has formed. 
 
Table 3.3 shows the 13C chemical shifts of the platinahomoditopic 
ligands discussed in this chapter. Spectra were recorded at 500 MHz in CDCl3 
solution apart from Pt(1-H)2(PPh3)2 which was recorded in C6D6. The 13C 
NMR spectra of Pt(7-H)2(PEt3)2 and Pt(7-H)2(PnBu3)2 are not listed in this table 
since the decomposition in solution to an insoluble orange solid meant that it 
was not possible to record a clean 13C NMR spectrum in a reasonable time 
frame.  
 
 A2 A3 A4 A5 A6 B2 B3 B4 
Pt(1-H)2(PEt3)2 156.6/ 
156.2 
121.1 136.6 123.5 148.8 156.6/ 
156.2 
108.1 166.6
Pt(1-H)2(PnBu3)2 157.0/ 
156.6 
121.7 137.2 124.1 149.3 157.0/ 
156.6 
108.7 167.1
Pt(1-H)2(PPh3)2 152.2/ 
157.0 
121.2 136.4 123.4 149.3 152.2/ 
157.0 
109.0 167.4
PtI(5-H)(PEt3)2 156.0/ 
157.1 
121.4 136.8 123.9 149.0 156.0/ 
157.1 
107.4 167.0
Pt(5-H)2(PEt3)2 157.1/ 
156.1 
121.3 136.8 123.8 149.0 157.1/ 
156.1 
107.4 167.0
         
 a b c d e    
Pt(1-H)2(PEt3)2 58.7        
Pt(1-H)2(PnBu3)2 58.7        
Pt(1-H)2(PPh3)2 58.8        
PtI(5-H)(PEt3)2 67.9 69.4 71.0 68.3 61.2    
Pt(5-H)2(PEt3)2 67.8 69.4 71.0 67.9 60.9    
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 w x y z  C≡CPt C≡CPt  
Pt(1-H)2(PEt3)2   15.8 8.0  101.2 104.8  
Pt(1-H)2(PnBu3)2 23.4 26.5/ 
24.1 
26.5/ 
24.1 
13.7  100.4 104.9  
Pt(1-H)2(PPh3)2 131.6 135.5 130.3  108.2/ 
105.2 
108.2/ 
105.2 
 
PtI(5-H)(PEt3)2   16.5 8.3  94.9 83.3  
Pt(5-H)2(PEt3)2   16.1 8.2  103.2 101.4  
 
Table 3.3: 13C Chemical shifts of platinahomoditopic ligands synthesised in this chapter. 
Spectra were recorded at 125 MHz apart from Pt(1-H)2(PnBu3)2 and Pt(1-H)2(PPh3)2 which 
were recorded at 100 MHz. Spectra were run in CDCl3 with the exception of Pt(1-H)2(PPh3)2 
which was run in C6D6.  
 
 DEPT spectra were also recorded. This enabled the distinction 
between different carbon environments since CH3 and CH environments 
appear pointing up, CH2 environments point down and quaternary carbons do 
not appear at all. The major difference therefore between the free ligand and 
the platinum complexes in terms of the DEPT spectra is the disappearance of 
the alkyne CH carbon in the free ligand since this carbon atom is now bound 
to platinum.  Figure 3.12 shows the DEPT spectrum of Pt(1-H)2(PEt3)2 
recorded at 125 MHz in CDCl3 solution. There are now no peaks in the 
aliphatic region belonging to the alkyne carbons. Carbons a and y which are 
both CH2 environments, are now inverted. 
 
Figure 3.12: DEPT spectrum of Pt(1-H)2(PEt3)2 recorded at 125 MHz in CDCl3 solution. 
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3.3.3 31P NMR Spectroscopy 
 
Phosphorus (31P) NMR spectroscopy is also a useful tool for 
characterisation of the complexes. There is clearly a difference between those 
phosphorus atoms which are uncoordinated and those which are coordinated 
to platinum(II). 195Pt is an NMR active nucleus with an abundance of 33.8 % 
which therefore means that satellite signals are observed in the 31P NMR 
spectra. These arise from coupling of 31P to this 33.8 % of NMR active 
platinum. The coupling constant between these satellite peaks is a good 
indication of the coordination geometry at the platinum(II) centre. A coupling 
constant of around 2300 Hz is characteristic of a trans geometry whereas a 
coupling of around 3000 Hz is characteristic or a cis geometry. Figure 3.13 
shows the phosphorus NMR spectrum of Pt(1-H)2(PEt3)2 with clear satellite 
peaks arising from coupling between 31P and the small amount of NMR active 
195Pt. Coupling here is 2340 Hz which confirms the geometry of the complex 
is trans.  
 
 
Figure 3.13: 500 MHz 31P NMR of Pt(1-H)2(PEt3)2 in CDCl3 showing two satellite peaks with a 
coupling constant of around 2300 Hz characteristic of trans geometry. Signals are referenced 
to 85 % H3PO4 (aq.) at δ 0 ppm.  
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 Table 3.4 shows the 31P NMR signals referenced to H3PO4 (aq., 85 %) 
of the various platinum(II) complexes synthesised in this chapter.  
 
Compound δ/ppm 
Pt(1-H)2(PEt3)2 10.8 
Pt(1-H)2(PnBu3)2 -0.4 
Pt(1-H)2(PPh3)2 20.2 
PtI(5-H)(PEt3)2 8.8 
Pt(5-H)2(PEt3)2 7.9 
Pt(7-H)2(PEt3)2 11.6 
Pt(7-H)2(PnBu3)2 0.9 
 
Table 3.4: 31P NMR chemical shifts (δ/ppm) of platinum complexes. All samples were 
recorded in CDCl3 apart from Pt(1-H)2(PPh3)2 and Pt(7-H)2(PnBu3)2 which were run in C6D6. All 
spectra were recorded at 202 MHz apart from Pt(1-H)2(PnBu3)2 and Pt(7-H)2(PnBu3)2 which 
were recorded at 162 MHz. Signals were referenced to H3PO4 (aq., 85 %). 
  
3.3.4  MALDI Mass Spectrometry 
 
The platinahomoditopic ligands synthesised in this chapter were also 
characterised by MALDI mass spectrometry.  A brief overview of the MALDI 
technique is given in Section 2.3.3. The platinum(II) complexes synthesised 
here are all neutral species and therefore to appear in the MALDI spectrum 
they must acquire a charge. This is usually done by loss of an electron or 
alternatively addition of a proton, sodium or potassium ion. MALDI spectra 
were recorded for all the complexes and on most occasions the molecular ion, 
[M]+, was seen. The base peak is often a fragment of the molecule in 
question.  Figure 3.14 shows the MALDI spectrum of Pt(1-H)2(PEt3)2 which is 
typical of this series of complexes. This example clearly shows the molecular 
ion at m/z 1003 and in this case the base peak corresponds to [M-(tpy-O)]+. 
The matrix used to record this particular spectrum was 2,5-dihydroxybenzoic 
acid.  
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Figure 3.14: MALDI mass spectrum of Pt(1-H)2(PEt3)2 recorded with a matrix of 2,5-
dihydroxybenzoic acid. 
 
3.3.5  UV/VIS and Luminescence Spectroscopy 
 
 UV/VIS and fluorescence spectra of the complexes were recorded in 
CH2Cl2 solution. In the UV/VIS spectra there are usually three bands around 
200-350 nm although sometimes one or more of these is not seen or appears 
only as a shoulder. The lowest energy band arises from the transition 
between the alkyne π and π* orbitals. The other bands arise from the charge 
transfer between the alkyne π orbitals and the metal (n+1p) orbitals.12  
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Figure 3.15: The fluorescence process- absorption and vibrational relaxation leads to short 
lived emission of a photon of lower energy (higher wavelength).   
 
Figure 3.16: The phosphorescence process- absorption and vibrational relaxation followed by 
intersystem crossing to the triplet state leads to long lived emission of a photon of lower 
energy (higher wavelength).   
 
When a molecule is irradiated with light of a certain wavelength it 
absorbs energy and becomes excited. The molecule gradually loses small 
amounts of energy by colliding with neighbouring molecules which is termed 
vibrational relaxation. However, to lose the large amount of energy needed to 
return completely to the ground state, it emits a photon.13 This process is 
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called fluorescence and is illustrated in figure 3.15. The wavelength of this 
emission is what is measured in fluorescence spectroscopy and the irradiation 
wavelength is chosen based on the UV/VIS absorption spectrum since this 
gives the wavelength at which maximum absorptions occur. Similar is the 
process of phosphorescence. In this case emission is much longer lived since 
a forbidden change in spin state occurs before the photon is emitted. This can 
be seen in figure 3.16. 
 
In the luminescence spectra of the complexes, a band can usually be 
seen around 400-450 nm. This is thought to be a fluorescence process due to 
the S1→S0 transition.14 Tables 3.5 and 3.6 show UV/VIS and luminescence 
data for platinum complexes synthesised in this chapter. 
 
 C A (ε) A (ε) A (ε) 
Pt(1-H)2(PEt3)2 1.88x10-5 246 (68900) 278 (69550)  
Pt(1-H)2(PnBu3)2 3.75x10-5 254 (19100) 279 (20700)  
Pt(1-H)2(PPh3)2 1.30x10-5 246 (70500) 278 (66700) 302 (36600) 
PtI(5-H)(PEt3)2 4.80x10-5 239 (48000) 276 (40400)  
Pt(5-H)2(PEt3)2 3.89x10-5 242 (27450) 277 (27200) 308 (10300)) 
Pt(7-H)2(PEt3)2 9.12x10-5 291 (16700)   
Pt(7-H)2(PnBu3)2 1.11x10-5 233 (73250) 285 (67900) 348 (61500) 
 
Table 3.5: UV/VIS data for platinum(II) complexes recorded in CH2Cl2 solution apart from 
Pt(1-H)2(PPh3)2 which was recorded in CHCl3. C (mol dm-3), A (nm), ε (dm3 mol-1 cm-1). 
 
 C Irradiation/nm Emission/nm 
Pt(1-H)2(PEt3)2 1.88x10-5 292 450 
Pt(1-H)2(PnBu3)2 3.75x10-5 322 452 
Pt(1-H)2(PPh3)2 1.30x10-5 325 455 
PtI(5-H)(PEt3)2 3.89x10-5 300 440 
Pt(5-H)2(PEt3)2 9.12x10-6 300 396 
Pt(7-H)2(PEt3)2 1.11x10-5 348 416 
 
Table 3.6: Luminescence data for platinum(II) complexes in CH2Cl2 solution apart from Pt(1-
H)2(PPh3)2 which was recorded in CHCl3. C (mol dm-3), irradiation and emission (nm). 
 86
 In the case of Pt(7-H)2(PEt3)2, the UV/VIS spectrum of this complex 
differs from those of the complexes with alkyl spacers. The tail of a band can 
be seen around 200 nm in the spectrum of Pt(7-H)2(PEt3)2, but the maximum 
of this absorption overlaps with the solvent cut-off and therefore was not 
determined. Shoulders can be seen around 300 nm and 400 nm but the only 
resolved peak was that at 291 nm. The UV/VIS spectrum of Pt(7-H)2(PEt3)2 is 
shown in figure 2.17. 
 
 
Figure 2.17: UV/VIS spectrum of Pt(7-H)2(PEt3)2. 
 
3.4 Crystal Structures 
 
3.4.1  Pt(1-H)2(PnBu3)26 
 
 Crystals of Pt(1-H)2(PnBu3)2 suitable for X-ray diffraction were grown 
from a solution of the product in CH2Cl2 layered with hexane. There are no 
solvent molecules present in the crystal lattice. An ORTEP representation is 
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shown in figure 3.18 as well as a packing diagram in figure 3.19; crystal data 
are given in the appendix and selected bond parameters are shown in table 
3.7.  
 
 
Figure 3.18: ORTEP representation of Pt(1-H)2(PnBu3)2. Crystals were grown from a CH2Cl2 
solution layered with hexane. 
 
Figure 3.19: Packing diagram of Pt(1-H)2(PnBu3)2. Molecules are stacked in rows and there 
are no solvent molecules present. 
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 The X-ray crystal structure shows the platinum atom lying on an 
inversion centre. The molecule shows square planar geometry as is expected 
for a d8 Pt(II) complex. The trans configuration is consistent with the coupling 
constants seen in the 31P NMR spectrum. 
 
 There is no π-stacking between the tpy rings in the solid state and rows 
of molecules are held together by several hydrogen bonds. The first hydrogen 
bond forms between N1 on one molecule and H16 of the molecule in the next 
row. The second hydrogen bond forms between H9 on the first molecule and 
O1 of the second. This continues with bonds between O1 and H9 as well as 
C16 and N1, in a symmetrical arrangement. The tpy rings are not quite planar 
and have torsion angles of 15.6(2) Å and 3.5(2) Å respectively (defined in 
table 3.7). 
 
Bond Distance/Å Bond Distance/Å 
Pt1-P1 2.2960(4)     Pt1-C18 2.0233(19)     
C17-C-18 1.099(3)     C16-C17 1.542(2)     
O1-C16 1.455(2)     C8-O1 1.357(2)     
    
Bonds Angle/deg. Bonds Angle/deg. 
P1-Pt1-P1_2 179.995     C18-Pt1-C18_2 179.994     
P1-Pt1-C18 92.67(5)     P1-Pt1-C18_2 87.33(5)     
C17-C18-Pt1 177.55(16)     C16-C17-C18 175.70(18)     
O1-C16-C17 111.92(14)     C8-O1-C16 117.35(14)     
    
N1-C11-C10-N2 15.6(2) N2-C6-C5-N3 3.5(2) 
 
Table 3.7: Selected bond lengths (Å), angles (˚) and torsion angles (˚) for Pt(1-H)2(PnBu3)2. 
 
 This compound has a similar structure to a square planar platinum(II) 
complex made in the group of Ziessel.15 In the literature complex there is no 
spacer between the tpy and the alkyne, the alkyne is directly attached to the 
tpy, whereas in the compound above the presence of an O-CH2 spacer 
between the tpy and the alkyne makes the complex above slightly more 
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flexible. Bond lengths are similar between the two compounds and so are the 
bond angles.  
 
3.4.2  Pt(1-H)2(PPh3)2.2C6H66 
  
Crystals of Pt(1-H)2(PPh3)2.2C6H6 were grown from a solution in 
benzene. An ORTEP representation of the structure is shown in figure 3.20. 
As with the R = Bu complex, the platinum(II) lies on an inversion centre. The 
complex is square planar and has a trans geometry which agrees with the 
coupling constant seen in the 31P NMR spectrum. There are slight torsion 
angles between the tpy rings of 5.1(5) Å and 3.0(4) Å respectively (defined in 
table 3.8). Selected bond lengths and angles are shown in table 3.8 and 
crystal data is given in the appendix.  
 
 
Figure 3.20:ORTEP representation of Pt(1-H)2(PPh3)2.2C6H6 with one solvent molecule 
shown. Crystals grown from a solution of the compound in C6H6. 
 
Molecules of Pt(1-H)2(PPh3)2 are stacked in columns. In this structure 
there are benzene solvent molecules present and these can be seen in the 
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packing diagram (figure 3.21). Solvent molecules are stacked in columns 
which separate the columns of Pt(1-H)2(PPh3)2. There are no π-stacking 
interactions in the unit cell due to the fact that the pyridine rings are offset 
from each other. 
 
 
Figure 3.21: Packing of Pt(1-H)2(PPh3)2. Molecules are arranged in rows separated by 
columns of benzene solvent molecules. 
 
Bond Distance/Å Bond Distance/Å 
Pt1-P1 2.3175(10)      Pt1-C18 1.993(5)      
C17-C-18 1.210(7) C16-C17 1.452(7) 
O1-C16 1.449(6)      C8-O1 1.364(6)      
    
Bonds Angle/deg. Bonds Angle/deg. 
P1-Pt1-P1_2 180.00    C18-Pt1-C18_2 180.00    
P1-Pt1-C18 89.07(13)    P1-Pt1-C18_2 90.93(13)    
C17-C18-Pt1 176.5(4) C16-C17-C18 175.8(5) 
O1-C16-C17 112.7(4) C8-O1-C16 117.6(3)    
    
N1-C5-C6-N2 5.1(5) N2-C10-C11-N3 3.0(4) 
 
Table 3.8: Selected bond lengths (Å), angles (˚) and torsion angles (˚) for Pt(1-H)2(PPh3)2. 
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3.4.3   [Cu2(PPh3)2(μ-I)(μ-7)]I11 
 
Crystals of [Cu2(PPh3)2(μ-I)(μ-7)]I were grown from a saturated solution 
of the compound in CH2Cl2 layered with hexane. An ORTEP representation is 
shown in figure 3.22 and the packing of the molecules is shown in figure 3.23. 
There is a significant torsion of the tpy of 25.2(5) ˚ (defined in table 3.9) due to 
the coordination to two copper atoms. Selected bond parameters are shown 
in table 3.9 and crystal data is given in the appendix. 
 
 
Figure 3.22: ORTEP representation of [Cu2(PPh3)2(μ-I)(μ-7)]I grown from a saturated solution 
of the compound in CH2Cl2 layered with hexane. 
 
 The complex [Cu2(PPh3)2(μ-I)(μ-7)]I is symmetrical about a C2 axis 
running through the length of the molecule from I1 to C32. It is also chiral 
since the tpy unit has a helical twist about it and crystallises in the chiral 
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space group C2221. This means that the molecule has resolved itself on 
crystallisation, rather than crystallising as a racemate. 
 
The copper atoms have approximately tetrahedral coordination with a 
Cu-Cu bond of length 2.6508(8) Å. The iodide counterion, I2, is located at a 
distance of 3.377 Å from C28 of one molecule as well as 2.923 Å from C32 of 
another molecule. 
 
Figure 3.23: Packing of [Cu2(PPh3)2(μ-I)( μ-7)]I. 
 
Bond Distance/Å Bond Distance/Å 
Cu1-Cu1_5 2.6508(8) Cu1-N1 2.019(3) 
Cu1-P1 2.1975(9) Cu1-I1 2.6216(5) 
C26-C27 1.521(8) C30-C31 1.526(10) 
C31-C32 1.143(8)   
    
Bonds Angle/deg. Bonds Angle/deg. 
Cu1-I1-Cu1_5 60.74(2) I1-Cu1-Cu1_5 59.631(10) 
I1-Cu1-P1 124.08(3) I1-Cu1-N1 104.39(9) 
I1-Cu1-N2 114.59(5) Cu1_5-Cu1-N1 91.13(9) 
    
N1-C23-C24-N2 25.2(5)   
 
Table 3.9: Selected bond lengths (Å), angles (˚) and torsion angles (˚) for [Cu2(PPh3)2(μ-I)(μ-
7)]I. 
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3.5  Conclusion 
 
In this chapter the synthesis of several platinahomoditopic ligands has 
been discussed. These molecules have been fully characterised using 
standard spectroscopic techniques and their electronic and luminescence 
properties have been recorded. X-ray crystal structures have been obtained 
for some complexes and these have been discussed.  
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Chapter 4 Gold(I) Alkynyl Complexes  
 
4.1 Gold(I) Alkynyl Complexes 
 
Having investigated platinum(II) alkynyl complexes as potential 
precursors to supramolecular macrocycles, an obvious extension of the 
methodology was to use gold(I) as an alternative to platinum(II). Gold(I) 
alkynyl complexes are well known in the literature for their luminescence 
properties which is thought arise due to their Au…Au interactions.1,2 These 
interactions are also very useful in supramolecular chemistry since they play 
an important part in the self assembly of gold(I) complexes in the solid 
state.3,4,5,6 It has also been shown that luminescence is dependent on the 
ligand used7 and so the investigation of gold(I) complexes of alkyne 
functionalised tpy ligands as luminescent materials is particularly important.  
 
Gold(I) complexes have been studied as luminescent sensors8 where 
the luminescence properties of the complex vary on further coordination of a 
metal at a remote site. This is something which could in theory apply to the 
gold(I) systems discussed in this chapter since the presence of pendant tpy 
moieties means there is a site available for coordination which could then alter 
the luminescence properties of the whole complex.  
 
Due to time limitations only a brief investigation of some gold(I) 
complexes was possible and preliminary results are presented in this chapter. 
It was not possible to investigate all the ligands discussed in Chapter 2 in 
reactions with gold(I) and it may be that the resulting luminescence of these 
potential complexes would be different depending on the ligand used. The 
numbering scheme for complexes discussed in this chapter is shown in figure 
4.1.  
 
 96
 
Figure 4.1: Numbering scheme for gold(I) complexes discussed in this chapter. 
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4.2 Synthesis of Gold(I) Alkynyl Complexes 
 
 The synthesis of these gold(I) complexes proceeded using the same 
method as that used for platinum(II). A base, in this case NEt3, is used to 
deprotonate the alkyne, CuI is used as a catalyst and a gold(I) chloride 
complex is used as the starting material. As is the case for a large number of 
literature gold acetylide complexes, 2,6,9,10,11 a phosphine is used as the 
auxiliary ligand. The main difference between gold(I) and platinum(II) is that 
while platinum(II) complexes are of square planar geometry, gold(I) 
complexes are usually linear.12  
 
In order to create a homoditopic ligand from a gold(I) complex it is 
therefore necessary to use a chelating phosphine in order to connect two 
gold(I) atoms together, thus providing the possibility for two tpy moieties, and 
this has the further possibility that the chelating phosphine used will bring the 
gold(I) atoms closer together, thus increasing the likelihood that Au…Au 
interactions will be present.13 Figure 4.2 shows the synthesis of gold(I) 
containing homoditopic ligands by this method. Various different length 
spacers can be used for the chelating phosphine. These can be simple alkyl 
chains or, alternately, something more complicated such as 
bis(diphenylphosphino)ferrocene.  
 
Most of the gold(I) complexes discussed in this chapter are 
synthesised using ligand 1 although one other ligand (12) was also used as a 
trial for multicentred gold(I) alkyne complexes (see figure 4.3). It was felt that 
since ligand 12 had three alkyne moieties, it was a suitable model ligand for 
the formation of multimetal systems. The successful formation of the 
compounds Au(1-H)(PnBu3) and (AuPnBu3)3(12-3H) demonstrates that this 
method for the coupling of gold(I) with alkynes is viable. The same method 
can in theory be used with the other tpy ligands discussed in Chapter 2 
although time restraints did not permit investigation of these in this thesis. 
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Figure 4.2: Synthesis of gold(I) alkyne complexes containing both mono- and bis-phosphine 
ligands. 
 
  
 
Figure 4.3: Ligand 12 was thought to be a suitable test molecule for the formation of 
multicentred gold(I) alkynyl complexes. 
 
 A trial of the proposed methodology was carried out using the simple 
gold(I) complex, ClAu(PnBu3),14 which has a monodentate phosphine. It was 
thought that this would prove the general concept and if successful, could 
then be extended to more complicated complexes. The synthesis of this first 
gold(I) complex was straightforward. Ligand 1 was reacted with ClAu(PnBu3) 
using CuI as a catalyst in a 50:50 mixture of NEt3 and CH2Cl2. The reaction 
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proceeded as with the platinum(II) analogues and a precipitate formed. The 
product was purified by column chromatography using 1 % acetone in CH2Cl2 
as the eluent. The single fraction was shown to contain a tpy binding unit by 
spotting a small amount of eluent onto an alumina covered TLC plate followed 
by dipping this in an aqueous solution of FeCl2.4H2O. The presence of a 
purple colour was indicative of a tpy moiety. This fraction was collected and 
the solvent removed to give Au(1-H)(PnBu3) in a yield of 45 %.  
 
 The same method was used in the reaction of ligand 12 with 
ClAu(PnBu3). This also proceeded to give a precipitate which was collected by 
filtration. This was purified by column chromatography on alumina using 1 % 
acetone in CH2Cl2 as the eluent. The only fraction was shown to contain a tpy 
moiety as above and this fraction was collected and the solvent removed, 
although the yield was significantly lower than in the previous reaction (8 %). 
The compound (AuPnBu3)3(12-3H) was characterised. Single crystals were 
grown from acetonitrile solution. 
 
 Characterisation of Au(1-H)(PnBu3) and (AuPnBu3)3(12-3H) by various 
methods, including 1H, 13C and 31P NMR spectroscopy, mass spectrometry, 
IR spectroscopy and X-ray crystallography showed that there had indeed 
been formation of the gold-carbon bond and that complexation had been 
successful. Importantly, there was a change in the chemical shift in the 31P 
NMR spectrum as well as loss of the signal corresponding to the alkyne 
proton in the 1H NMR spectrum. Mass spectrometry showed peaks arising 
from the molecular ion in both complexes. The characterisation of both these 
complexes is discussed in more detail later in the chapter. 
 
 Having established that this alkyne coupling was a viable method, 
investigation of various gold(I) complexes of chelating phosphines was the 
next step. These chelating phosphines included dppm, dppe, dppf and dpph 
(figure 4.4). Results from these studies were mixed and the only success was 
using dppe, where an X-ray crystal structure of the desired product was 
obtained.  
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Figure 4.4: Bis-phosphines used in forming ditopic ligands by reaction with gold(I). 
 
 Ligand 1 was reacted with (AuCl)2(dppm) using the above method. 
This produced a mixture of products and attempts at separating this using 
column chromatography were unsuccessful. Leaving a sample in CDCl3 
solution resulted in decomposition of the product. At this point it was decided 
to continue with the next step, the reaction of the product with Fe(II), since it 
was felt that attempts at recrystallisation would result in decomposition. The 
result of the addition of FeCl2.4H2O to the mixture produced from the reaction 
of 1 with (AuCl)2(dppm) was still a mixture, chromatography was once again 
unsuccessful, however attempts at crystallisation did produce a colourless 
crystal in a purple solution. This was confirmed by X-ray crystallography to be 
a [(dppm)2Au3Cl2][PF6] cluster (shown schematically in figure 4.5). The 
structure  is discussed in Section 4.4.3. 
 
Figure 4.5: Gold(I) dppm complex formed during the attempted reaction of 1 with dppm. 
 
 The reaction of ligand 1 with (ClAu)2(dppf)15 (figure 4.6) was also 
problematic. The solid obtained from the reaction gradually became purple in 
colour. This indicated coordination of the tpy unit to the Fe(II), but the only 
source of Fe(II) in the reaction mixture was the ferrocene unit and it seems 
rather unlikely that tpy can remove Fe(II) from the ferrocenyl moiety. There 
were problems with solubility, and purification by chromatography was 
unsuccessful. Due to the low solubility, crystallisation was not an option and it 
was again decided to continue and react the mixture with Fe(II). A mixture 
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was obtained which was not possible to separate by chromatography and 
crystallisation was attempted. One colourless crystal was suitable for X-ray 
diffraction and this proved to be the original starting material, 
(ClAu)2(dppf).16,17,18  
 
 
Figure 4.6: The reaction of ligand 1 with (ClAu)2(dppf) was unsuccessful. 
 
 The reaction of ligand 1 with (ClAu)2(dpph) was also unsuccessful. On 
first attempt, no reaction occurred at all. On repeating the experiment a 
reaction did occur giving an insoluble black precipitate which was removed 
from the reaction mixture. After removal of the solvent from the filtrate, NMR 
spectroscopy showed that there were no signals in the aliphatic region which 
could correspond to the alkyl spacer of the dpph part of the molecule. The 
aromatic region of the spectrum showed several overlapping peaks, many of 
which were broadened, and it was therefore concluded that the reaction had 
not produced the desired product. 
 
 The reaction of (ClAu)2(dppe)19,20,21 with ligand 1 in the presence of CuI 
proceeded successfully to produce a precipitate. This precipitate was 
collected by filtration and purified by column chromatography on alumina 
using 1 % acetone in CH2Cl2 as the eluent.  There was only one fraction 
which was confirmed as having a tpy moiety present by spotting a small 
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amount of eluent onto an alumina covered TLC plate and then dipping this 
into an aqueous FeCl2.4H2O solution, the presence of a purple colour 
confirming the presence of the Fe(II)(tpy)2 chromophore. The solvent was 
removed from this fraction and X-ray quality crystals were grown easily. The 
structure of the product is discussed later in the chapter. 
 
4.3 Characterisation 
 
4.3.1  1H NMR Spectroscopy 
 
 Gold(I) complexes were characterised using 1H NMR spectroscopy. 
Complexes were all soluble in CDCl3. It was possible to assign signals based 
on the 1H NMR spectrum for ligand 1 as well as the relative integrals of the 
signals. Chemical shifts are shown in table 4.1.  
 
 A3 A4 A5 A6 B3 
Au(1-H)(PnBu3) 8.54 7.79 7.26 8.65 8.04 
(Au(1-H))2(dppe) 8.55 7.78 7.25 8.63 8.06 
(AuPnBu3)3(12-3H) 8.55 7.78 7.25 8.66 7.98 
      
 a b c   
Au(1-H)(PnBu3) 5.01     
(Au(1-H))2(dppe) 5.00 1.94    
(AuPnBu3)3(12-3H) 4.30 3.71 4.22   
      
 w x y z  
Au(1-H)(PnBu3) 1.67 1.48 1.38 0.87  
(Au(1-H))2(dppe)  7.56 7.34  
(AuPnBu3)3(12-3H) 1.66 1.50 1.38 0.88  
 
Table 4.1: Table of 400 MHz 1H NMR spectroscopic data for gold(I) complexes in CDCl3. 
Chemical shifts are shown in δ/ppm. Atom labelling is shown in figure 4.1. 
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 From looking at table 4.1 it can be seen that there is very little 
difference in chemical shifts of the tpy protons in the three gold(I) complexes. 
As with the platinum(II) complexes, the loss of the diagnostic signal for the 
alkyne proton is evidence for the formation of the gold(I) complex. This can be 
seen in the 1H NMR of (AuPnBu3)3(12-3H) where a small amount of the 
unreacted tpy ligand can be seen as an impurity in the spectrum, shown in 
figure 4.7. It is also possible to see that the chemical shifts of the protons do 
not change much when the alkyne is coordinated to the gold(I) centre. The 
signal which shifts the most is that of proton c, nearest to the gold(I) centre. 
 
Figure 4.7: Expansion of the 400 MHz 1H NMR spectrum of (AuPnBu3)3(12-3H) in CDCl3 
(peaks marked in black). Ligand 12 impurities are marked in red. 
 
4.3.2  13C NMR Spectroscopy 
 
 Gold(I) complexes were also characterised using 13C NMR 
spectroscopy. It was possible to assign the signals based on comparison with 
the 13C NMR spectra of ligand 1 and ligand 12 in the cases of Au(1-H)(PnBu3) 
and (AuPnBu3)3(12-3H). Table 4.2 shows the 13C NMR chemical shifts for the 
three gold(I) complexes discussed in this chapter. 
 
 104
 A2 A3 A4 A5 A6 B2 B3 B4 
Au(1-H)(PnBu3) 157.4/ 
156.7 
121.7 137.0 124.0 149.4 157.4/ 
156.7 
108.2 166.9 
(Au(1-H))2(dppe) 157.0/ 
156.2 
121.3 136.7 123.9 149.0 157.0/ 
156.2 
107.8 166.6 
(AuPnBu3)3(12-3H) 156.6/ 
156.4 
121.1 136.5 123.3 148.9 156.6/ 
156.4 
107.8 167.4 
 
 a b c  w x y z 
Au(1-H)(PnBu3) 57.7    25.87 24.63 27.58 14.02 
(Au(1-H))2(dppe) 57.1 23.7   128.5 133.3, 132.2, 129.5 
(AuPnBu3)3(12-3H) 68.0 69.3 60.0  25.4 24.2 27.1 13.6 
 
 C≡CAu C≡CAu C(CH2)4      
Au(1-H)(PnBu3) 97.2 107.9       
(Au(1-H))2(dppe) 97.0 107.5       
(AuPnBu3)3(12-3H) Not 
seen 
100.1 44.9      
 
Table 4.2: 100 MHz 13C NMR chemical shifts for gold(I) complexes. NMR spectra were 
recorded in CDCl3. 
 
4.3.3  31P NMR Spectroscopy 
 
 Gold, unlike platinum, does not have an NMR active nuclei. This has a 
consequence for the 31P NMR since there are now no satellite peaks present 
in the 31P spectrum and all peaks appear as singlets. 31P chemical shifts of 
phosphorus atoms in the gold(I) complexes are given in table 4.3.  
 
Compound δ/ppm 
Au(1-H)(PnBu3) 25.7 
(Au(1-H))2(dppe) 36.5 
(AuPnBu3)3(12-3H) 25.8 
 
Table 4.3: 162 MHz 31P NMR spectroscopic data for gold(I) complexes. Chemical shifts are 
shown in δ/ppm. Signals were referenced to H3PO4 (aq., 85 %) δ 0 ppm. 
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4.3.4  MALDI Mass Spectrometry 
 
 Gold(I) complexes were characterised by MALDI mass spectrometry. A 
brief explanation of the MALDI technique is given in Section 2.3.3. Like their 
platinum(II) analogues, the gold(I) complexes discussed here are neutral 
species and need to acquire a charge to appear in the MALDI spectrum.  
 
 
 
Figure 4.8: MALDI mass spectrum of (Au(1-H))2(dppe) run with a matrix of α-Cyano-4-
hydroxycinnamic acid of mass 189. Peaks can be seen for [M – 1]+ (1078), [M – 1 + K]+ 
(1116), [M + Na]+ (1388) and [M + K]+ (1405). 
 
The MALDI spectrum of (Au(1-H))2(dppe) is shown in figure 4.8 Peaks 
can be seen for [M – (1-H) + H]+ (1078), [M – (1-H) + K]+ (1116), [M + Na]+ 
(1388) and [M + K]+ (1405). The peak at m/z 1562 is of a larger mass than the 
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product and possibly arises from some kind of aggregate of the product or 
impurity.  
 
This spectrum as well as those of the other two gold(I) complexes was 
run with a matrix of α-cyano-4-hydroxycinnamic acid, of Mw 189. The matrix 
can sometimes appear in the spectrum as an addition to the mass of a 
molecular ion (for example peaks are often seen for [M + matrix]+) and so it is 
important to know the mass of the matrix in order to assign the peaks seen in 
the mass spectrum. The MALDI spectrum of Au(1-H)(PnBu3) showed peaks 
for the molecular ion [M]+ (686) as well as [M + Na]+ (707), and the spectrum 
of (AuPnBu3)3(12-3H) showed [M]+ (1679), [M – (PnBu3)]+ (1477), [M – 
2(PnBu3)]+ (1274), [M – 3(PnBu3)]+ (1078) and [12]+ (483). 
 
4.3.5  UV/VIS Spectroscopy 
 
The gold(I) complexes synthesised in this chapter were characterised 
by UV/VIS spectroscopy (table 4.4). A brief outline of this technique is given in 
Section 3.3.5. In contrast to their platinum(II) analogues, the gold(I) 
complexes discussed here were non-luminescent. It is thought that Au…Au 
interactions give rise to luminescence in gold(I) complexes and the 
observation that the tpy-containing complexes synthesised here were non-
luminescent is probably due to the fact that in none of these complexes were 
there two gold(I) centres in a single molecule in close proximity (~3 Å). 
Interactions were seen in the solid state between two separate molecules of 
(AuPnBu3)3(12-3H) (see Section 4.4.2), but since these interactions are not 
present in solution this molecule was also non-luminescent.  
 
 C A (ε) A (ε) A (ε) 
Au(1-H)(PnBu3)  247 277  
(AuPnBu3)3(12-3H) 2.39x10-5 249 (106200) 278 (72700)  
(Au(1-H))2(dppe) 4.62x10-5 233 (55500) 253 (sh) (37900) 277 (30400) 
 
Table 4.4: UV/VIS absorption data for gold(I) complexes recorded in CH2Cl2 solution. C (mol 
dm-3), A (nm), ε (dm3 mol-1 cm-1). 
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4.4 Crystal Structures 
 
4.4.1  Au(1-H)(PnBu3) 
 
 X-ray quality crystals of Au(1-H)(PnBu3) were grown by slow 
evaporation of the filtrate from the reaction mixture, the solvent being a 50:50 
mixture of NEt3 and CH2Cl2. There were two types of crystal present after a 
week, the gold complex shown here and ligand 1. Crystals were separated by 
eye, the crystals of ligand 1 being large blocks and the crystals of Au(1-
H)(PnBu3) being long needles. An ORTEP representation of Au(1-H)(PnBu3) is 
shown in figure 4.9  and a diagram of the packing of the molecules can be 
seen in figure 4.10.  Selected bond parameters are shown in table 4.5 and 
crystal data are given in the appendix.  
 
 
Figure 4.9: ORTEP representation of Au(1-H)(PnBu3). Crystals were grown by slow 
evaporation from solution where the solvent was a 50:50 mix of NEt3 and CH2Cl2.  
 
 The structure of the molecule is fairly simple. As expected, the alkyne 
carbon atoms as well as the gold(I) centre are colinear. The Au-C-C vector is 
not completely straight as would be expected, but rather there is a slight bend 
and bond angles along this line are typically around 175 ˚ rather than 180 ˚ 
(defined in table 4.5). There are small torsion angles between the pyridine 
rings of the tpy of 11.9 and 3.6 ˚ (defined in table 4.5). 
 
 108
 
 
Figure 4.10: Diagram of the packing of Au(1-H)(PnBu3).  
 
 Molecules of this simple gold(I) complex are packed such that the tpy 
moieties form a layer with the phosphine groups pointing alternately up and 
down to form a layer between the tpy layers. This arrangement effectively 
separates the tpy layers from one another and prevents any π-stacking. Gold 
atoms are at a distance of 5.2 Å from one another which is too large to permit 
any Au…Au interactions. 
 
Bond Distance/Å Bond Distance/Å 
Au1-P1 2.2787(12)     C16-C17 1.467(5)     
C18-Au1 2.018(4)     O1-C16 1.443(4)     
C17-C18 1.186(5)     C8-O1 1.367(4)     
C8-C7 1.383(4)     P1-C19 1.821(4)     
C6-C7 1.391(5)     P1-C23 1.800(5)     
N2-C6 1.345(4)     P1-C27 1.844(5)     
C5-C6 1.491(4)       
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Bonds Angle/deg. Bonds Angle/deg. 
C18-Au1-P1 175.09(11)     N2-C6-C7 123.8(3)     
C17-C18-Au1 175.3(3)     N2-C10-C9 123.1(3)     
C16-C17-C18 176.7(4)     Au1-P1-C27 111.86(17)     
O1-C16-C17 111.5(3)     Au1-P1-C23 112.03(14)     
C8-O1-C16 117.4(3)     Au1-P1-C19 117.01(16)     
C7-C8-C9 119.1(3)       
    
N1-C5-C6-N2 11.9(4) N2-C10-C11-N3 3.6(3) 
 
Table 4.5: Selected bond lengths (Å), bond angles (˚) and torsion angles (˚) for Au(1-
H)(PnBu3). 
 
4.4.2  (AuPnBu3)3(12 – 3H) 
 
 Crystals of (AuPnBu3)3(12 – 3H) were grown from CD3CN solution. An 
ORTEP representation is shown in figure 4.11 and a packing diagram is 
shown in figure 4.12.  Selected bond parameters are shown in table 4.6 and 
crystal data are given in the appendix. Gold(I) atoms are close enough 
together in this structure to permit Au…Au interactions. These have a 
distance of 3.1 Å and link adjacent molecules together to form chains.  
 
Figure 4.11: ORTEP representation of (AuPnBu3)3(12 – 3H). 
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Figure 4.12: Packing diagram of (AuPnBu3)3(12 – 3H). Au…Au interactions can be seen 
between molecules so that molecules are arranged in chains.  
 
As with the simple gold(I) complex Au(1-H)(PnBu3), this complex 
displays an alkyne-gold(I) bond. This is expected to be linear but once again 
deviates slightly from linearity. The pyridine rings of the tpy are not co-planar 
(torsion angles are 9.0 and 14.9 ˚). Torsion angles are defined in table 4.6. 
 
Bond Distance/Å Bond Distance/Å 
Au1-P1 2.278(5)     C24-C23 1.18(2)     
Au1-C4 1.993(14)     C23-C22 1.49(2)     
C4-C3 1.17(2)     C22-O2 1.408(18)     
C3-C2 1.46(3)     O2-C21 1.399(18)     
C2-O1 1.45(2)     C100-C1 1.53(2)     
O1-C1 1.425(18)     C100-C41 1.52(2)     
Au4-P4 2.262(5)     C100-C61 1.51(2)     
Au4-C44 2.027(18)     C100-C21 1.53(2)     
C44-C43 1.16(2)     C61-O6 1.43(2)     
C43-C42 1.47(2)     O6-C69 1.377(19)     
C42-O4 1.42(2)     C69-C68 1.39(2)     
O4-C41 1.391(19)     C69-C70 1.35(2)     
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Au2-P2 2.259(5)     Au2-C24 2.006(13)     
    
Bonds Angle/deg. Bonds Angle/deg. 
Au2-Au1-P1 100.43(13)     C5-P1-C13 101.8(9)     
Au2-Au1-C4 87.3(5)     C9-P1-C13 95.9(11)     
P1-Au1-C4 171.7(5)     Au2-P2-C25 115.9(5)     
Au1-Au2-P2 100.68(13)     Au2-P2-C29 116.7(9)     
Au1-Au2-C24 82.9(4)     C25-P2-C29 114.5(11)     
P2-Au2-C24 176.4(4)     Au2-P2-C33 116.2(10)     
P4-Au4-C44 174.3(6)     C25-P2-C33 109.6(12)     
Au1-P1-C5    111.4(6) C29-P2-C33 78.1(14)     
Au1-P1-C9 116.2(8)     Au4-P4-C45 113.8(9)     
C5-P1-C9 112.0(12)     Au4-P4-C49 110.2(9)     
Au1-P1-C13 117.8(7)     C45-P4-C49 101.0(12)     
Au4-P4-C53 125.3(9)     C45-P4-C53 104.1(13)     
C49-P4-C53 99.0(14)     C100-C1-O1 108.4(14)     
C3-C2-O1 112.1(15)     C2-C3-C4 176.3(18)     
Au1-C4-C3 178.5(16)     C23-C22-O2 114.2(14)     
C5-C6-C7 114.1(14)     Au2-C24-C23 175.0(15)     
C100-C21-O2 109.5(12)     C100-C41-O4 110.0(12)     
C22-C23-C24 178.5(16)     C42-C43-C44 176.4(19)     
C43-C42-O4 114.3(16)     C21-C100-C41 111.7(13)     
Au4-C44-C43 172.2(17)     C21-C100-C61 109.0(13)     
C21-C100-C1 108.6(14)     C41-C100-C61 107.6(14)     
C1-C100-C41 109.7(13)     C22-O2-C21 111.5(11)     
C1-C100-C61 110.4(14)     C61-O6-C69 118.1(13)     
C2-O1-C1 111.3(13)     C71-N2-C67 118.6(14)     
C42-O4-C41 113.9(13)     C100-C61-O6 110.2(13)     
C66-N1-C62 117.9(20)     C76-N3-C72 112.3(20)     
    
N1-C66-C67-N2 9.0(2) N2-C72-C73-N3 14.9(2) 
 
Table 4.6: Selected bond lengths (Å), angles (˚) and torsion angles (˚) of (AuPnBu3)3(12 – 3H).  
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4.4.3  [Au3Cl2(dppm)2][PF6] 
 
 X-ray quality crystals of [Au3Cl2(dppm)2][PF6] were grown from a 
solution of the complex in CH2Cl2 layered with hexane. The structure of 
another salt, [Au3Cl2(dppm)2]Cl, has previously been determined.22 However, 
there are significant differences between the structures of the 
[Au3Cl2(dppm)2]+ cations in the two salts. The structure described here is 
asymmetric, whereas the literature structure has C2 symmetry, with both the 
gold(I) centres attached to chloride ligands being equivalent. There is some 
disorder in two of the phenyl rings and an ORTEP representation is shown in 
figure 4.13.  A packing diagram is shown in figure 4.14 and selected bond 
parameters are shown in table 4.7. Crystal data are given in the appendix. 
 
Figure 4.13: ORTEP representation of the [Au3Cl2(dppm)2]+ cation in [Au3Cl2(dppm)2][PF6]. 
The phenyl rings attached to P4 are disordered. 
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Figure 4.14: Packing diagram of [Au3Cl2(dppm)2][PF6]. The hexafluorophosphate counterions 
can be seen amongst the phenyl groups. Two phenyl groups per molecule are disordered. 
 
The structure of this gold(I) complex shows short distances between 
each adjacent pair of Au atoms. These distances are short enough to allow for 
Au…Au interactions and are 3.2 Å between Au1-Au3 and Au1-Au2, and 3.3 Å 
between Au2-Au3. These differ from the literature structure22 where the 
reported Au-Au distances are 3.1 and 3.7 Å respectively. 
 
Bond Distance/Å Bond Distance/Å 
Cl2-Au2 2.3496(17)     P4-Au3 2.242(2)     
Au2-P2 2.2442(17)     Au3-Cl3 2.3559(18)     
P2-C13 1.814(7)     P2-C14 1.805(7)     
C13-P1 1.832(7)     P2-C20 1.823(7)     
P1-Au1 2.3048(17)     P3-C26 1.814(7)     
Au1-P3 2.3083(16)     P3-C32 1.817(7)     
P3-C38 1.832(7)     P1-C7 1.812(7)     
C38-P4 1.822(7)     P1-C1 1.815(7)     
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Bonds Angle/deg. Bonds Angle/deg. 
Cl2-Au2-P2 169.64(7)     Au1-P3-C38 113.9(2)     
Au2-P2-C13 115.4(2)  Au1-P3-C26 111.9(3)     
Au2-P2-C14 111.4(2)     Au1-P3-C32 113.3(2)     
Au2-P2-C20 113.1(2)     P3-C38-P4 111.3(4)     
P2-C13-P1 114.0(3)     C38-P4-Au3 115.6(3)     
P1-Au1-P3 167.01(6)     P4-Au3-Cl3 171.67(7)     
 
Table 4.7: Selected bond lengths (Å) and bond angles (˚) for [Au3Cl2(dppm)2][PF6].   
 
4.4.4  (Au(1-H))2(dppe).4CHCl3 
 
X-ray quality crystals of (Au(1-H))2(dppe).4CHCl3 were grown from a 
solution in CHCl3 and there are solvent molecules present in the structure. An 
ORTEP representation is shown in figure 4.15 as well as a packing diagram in 
figure 4.16. Selected bond parameters are given in table 4.8 and crystal data 
are given in the appendix. 
 
Figure 4.15: ORTEP representation of (Au(1-H))2(dppe). 
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 The gold(I) complex (Au(1-H))2(dppe) displays an inversion centre 
situated between C31 and C31_2. There is a slight deviation from linearity 
along the Au1-C18-C17 axis with bond angles being 176-179 ˚. The P atoms 
have a near tetrahedral geometry with bond angles in the range 113-114 ˚. 
The pyridine rings of the tpy are not co-planar and there are torsion angles of 
5.8 and 6.4 ˚ (defined in table 4.8). 
 
Figure 4.16: Packing diagram of (Au(1-H))2(dppe).4CHCl3. Solvent molecules can be seen in 
the structure. 
  
The packing of the complex (Au(1-H))2(dppe) is reminiscent of that of 
Au(1-H)(PnBu3) in that the tpy moieties are arranged in layers separated by 
the phosphine groups of the molecule. There are hydrogen bonds 
(C16H16…N3 = 2.5 Å) between H16 of one molecule and N3 of another, as 
well as between O1 and H9 (O1…H9C9 = 2.6 Å). CHCl3 solvent molecules 
are present in the crystal lattice; some are disordered and these are not 
shown on the packing diagram. 
 
Bond Distance/Å Bond Distance/Å 
Au1-P1 2.2748(13)     C7-C8 1.391(8)     
P1-C31 1.837(5)     C8-C9 1.383(8)     
C31-C31_2 1.523(10)     C9-C10 1.387(8)     
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Au1-C18 2.062(6)     C10-N2 1.350(7)     
C17-C18 1.117(8)     C5-C6 1.502(8)     
C16-C17 1.481(8)     C10-C11 1.491(8)     
O1-C16 1.449(7)     P1-C19 1.814(5)     
C8-O1 1.361(7)     P1-C25 1.815(6)     
    
Bonds Angle/deg. Bonds Angle/deg. 
P1-C31-C31_2 110.6(5)     C8-O1-C16 119.0(4)     
Au1-P1-C31 113.25(17)     Au1-P1-C25 113.75(18)     
C18-Au1-P1 178.79(17)     Au1-P1-C19 114.36(18)     
C17-C18-Au1 177.6(5)     C7-C8-O1 124.7(5)     
C16-C17-C18 176.2(6)     C6-C7-C8 117.5(5)     
O1-C16-C17 112.3(5)     N2-C6-C7 123.2(5)     
    
N1-C5-C6-N2 5.8(5) N2-C10-C11-N3 6.4(5) 
 
Table 4.8: Selected bond lengths (Å), bond angles (˚) and torsion angles (˚) for (Au(1-
H))2(dppe). 
 
 4.4.5  (AuCl)2(dppf) 
 
 X-ray quality crystals of (AuCl)2(dppf) were grown from a MeCN 
solution. The structure differs from those published in the literature,16,17,18 
although two of these known structures are solvates. The literature complex 
which is not a solvate16 crystallised in the monoclinic space group whereas 
the structure obtained here crystallised in the triclinic space group. The phenyl 
rings are rotated slightly differently in the two structures and therefore the 
structure obtained here is a polymorph. The differences between the two 
structures can be seen in figure 4.17. An ORTEP representation is shown in 
figure 4.18 and a packing diagram is shown in figure 4.19. Selected bond 
parameters are shown in table 4.9 and crystal data are given in the appendix. 
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Figure 4.17: Diagram showing the structure of (AuCl)2(dppf) obtained overlaid on the literature 
structure.16 The difference between the phosphine groups in the two structures can clearly be 
seen, demonstrating that these two structures are polymorphs. 
 
Figure 4.18: ORTEP representation of (AuCl)2(dppf). 
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 The molecule possesses an inversion centre situated at the Fe(II) 
centre. The Cl1-Au1-P1 unit deviates little from linearity with a bond angle of 
179 ˚. 
 
Figure 4.19: Packing diagram of (AuCl)2(dppf). The complex crystallised without solvent 
molecules. 
 
 The packing of the molecules can be seen in figure 4.19. The gold(I) 
chloride moieties point in alternating directions which enables the molecules 
to interlock, the chloride ligands pointing at the ferrocene of a neighbouring 
molecule. 
 
Bond Distance/Å Bond Distance/Å 
Cl1-Au1 2.2838(8)     C1-C2 1.436(4)     
Au1-P1 2.2283(7)     C2-C3 1.422(5)     
P1-C1 1.793(3)     C3-C4 1.411(5)     
P1-C6 1.821(3)     C4-C5 1.429(4)     
P1-C12 1.811(3)     C5-C1 1.428(4)     
C1-Fe1 2.033(3)       
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Bonds Angle/deg. Bonds Angle/deg. 
Cl1-Au1-P1 178.51(2)     Au1-P1-C12 112.80(10)     
Au1-P1-C1 113.78(10)     P1-C1-Fe1 131.79(15)     
Au1-P1-C6 112.85(10)       
 
Table 4.9: Selected bond lengths (Å) and angles (˚) for (AuCl)2(dppf). 
 
 4.5  Conclusion 
 
 The coupling of gold(I) to alkyne functionalised tpy ligands has been 
achieved in three cases although problems were encountered when using 
certain bidentate phosphines. The molecules were characterised using NMR 
spectroscopy, mass spectrometry and UV/VIS spectroscopy and X-ray crystal 
structures were obtained from all reactions although these were not always 
the desired product.  
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Chapter 5 Iron(II) Complexes of 2,2':6',2"-Terpyridine 
Ligands and the Assembly of Heterometallic Macrocycles 
 
5.1 Iron(II)  2,2':6',2"-Terpyridine Complexes 
 
Iron(II) tpy complexes display octahedral coordination1,2,3 and, due to 
the high crystal field splitting of the tpy ligand, are always in a low spin 
configuration.4 The tpy ligand is symmetrical when mono-substituted, and 
therefore complexes of the type [M(tpyX)2]2+ (X = 4'-substituent) are achiral 
and neither do they possess any other type of isomerism (such as the fac mer 
isomerism seen with complexes of bpy and phen).3 Thus, their structures are 
highly predictable, a characteristic desirable in supramolecular self-assembly.  
 
5.2 Synthesis of Iron(II) Complexes 
 
For the purposes of this chapter, the term “tpy” refers to ligands of the 
type discussed in Chapter 2, as well as the platinahomoditopic ligands 
discussed in Chapter 3 and the gold containing ligands discussed in Chapter 
4. The synthesis of iron(II) bis(tpy) complexes is straightforward and occurs in 
one step at room temperature.4 Two equivalents of the ligand are reacted with 
one equivalent of an iron(II) salt, usually iron(II) chloride,  in methanol. A 
purple colour appears instantly and this is an indication of the formation of the 
[Fe(tpy)2]2+ chromophore. Addition of an aqueous solution of ammonium 
hexafluorophosphate, and removal of some of the methanol, precipitates the 
hexafluorophosphate salt as a purple solid. Figure 5.1 shows the general 
synthesis of [Fe(tpy)2]2+ containing complexes. 
 
Figure 5.1: Synthesis of [Fe(tpy)2]2+ complexes. 
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 Two model Fe(II) bis(tpy) complexes were synthesised in this way, 
[Fe(4)2][PF6]2 and [Fe(5)2][PF6]2 (figure 5.2). This was a good way of testing 
the methodology as well as providing characterisation data which would be 
useful for comparative purposes at a later stage. Both complexes were 
synthesised with no need for purification, and X-ray quality crystals of 
[Fe(5)2][PF6]2 were grown from a solution of the complex in MeCN layered on 
top of toluene. The crystal structure of this complex is discussed later in the 
chapter. 
 
 
 
Figure 5.2: Synthesis of [Fe(4)2][PF6]2 and [Fe(5)2][PF6]2 complete with numbering scheme. 
 
The same method was attempted in forming the iron(II) complex of 
Au(1-H)(PnBu3). Since the phosphine PnBu3 was not a chelating phosphine 
there was no opportunity for the formation of macrocycles or polymers, and a 
model iron(II) bis(tpy) complex was formed containing pendant gold(I) 
moieties (figure 5.3). However, due to the formation of a brown decomposition 
product after a period of time in solution, it was not possible to obtain well 
resolved NMR spectroscopic data on this complex.  
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Figure 5.3: The iron(II) bis(tpy) complex formed from the reaction of Au(1-H)(PnBu3) with 
FeCl2.4H2O. 
 
The general reaction of Pt(L-H)2(PR3)2 (where Pt(L-H)2(PR3)2 is of the 
type discussed in Chapter 3) with FeCl2.4H2O should proceed to give either a 
polymer or a macrocycle since there are now two tpy moieties available for 
coordination per single molecule. The result should, in theory, be influenced 
by two factors: the flexibility of the spacer between the tpy and the alkyne, as 
well as the steric bulk of the auxiliary phosphine groups on the platinum(II) 
centre. In the first instance, the reaction of ligand Pt(1-H)2(PEt3)2 (i.e. one with 
a short spacer) with Fe(II) gave a mixture of three products. Recrystallisation 
of this mixture from a toluene/MeCN solution gave X-ray quality crystals and 
the structure was confirmed as that of [2+2] macrocycle [Fe2{Pt(1-
H)2(PEt3)2}2][PF6]4.5 Figure 5.4 shows the formation of the [2+2] macrocycle 
from the reaction of Pt(1-H)2(PEt3)2 with FeCl2.4H2O.  
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Figure 5.4: The formation of a [2+2] macrocycle from the reaction of Pt(1-H)2(PEt3)2 with 
FeCl2.4H2O. 
 
 The same reaction conditions were used in the reaction of Pt(1-
H)2(PnBu3)2 and Pt(1-H)2(PPh3)2 with FeCl2.4H2O. In each case, a mixture 
was produced once again, and attempts to separate the products by 
chromatography were unsuccessful and so attempts at crystallisation were 
made. After several months, it was apparent that crystals had not grown and 
the 31P NMR spectra of [Fen{Pt(1-H)2(PEt3)2}n][PF6]2n, [Fen{Pt(1-
H)2(PnBu3)2}n][PF6]2n and [Fen{Pt(1-H)2(PPh3)2}n][PF6]2n solutions were 
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recorded. It was noted that over the period of months the ratios of the signals 
in the 31P NMR spectra had changed. Since it was not possible to separate 
the components of the mixture, it was decided to try using the technique of 
PGSE (pulsed-field gradient spin-echo) NMR spectroscopy to gain information 
about the components of the mixtures. This technique as well as the results 
obtained is discussed further in Section 5.2.2. 
 
Results of the PGSE NMR spectroscopy of all three mixtures showed 
that one of the components of each mixture had a calculated radius of 
between 9.7 and 10 Å; the other components had larger radii. The calculated 
radius of 9.7 Å was in good agreement with the radius measured form the X-
ray crystal structure of [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 (see section 5.4.2), 
therefore the sets of peaks of this radius were assigned to the [2+2] 
macrocycle in each case. It was then possible to assign 1H NMR peaks to 
macrocycles of different radii by making a DOSY plot (see later), and in turn it 
was possible to correlate 1H NMR signals with signals observed in the 31P 
NMR spectrum. From looking at how the peaks changed on standing in 
solution for several hours, it was proposed that the initial reaction mixture 
consisted of the kinetic products, metallomacrocycles of sizes larger than 
[2+2], and that over time, the distribution of products changed to favour the 
thermodynamic [2+2] product. This observation explains the growth of crystals 
of the [2+2] macrocycle, as well as why crystals of larger size cycles were 
never obtained. 
 
 Having established that platinum(II) containing macrocycles of different 
sizes interconvert in solution, reaction of the model complex, Au(1-H)(PnBu3) 
with iron(II) was carried out. Attempts at separating the product 
chromatographically still gave a mixture, and this decomposed in solution over 
a short period to form a brown precipitate visible in the NMR tube. This 
precluded the recording of well resolved NMR spectra.   
 
A similar study of the reaction of the gold(I) containing ditopic ligand 
(Au(1-H))2(dppe) with Fe(II) was also carried out. Again an inseparable 
mixture was produced. The NMR spectra of the mixture were recorded and 
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attempts at crystallisation were made. Crystals suitable for X-ray diffraction 
studies were not obtained and the NMR spectra of the mixture were recorded 
again. Significantly, the 31P spectrum had changed, with a new signal growing 
in. The 31P spectrum of this complex is discussed in more detail later in the 
chapter. Due to time constraints, the PGSE NMR spectrum of this product 
was not recorded. However, by analogy with the Pt(II) containing systems it is 
assumed that a similar interconversion between macrocycles takes place. 
 
Reaction of the mixtures produced from attempts to form (Au(1-
H))2(dppm) and (Au(1-H))2(dppf) with Fe(II) also gave inseparable mixtures.  
1H NMR spectra were broad and attempts at growing crystals suitable for X-
ray diffraction produced only colourless crystals, one being 
[Au3Cl2(dppm)2][PF6] (see Section 4.4.3 for structure) and the other being 
(AuCl)2(dppf) (see Section 4.4.5 for structure). It therefore seems that there 
are more problems with gold(I) containing ditopic ligands than with their 
platinum(II) analogues and further investigation of these systems is 
warranted. 
 
5.3 Characterisation 
 
5.3.1  1H NMR Spectroscopy 
 
Iron(II) bis(tpy) complexes were characterised by 1H NMR 
spectroscopy. A corresponding numbering scheme to those used in Chapters 
2, 3 and 4 is used for assignments of peaks. NMR spectra of iron complexes 
synthesised in this chapter were run in CD3CN solutions. 
 
The main difference between the 1H NMR spectra of the uncoordinated 
tpy ligands discussed in earlier chapters and those of the coordinated tpy 
regions discussed here is the change in the order of the peaks. In the spectra 
of uncoordinated tpy ligands, the protons almost always come in the order A6, 
A3, B3, A4 and A5, with A6 being of highest chemical shift.6 On coordination, 
this order changes and B3 now has the highest chemical shift, followed by A3, 
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A4, A6, and A5. This movement of the tpy signals, in particular the B3 signal, 
is diagnostic of coordination. Figure 5.5 compares the 1H NMR spectra of 
uncoordinated ligand 5 with the iron(II) complex [Fe(5)2][PF6]2.7 The difference 
between the aromatic regions of the two spectra can be clearly seen. As 
expected, there is not a huge difference between the two aliphatic regions. 
The signals for the a protons (see figure 5.2 for numbering scheme) are most 
significantly shifted since these are the protons nearest the tpy region. 
Although different solvents were used for the platinahomoditopic ligand 
(CDCl3) and the iron(II) complex (CD3CN), solvent effects are negligible and 
the differences in the spectra arise wholly from coordination of the tpy moiety 
to iron(II).  
 
 
Figure 5.5: Comparison of the 500 MHz 1H NMR spectra of ligand 5 (above) run in CDCl3 
solution and [Fe(5)2][PF6]2 (below) run in CD3CN solution. 
  
If the tpy is a homoditopic ligand, the iron(II) complex formed is a 
heterometallic macrocycle.  Formation of this type of complex is accompanied 
by a shift of the B3 proton to even higher ppm values. This has been seen in 
the reaction of Pt(1-H)2(PEt3)2 with Fe(II) to form [Fe2{Pt(1-H)2(PEt3)2}2][PF6]45 
 128
where the B3 proton shifts from δ 8.06 ppm to δ 8.56 ppm as well as in the 
reaction of Pt(5-H)2(PEt3)2 with Fe(II) to form [Fe{Pt(5-H)2(PEt3)2}][PF6]2.7  
 
Chemical shifts of protons in [Fe{Pt(5-H)2(PEt3)2}][PF6]2 were assigned 
using COSY and NOESY techniques. [Fe{Pt(5-H)2(PEt3)2}][PF6]2 could only 
be characterised as part of a mixture since its formation was accompanied by 
significant cleavage of the ether bonds along the spacer and the resulting 
mixture was not separated with any success. Therefore, COSY and NOESY 
played a significantly more important part in the assignment of peaks for this 
compound than for any other. The B3 signal proved a good starting point 
because of its larger change in chemical shift than the other components of 
the mixture, and cross peaks between this and other aromatic protons 
enabled the assignment of all signals. The other components of the mixture 
were assumed to be cleavage products similar to [Fe(4)2][PF6]2, based on 1H 
chemical shifts as well as the presence of a signal in the 31P spectrum 
corresponding to the literature reported8 chemical shift for Pt(C≡CR)2(PEt3)2 
where R = H or CH3.  The chemical shifts for all other protons in the mixture 
showed significant overlap.  
 
As discussed earlier in the chapter, the NMR spectra of the products 
obtained from reaction of platinahomoditopic ligands with Fe(II) was more 
complicated than with the model complexes. Leaving a sample standing in 
solution for several days or even weeks resulted in changes in both the 1H 
and 31P NMR spectra. Heating of the samples meant that changes happened 
at a faster rate and monitoring of the 1H and 31P together meant that the 
spectra could be correlated. Peaks were assigned in the 1H NMR spectrum 
due to PGSE NMR spectroscopy (discussed in Section 5.3.2) and once these 
were correlated with the 31P signals, interconversion of the macrocycles was 
monitored using 31P NMR. The results of this interconversion study are 
discussed in Section 5.3.4. 
 
Table 5.1 shows chemical shifts of protons in representative iron 
complexes discussed in this chapter. As discussed, peaks were assigned 
from mixtures using PGSE NMR spectroscopy. It was not possible to assign 
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protons in the 1H NMR spectrum of [Fen{Pt(1-H)2(PPh3)2}n][PF6]2n since all 
signals were overlapping and it was impossible to distinguish between them. 
 
 A3 A4 A5 A6 B3   
[Fe(4)2][PF6]2 8.44 7.86 7.07 7.16 8.49   
[Fe(5)2][PF6]2 8.43 7.86 7.06 7.16 8.48   
[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 8.27 7.79 6.96 6.93 8.56   
[Fe2{Pt(1-H)2(PnBu3)2}2][PF6]4 8.27 7.84 6.97 6.91 8.49   
[Fe{Pt(5-H)2(PEt3)2}][PF6]2 8.39 8.01 7.15 7.07 8.63   
        
 a b c d e OH CCH
[Fe(4)2][PF6]2 4.76 4.10 3.73  2.84  
[Fe(5)2][PF6]2 4.74 4.09 3.73 3.82 4.21  2.71
[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 5.35       
[Fe2{Pt(1-H)2(PnBu3)2}2][PF6]4 5.33       
[Fe{Pt(5-H)2(PEt3)2}][PF6]2 4.92 4.04 3.65 3.54 4.12   
 
 w x y z 
[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4   2.03 0.96
[Fe2{Pt(1-H)2(PnBu3)2}2][PF6]4 Not 
observed. 
1.47 1.25 0.60
 
[Fe{Pt(5-H)2(PEt3)2}][PF6]2   1.66 0.72    
 
Table 5.1: 500 MHz 1H chemical shifts for representative iron(II) complexes recorded in 
CD3CN. The peak for the w protons in [Fe2{Pt(1-H)2(PnBu3)2}2][PF6]4 is not observed since it 
overlaps with the solvent peak. 
  
5.3.2  PGSE NMR Spectroscopy 
 
 When the reaction of tpy ligands Pt(1-H)2(PR3)2 (R = Et, Bu and Ph) 
with Fe(II) was carried out, it was observed that the 1H and also the 31P NMR 
spectra were not clean. The samples were left standing at room temperature 
for several weeks and on re-recording the 1H and 31P NMR spectra it was 
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noted that the ratio of the signals had changed since the first time the spectra 
were recorded. This observation prompted further investigation of these three 
mixtures.  
 
The use of pulsed-field gradient spin-echo (PGSE) diffusion NMR 
spectroscopy was a useful tool in trying to determine the size of macrocycles 
produced from these reactions.9 This is a technique which is used to 
determine the diffusion coefficients10 of molecules in solution and this 
information can then be used to calculate an approximate radius for the 
molecules in question using the Stokes-Einstein equation (equation 5.1).11 
This technique has in the past been applied to various different systems 
including metallomacrocycles12,13 and was applied to the macrocycles 
[Fen{Pt(1-H)2(PR3)2}n][PF6]2n where R = Et, Bu and Ph.  
 
 
 
Equation 5.1: Stokes-Einstein equation for calculating the hydrodynamic radius (rH) from the 
diffusion coefficient (D). T is absolute temperature, kb is the Boltzmann constant and η is the 
viscosity of the solvent. 
 
The aim of this study (carried out in conjunction with Jon Beves) was to 
confirm which NMR signals belong to which individual species, as well as to 
assign relative sizes to each of the components of each mixture. The signals 
in the 1H NMR spectrum for the B3 protons of two components were suitably 
well resolved so that these could be used to determine the diffusion 
coefficients of each component. Hydrodynamic radii were calculated for each 
signal and a DOSY plot was obtained which correlates each signal with its 
calculated radius. Figure 5.6 shows the DOSY plot of the aromatic region of 
the 1H NMR for [Fen{Pt(1-H)2(PEt3)2}n][PF6]2n.  
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Figure 5.6: DOSY plot of the aromatic region of the 1H NMR spectrum of macrocycles 
[Fen{Pt(1-H)2(PEt3)2}n][PF6]2n. There is good agreement with there being one macrocycle of 
radius approximately 10 Å as well as several other larger species of radius ~12-13 Å. The 
spectrum was run in CD3CN at 500 MHz. 
 
The 31P NMR spectrum showed that the crude reaction mixture 
obtained on adding iron(II) to the platinahomoditopic ligand Pt(1-H)2(PEt3)2 
contained three species although the 1H NMR signal corresponding to the B3 
proton for one of these species was not well enough resolved to obtain a 
diffusion coefficient. The important point to note from the DOSY plot in figure 
5.6 is that the 1H NMR signals fall into two bands. The major component is 
assigned to the [2+2] macrocycle. The value for rH of 9.7 Å gives a molecular 
diameter of 19.4 Å and this is in good agreement with that estimated from the 
X-ray crystal structure of 18-19 Å (see Section 5.4.2). Although the error bars 
are large, it can be seen clearly that the minor component has a significantly 
larger radius than the [2+2] macrocycle. Molecular modelling showed that 
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there is significant strain in a [1+1] macrocycle, indicating that only products of 
size [2+2] and larger are able to form. This observation is in accordance with 
the results seen in the DOSY plot. The second solution species has a radius 
obtained from the DOSY plot of approximately 12-12.5 Å which suggests the 
formation of a [3+3] macrocycle, [Fe3{Pt(1-H)2(PEt3)2}3][PF6]6. It would seem 
that on reaction of Pt(1-H)2(PEt3)2 with FeCl2.4H2O at either room temperature 
or at reflux in MeOH, a mixture of three  kinetic products is obtained, most 
probably [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4, [Fe3{Pt(1-H)2(PEt3)2}3][PF6]6 and 
[Fe4{Pt(1-H)2(PEt3)2}4][PF6]8. On allowing the solution to stand for a period of 
several weeks the two larger species convert to [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4, 
the thermodynamic product. Similar results have been observed where R = 
nBu and Ph, but well resolved DOSY spectra were difficult to obtain. 
 
5.3.3  13C NMR Spectroscopy 
 
Iron(II) complexes were characterised by 13C NMR spectroscopy and 
spectra were obtained in CD3CN solution. Table 5.2 shows the 13C NMR 
chemical shifts for representative iron(II) tpy complexes synthesised in this 
chapter. Due to the small quantities obtained it was not possible to record well 
resolved spectra for the [Fe2{Pt(1-H)2(PnBu3)2}2][PF6]4 and [Fe2{Pt(1-
H)2(PPh3)2}2][PF6]4 complexes. It was also not possible to observe the signals 
corresponding to the alkyne carbons in [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4. 
 
 A2 A3 A4 A5 A6  
[Fe(4)2][PF6]2 161.7/ 
158.9 
124.5 139.3 128.1 154.3  
[Fe(5)2][PF6]2 161.7/ 
158.9 
124.4 139.3 128.0 154.3  
[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 161.1/ 
159.0 
124.3 139.4 127.9 153.9  
       
 B2 B3 B4    
[Fe(4)2][PF6]2 161.7/ 
158.9 
112.3 168.8    
[Fe(5)2][PF6]2 161.7/ 
158.9 
112.4 168.7    
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[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 161.1/ 
159.0 
113.2 168.3    
 
 a b c d e  
[Fe(4)2][PF6]2 71.0 69.8 73.7/ 
62.0 
73.7/ 
62.0 
  
[Fe(5)2][PF6]2 70.9 69.8 69.9 71.3 58.7  
[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 61.7      
 
 w x y z C≡CR C≡CR 
[Fe(4)2][PF6]2       
[Fe(5)2][PF6]2     80.8 75.7 
[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4   17.1 8.7 Not observed. 
 
Table 5.2: 125 MHz 13C chemical shifts for representative iron(II) complexes synthesised. All 
spectra were recorded in CD3CN. 
 
 13C NMR chemical shifts were assigned using HMQC and HMBC 
techniques. As expected there is very little difference in the chemical shifts of 
carbon atoms between complexes [Fe(4)2][PF6]2 and [Fe(5)2][PF6]2. 
 
5.3.4  31P NMR Spectroscopy 
 
Iron(II) bis(tpy) complexes were characterised by 31P  NMR 
spectroscopy. Since all complexes were isolated as the hexafluorophosphate 
salts, the septet arising from this could be used as an internal reference (δ -
144.6 ppm). As for the platinahomoditopic ligands, the macrocycles formed 
from these starting materials contain phosphorus atoms bound directly to the 
platinum(II) centre. This means that the coupling constant of the satellite 
peaks arising from coupling of the 31P nuclei to NMR active 195Pt (I = ½ , 33.8 
%) is a useful way of confirming that the geometry around the Pt(II) centre 
remains trans and has not changed to cis on coordination of the tpy with 
Fe(II). As with the platinahomoditopic ligands, a coupling constant of around 
2300 Hz is indicative of trans geometry, one around 3000 Hz indicates cis. 
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With the Au(I) ditopic ligands there are no satellites and so the 31P NMR 
signals for these complexes appear as singlets. Table 5.3 shows 31P chemical 
shifts for Fe(II) complexes synthesised in this chapter.  
 
Compound δ/ppm 
[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 12.0 
[Fe2{Pt(1-H)2(PnBu3)2}2][PF6]4 3.0 
[Fe{Pt(5-H)2(PEt3)2}][PF6]2 8.8 
[Fe{Au(1-H)(PnBu3)}2][PF6]2 36.3 
 
Table 5.3: 202 MHz 31P chemical shifts (δ/ppm) for Fe(II) complexes. All shifts are referenced 
with respect to the internal reference of PF6- at δ -144.6 ppm. All spectra were recorded in 
CD3CN solution. 
 
The observation that the ratio of the different peaks in the 31P NMR 
was changing over time prompted attempts to interconvert the macrocycles by 
heating the samples. Monitoring the conversion by 31P NMR spectroscopy 
showed that this was indeed the case. A new solution of [Fen{Pt(1-
H)2(PnBu3)2}n][PF6]2n in CD3CN was heated at around 55 ˚C for a total of 247 
hours. The 31P NMR spectrum was recorded periodically and the relative 
integrals of the different signals were noted.  
 
Figure 5.7 shows a graph of the relative integrals of the 31P NMR 
signals of the species versus time. Integrals were measured with respect to 
PF6- (which was set to 100). The graph clearly shows how the species 
assigned to the [2+2] species using PGSE NMR spectroscopy increases with 
time at the expense of the other, larger, species. There are some anomalies 
in the graph, the most important one being the increase in the quantity of 
larger species at the start of the measurements before the eventual decrease. 
These anomalies can most likely be explained by the fact that the integration 
of NMR spectra is not an exact science. Although care was taken to measure 
the integrals from approximately the same point of each spectrum there are 
always going to be slight differences in the width of the integral and therefore 
the calculation. Integrals were corrected using the automatic integration 
correction function which is built into the software used to view and compare 
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NMR spectra and this in itself means there is a certain margin of error in each 
point on the graph. 
 
 
 
Figure 5.7: Graph of the relative intensity of 31P NMR signals with respect to an internal 
reference of PF6- over time. 
 
If we take the PF6- out of the equation and plot a graph of the ratio of 
the integrals of the [2+2] macrocycle to the larger species against time the 
results are much clearer. It is easy to see from the graph in figure 5.8 how the 
relative quantity of the [2+2] species increases at the expense of the larger 
species.  Due to problems with loss of solvent from the sample over the first 
24 hour period, the line of best fit on the graph in figure 5.8 does not pass 
through zero. For much of this 24 hour period the sample had no solvent in 
and therefore the larger components of the mixture were unable to convert 
into the [2+2] macrocycle.  After 24 hours the solvent was replaced and 
further monitoring of the conversion showed that there was a linear 
relationship between the ratio of the macrocycles and the time the sample 
was in solution at elevated temperature. 
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Figure 5.8: Graph showing the increase of the [2+2] species relative to larger species. Points 
were plotted as a ratio of [2+2]:[larger species], integrals were not calculated with respect to 
an internal reference of PF6-. 
 
 
Figure 5.9: 162 MHz 31P NMR spectra of [Fen{(Au(1-H))2(dppe)}n][PF6]2n recorded in CD3CN 
before (above) and after (below) standing in MeCN solution at room temperature for several 
days. 
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Reaction of (Au(1-H))2(dppe) with Fe(II) also produced a mixture, 
several peaks being seen in the 31P NMR spectrum. Standing a sample of this 
mixture in solution for several days resulted in a change in the NMR signals, 
similar to those observed with the platinum(II) analogues. Figure 5.9 shows 
the two 31P NMR spectra of the mixture obtained from the reaction of (Au(1-
H))2(dppe) with Fe(II), the top spectrum is that obtained immediately after 
reaction, the bottom spectrum is after the solution had been standing for 
several days. It can be seen that the peak around δ 31 ppm decreases while 
the peak at δ 21 ppm grows in. While limited time meant that PGSE NMR 
studies were not carried out on this sample, these preliminary results show 
that perhaps a similar interconversion to that seen with the platinum(II) 
containing macrocycles is taking place. 
 
5.3.5  MALDI and ES Mass Spectrometry 
 
Mass spectrometry, both MALDI and/or ESMS, was a useful tool for 
characterisation of these complexes. As well as information on the molecular 
masses of fragments, ESMS gives information about the charges and it is 
possible to expand the spectra in order to see isotope patterns which can then 
be compared with calculated isotope patterns as another way of confirming 
the assignment of the fragment seen in the spectrum is correct. Figure 5.10 
shows the ES mass spectrum of [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 in MeCN.  
 
Peaks can be assigned to various fragments of a [2+2] macrocycle, 
corresponding with the information obtained from the X-ray crystal structure 
(see chapter 5.4.2). The most important peaks are m/z 1086.8 corresponding 
to [M - 2(PEt3) - 2(PF6-)]2+, 755.1 [M - 3(PF6-)]3+ and 704.9 [M - 3(Et) - 3(PF6-
)]3+. 
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Figure 5.10: ES mass spectrum of [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 in MeCN. 
 
 5.3.6  UV/VIS Spectroscopy 
 
Iron(II) complexes were characterised by UV/VIS spectroscopy in 
MeCN solution. The spectra were similar to those for the tpy ligands at lower 
wavelengths. However, the presence of an asymmetrical MLCT (metal to 
ligand charge transfer) band around 550 nm is further evidence for 
coordination of the tpy moiety.14 This absorption is responsible for the purple 
colour of the iron(II) bis(tpy) complexes, since light of this wavelength is green 
in colour, meaning the blue and red light is reflected and the complex appears 
purple. The UV/VIS spectrum of [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 in MeCN can be 
seen in figure 5.11.  
 
UV/VIS data for representative iron(II) tpy complexes synthesised in 
this chapter can be seen in table 5.4. 
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Figure 5.11: UV/VIS spectrum of [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 in MeCN. The MLCT band can 
clearly be seen at 555 nm. 
 
 C A (ε) A (ε) A (ε) A (ε) 
[Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 7.41x10-5 245  
(99600) 
272 
 (116400)
312 
 (81900) 
557 
(23350) 
[Fe2{Pt(1-H)2(PnBu3)2}2][PF6]4 2.64x10-5 246 
(67200) 
271 
(78500) 
313 
(49300) 
558 
(13000) 
[Fe{Au(1-H)(PnBu3)}2][PF6]2 1.75x10-5 243 
(30100) 
273 
(29600) 
315 
(22600) 
556 
(6700) 
 
Table 5.4: UV/VIS data for representative iron(II) bis(tpy) complexes. All spectra were 
recorded in MeCN. C (mol dm-3), A (nm), ε (dm3 mol-1 cm-1). 
 
5.4 Crystal Structures 
 
5.4.1  [Fe(5)2][PF6]2 
 
Crystals of [Fe(5)2][PF6]2 were grown from a solution in CH2Cl2 layered 
with hexane. An ORTEP representation is shown in figure 5.12 as well as a 
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packing diagram in figure 5.13 and selected bond lengths and angles in table 
5.5.  
 
 
 
Figure 5.12: ORTEP representation of the cation in [Fe(5)2][PF6]2. Crystals were grown from a 
solution in CH2Cl2 layered with hexane.  
 
 The structure of the [Fe(5)2]2+ cation in [Fe(5)2][PF6]2 is not 
symmetrical. The conformation of each of the spacers is different, due to 
intermolecular hydrogen bonds between H42 and O1 as well as interactions 
of the chains with the PF6- counterions. The iron(II) is octahedrally 
coordinated as expected. 
 
 
Figure 5.13: Packing diagram of [Fe(5)2][PF6]2. PF6- ions have been removed for clarity. 
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Bond Distance/Å Bond Distance/Å 
Fe1-N1 1.982(2)     Fe1-N4 1.982(2)     
Fe1-N2 1.892(2)     Fe1-N5 1.886(2)     
Fe1-N3 1.983(2)     Fe1-N6 1.978(2)     
C8-O1 1.334(3)     C23-O4 1.349(3)     
O1-C31 1.453(3)     O4-C38 1.439(3)     
C31-C32 1.504(4)     C38-C39 1.509(4)     
C32-O2 1.409(4)     C39-O5 1.396(4)     
O2-C33 1.424(4)     O5-C40 1.433(4)     
C33-C34 1.493(5)     C40-C41 1.477(5)     
C34-O3 1.416(4)     C41-O6 1.393(5)     
O3-C35 1.431(4)     O6-C42 1.391(5)     
C35-C36 1.449(5)     C42-C43 1.499(6)     
C36-C37 1.192(5)     C43-C44 1.142(6)     
    
Bonds Angle/deg. Bonds Angle/deg. 
N1-Fe1-N2 80.54(9)     C32-O2-C33 115.7(2)     
N2-Fe1-N3 80.87(9)     C33-C34-O3 108.6(3)     
N4-Fe1-N5 80.45(9)     C34-O3-C35 111.8(3)     
N5-Fe1-N6 81.07(9)     C35-C36-C37 178.1(3)     
C6-N2-C10 120.5(2)     C23-O4-C38 117.1(2)     
C1-N1-C5 118.6(2)     O4-C38-C39 107.8(2)     
C11-N3-C15 117.6(2)     C38-C39-O5 113.4(3)     
C16-N4-C20 118.8(2)     C39-O5-C40 115.7(3)     
C21-N5-C25 120.3(2)     O5-C40-C41 109.7(3)     
C26-N6-C30 118.8(2)     C40-C41-O6 108.8(3)     
C8-O1-C31 118.5(2)     C41-O6-C42 114.4(4)     
O1-C31-C32 106.4(2)     C42-C43-C44 172.6(6)     
C31-C32-O2 112.9(3)       
 
Table 5.5: Selected bond lengths (Å) and angles (˚) for [Fe(5)2][PF6]2. 
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5.4.2  [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4.C6H5CH3.4MeCN 
 
Crystals of [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4.C6H5CH3.4MeCN were grown 
from a solution in MeCN layered on top of toluene. An ORTEP representation 
is shown in figure 5.14 and a packing diagram is shown in figure 5.15. 
Selected bond parameters are given in table 5.6.  
 
 
Figure 5.14: ORTEP representation of the cation in [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4. 
 
 The [2+2] macrocycle [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4 is symmetrical about 
an inversion centre at the middle of its cavity. Two phosphine groups point 
into the centre of the cycle and two point outside, and the corners of the 
rectangular structure are formed by the ether part of the spacer. The molecule 
measures 10.5 Å between the two iron(II) centres and 13.6 Å between the two 
platinum(II) centres. 
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Figure 5.15: Packing diagram of [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4. 
 
Bond Distance/Å Bond Distance/Å 
Pt1-P1 2.3042(12)     C17-C16 1.465(6)     
Pt1-P2 2.3068(12)     C16-O1 1.446(5)     
Pt1-C36 1.992(5)     O1-C8 1.349(4)     
C36-C35 1.200(6)     Fe2-N1 1.975(3)     
C35-C34 1.469(7)     Fe2-N2 1.888(3)     
C34-O2 1.455(6)     Fe2-N3 1.981(3)     
O2-C26 1.358(4)     Fe2-N4 1.965(3)     
Pt1-C18 2.003(5)     Fe2-N5 1.892(3)     
C18-C17 1.204(6)     Fe2-N6 1.971(3)     
    
Bonds Angle/deg. Bonds Angle/deg. 
P1-Pt1-P2 175.45(4)     C18-C17-C16 174.0(5)     
C18-Pt1-C36 175.23(17)     C17-C16-O1 112.9(3)     
P1-Pt1-C36 89.64(13)     C16-O1-C8 118.7(3)     
P1-Pt1-C18 93.28(12)     Pt1-C36-C35 176.7(4)     
P2-Pt1-C18 87.90(12)     C36-C35-C34 177.0(5)     
P2-Pt1-C36 88.90(13)     C35-C34-O2 114.3(4)     
Pt1-C18-C17 174.2(4)     C34-O2-C26 118.2(3)     
 
Table 5.6: Selected bond lengths (Å) and angles (˚) of [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4. 
 
 144
5.5 Conclusion 
 
Several different iron(II) bis(tpy) complexes have been synthesised. In 
the cases where these have been synthesised starting from a 
platinahomoditopic ligand, macrocyclic species of varying sizes were 
produced. Initial mixtures of macrocycles have been shown to interconvert to 
one thermodynamically stable product on standing in solution for a period of 
time. An example of a [2+2] macrocycle has been characterised by X-ray 
crystallography and this has proved that platinahomoditopic ligands are a 
viable precursor to the supramolecular assembly of heterometallic 
macrocycles. 
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Chapter 6 Experimental 
 
6.1  2,2':6',2"-Terpyridine Ligands 
 
6.1.1  4'-Hydroxy-2,2':6',2"-terpyridine HO-tpy1 
 
A solution of 1,5-bis(2'-pyridyl)pentane-1,3,5-trione (1.99 g, 7.42 mmol) 
and ammonium acetate (4.0 g) in ethanol (50 ml) was heated to reflux for 6 
hours. The dark brown solution was then concentrated to half volume. The 
solution was cooled in ice and a precipitate formed. This was filtered, washed 
with diethyl ether and recrystallised from ethanol (1.08 g, 4.33 mmol, 58 %).  
 
1H NMR (CDCl3, 250 MHz): δ/ppm 12.05 (s, NH, 1H); 8.80 (dt, 2H, J 4.8, 1.2 
Hz, 2H, A6,); 7.90 (m, 4H, A3 and A4); 7.44 (td, J 4.8, 1.6 Hz, 2H, A5); 7.18 
(s, 2H, B3).   
 
6.1.2  4'-(2-Propyn-1-oxy)-2,2':6',2"-terpyridine 12 
 
A solution of HO-tpy (0.451 g, 1.81 mmol) in acetonitrile (60 ml) was 
stirred, then treated with potassium carbonate (1.50 g, 10.9 mmol) then 3-
bromoprop-1-yne (80 % solution in toluene) (0.225 ml, 2.09 mmol) was 
added. The suspension was heated at 60 ˚C for 12 hours. The reaction 
mixture was then cooled to room temperature and poured into water (100 ml). 
The precipitate formed was collected by filtration. The product was 
recrystallised from a solution in CH2Cl2 layered with hexane. The 13C NMR 
spectrum had not previously been assigned and was recorded (0.360 g, 1.25 
mmol, 66 %). 
 
1H NMR (CDCl3, 500 MHz): δ/ppm 8.69 (dq, J 4.8, 0.9 Hz, 2H, A6); 8.61 (dt, J 
7.9, 1.0 Hz, 2H, A3); 8.09 (s, 2H, B3); 7.84 (td, J 7.9, 1.8 Hz, 2H, A4); 7.33 
(ddd, J 7.5, 4.8, 1.2 Hz, 2H, A5); 4.93 (d, J 2.4 Hz, 2H, CH2); 2.58 (t, J 2.4 Hz, 
1H, C≡CH).  
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13C NMR (CDCl3, 125 MHz): δ/ppm 165.85 (B4); 157.28 (A2/B2); 155.92 
(A2/B2); 149.11 (A6); 136.80 (A4); 123.91 (A5); 121.37 (A3); 107.57 (B3); 
77.59 (C≡CH); 76.32 (C≡CH); 55.85 (a). 
 
6.1.3  4'-(4-Pentyn-1-oxy)-2,2':6',2"-terpyridine 2 
 
HO-tpy (0.219 g, 0.879 mmol) in MeCN (30 ml) was stirred then 
treated with K2CO3 (1 g, excess) and 5-bromopent-1-yne (0.264 g, 1.80 
mmol). The suspension was heated at 60°C for 12 hours. It was then poured 
into iced water and the precipitate was collected by filtration. The product was 
purified by recrystallisation from CH2Cl2/hexane (0.0881 g, 0.279 mmol, 29 
%). 
 
1H NMR (CDCl3, 400 MHz): δ/ppm 8.69 (d, J 4.5 Hz, 2H, A6); 8.62 (d, J 7.8 
Hz, 2H, A3); 8.03 (s, 2H, B3); 7.83 (td, J 7.8, 1.5 Hz, 2H, A4); 7.33 (dd, J 7.3, 
5.1 Hz, 2H, A5); 4.35 (t, J 6.1 Hz, 2H, a); 2.45 (td, J 6.9, 2.5 Hz, 2H, c); 2.08 
(m, J 6.6 Hz, 2H, b); 1.98 (t, J 2.5 Hz, 1H, C≡CH). 
 
13C NMR (CDCl3 100 MHz): δ/ppm 167.6 (B4); 157.4 (A2/B2); 156.4 (A2/B2); 
149.4 (A6); 137.4 (A4); 124.3 (A5); 121.8 (A3); 107.79 (B3); 83.6 (C≡CH); 
69.5 (C≡CH); 66.8 (a); 28.4 (b); 15.5 (c).   
 
MALDI: M/z 316 [M]+. 
 
IR (solid, cm-1): 3296w, 3258w, 3194w, 2937w, 1599m, 1582s, 1559s, 1466s, 
1443s, 1404s, 1364s, 1342s, 1252m, 1200s, 1117w, 1094m, 1040s, 991s, 
960m, 903w, 885m, 860m, 795s, 743s, 696s, 658s, 621s.  
 
UV/VIS λmax/nm (2.41x10-5 mol dm-3 CH2Cl2) 278 (ε/dm3 mol-1 cm-1 12000). 
 
Elemental analysis: Calc. C 76.17 %, H 5.43 %, N 13.32 %; Found C 
75.32/75.41 %, H 5.33/5.43 %, N 13.04/13.06 %. 
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Melting Point: STA shows two different phase changes at 96 and 115 ˚C. 
 
6.1.4  4'-(5-Hexyn-1-oxy)-2,2':6',2"-terpyridine 33 
 
HO-tpy (0.520 g, 2.09 mmol), K2CO3 (2.2 g, excess) and 6-bromohex-
1-yne (0.697 g, 4.33 mmol) in MeCN (50 ml) were stirred at 60°C for 12 hours. 
The reaction was poured into iced water and the precipitate collected by 
filtration and purified by recrystallisation from EtOH (0.384 g, 1.15 mmol, 56 
%).  
 
1H NMR (CDCl3, 400 MHz): δ/ppm 8.70 (ddd, J 4.8, 1.6, 0.8 Hz, 2H, A6); 8.63 
(dt, J 8.0, 1.1 Hz, 2H, A3); 8.04 (s, 2H, B3); 7.88 (td, J 7.6, 1.6 Hz, 2H, A4); 
7.35 (ddd, J 7.2, 4.8, 1.2 Hz, 2H, A5); 4.28 (t, J 6.4 Hz, 2H, a); 2.30 (td, J 7.2, 
2.4 Hz, 2H, d); 2.00 (quintet, J 6.8 Hz, 2H, b); 1.99 (t, J 2.4 Hz, 1H, C≡CH); 
1.77 (quintet, J 6.8 Hz, 2H, c).  
 
13C NMR (CDCl3 125 MHz): δ/ppm 167.4 (B4), 157.0 (A2/B2), 156.0 (A2/B2), 
149.0 (A6), 136.9 (A4), 123.9 (A5), 121.4 (A3), 107.4 (B3), 84.0 (C≡CH), 68.8 
(C≡CH), 67.6 (a), 28.0 (b), 24.9 (c), 18.1 (d).  
 
MALDI: M/z 331 [M]+. 
 
IR (solid, cm-1): 3202w, 2947w, 2870w, 1558s, 1466m, 1442.66s, 1404s, 
1358s, 1250m, 1204s, 1157m, 1119m, 1088m, 1018s, 987s, 918s, 864s, 
787s, 733s, 694s, 656s, 617s. 
 
UV/VIS λmax/nm (1.82x10-5 mol dm-3 CH2Cl2) 211 (ε/dm3 mol-1 cm-1 34500), 
242 (28600). 
 
Elemental analysis: Calc. C 76.57 %, H 5.81 %, N 12.76 %; Found C 
74.97/74.90 %, H 5.70/5.80 %, N 12.37/12.53 %. 
 
Melting Point: 97.1 - 98.9 °C (both polymorphs). 
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6.1.5  4'-[2-(2-Hydroxyethoxy)ethoxy]-2,2':6',2"-
terpyridine 44 
 
HO-tpy (0.509 g, 2.04 mmol), KI (0.310 g, 2.06 mmol) and K2CO3 (1.13 
g, 8.16 mmol) in DMF (20 ml) were stirred at 70°C for 1 hour. 2-(2-
Chloroethoxy)ethanol (0.23 ml, 2.18 mmol) was added and the reaction stirred 
at this temperature for 48 hours. The solvent was removed and the residue 
suspended in CH2Cl2. This was washed with 2M NaOH solution, saturated 
NaHCO3 and finally water. The water phase was washed with CH2Cl2 and the 
combined CH2Cl2 phases dried over MgSO4. The solvent was removed to 
leave a brown oil which later solidified. The 1H NMR spectrum agreed with 
those values reported in the literature. The 13C NMR spectrum had been 
reported4 but the peaks had not been assigned (0.41 g, 1.18 mmol, 57 %).   
 
1H NMR (CDCl3, 500 MHz): δ/ppm 8.66 (dq, J 4.8, 0.9 Hz, 2H, A6); 8.57 (dt, J 
7.9, 0.9 Hz, 2H, A3); 8.07 (s, 2H, B3); 7.82 (td, J 7.9, 1.4 Hz, 2H, A4); 7.31 
(ddd, J 7.4, 4.8, 1.1 Hz, 2H, A5); 4.41 (t, J 4.5 Hz, 2H, a); 3.91 (t, J 4.5 Hz, 
2H, b); 3.76 (t, J 4.7 Hz,  2H, d); 3.66 (t, J 4.0 Hz, 2H, c). 
 
13C NMR (CDCl3, 125 MHz): δ/ppm 167.0 (B4); 156.9 (A2/B2); 155.9 (A2/B2); 
148.9 (A6); 136.8 (A4); 123.8 (A5); 121.3 (A3); 107.7 (B3); 72.8 (c); 69.9 (b); 
67.9 (a); 61.7 (d). 
 
6.1.6  4'-(4,7,10-Trioxa-10-dec-1-ynyl)-2,2':6',2"-
terpyridine 55 
 
Ligand 4 (0.398 g, 1.15 mmol) in MeCN with KOH (0.687 g, 12.2 mmol) 
were stirred for 1 hour at room temperature. Propargyl bromide (80 % in 
toluene) (0.14 ml, 1.26 mmol) was added and the mixture stirred at 60°C for 
24 hours. The reaction mixture was poured into water and extracted with 
CH2Cl2. The CH2Cl2 layer was dried over MgSO4 and the solvent was 
removed to yield a brown oil (0.23 g, 0.597 mmol, 53 %). 
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1H NMR (CDCl3, 400 MHz): δ/ppm 8.68 (d, J 4.5 Hz, 2H, A6); 8.59 (d, J 8.1 
Hz, 2H, A3); 8.03 (s, 2H, B3); 7.84 (td, J 7.6, 1.5 Hz, 2H, A4); 7.32 (dd, J 7.6, 
4.5 Hz, 2H, A5); 4.40 (t, J 4.5 Hz, 2H, a); 4.21 (d, J 2.0 Hz, 2H, e); 3.89 (t, J 
4.5 Hz, 2H, b); 3.78 (m, 2H, d); 3.73 (m, 2H, c); 2.44 (t, J 2.0 Hz, 2H, C≡CH). 
 
13C NMR (CDCl3 100 MHz): δ/ppm 167.3 (B4); 157.5 (A2/B2); 156.4 (A2/B2); 
149.4 (A6); 137.2 (A4); 124.22 (A5); 121.7 (A3); 107.8 (B3); 79.6 (C≡CH); 
74.6 (C≡CH); 70.3 (c); 69.4 (b); 69.1 (d); 67.8 (a); 58.4 (e). 
 
MALDI: M/z 377 [M]+. 
 
IR (solid, cm-1): 3232w, 2947w, 2878w, 1983w, 1558s, 1466m, 1443m, 1404s, 
1366m, 1250w, 1204s, 1119s, 1065m, 1034s, 987m, 926m, 895m, 864m, 
787s, 741s, 694m, 656m, 617m.  
 
UV/VIS λmax/nm (3.18x10-5 mol dm-3 CH2Cl2) 242 (ε/dm3 mol-1 cm-1 25000), 
278 (23800). 
 
Elemental analysis: Calc. +0.5 H2O C 68.73 %, H 5.77 %, N 10.93 %; Found 
C 69.19/69.49 %, H 5.79/5.65 %, N 10.80/10.83 %. 
 
6.1.7  4'-(4-Bromophenyl)-2,2':6',2"-terpyridine 66 
 
4-Bromobenzaldehyde (1.10 g, 5.96 mmol) and 2-acetylpyridine (1.32 
g, 10.9 mmol) were ground with powdered NaOH (0.477 g, 11.9 mmol) until a 
yellow solid formed. The solid was washed with water and collected by 
filtration. This was then heated to reflux with ammonium acetate (5 g, excess) 
in acetic acid (25 ml). Water (50 ml) was then added and the precipitate was 
collected. The product was purified by recrystallisation from ethanol. The 1H 
NMR agreed well with that published in the literature (0.692 g, 1.78 mmol, 30 
%). 
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1H NMR (CDCl3, 250 MHz): δ/ppm 8.76 (d, J 6.4 Hz, 2H, A6); 8.74 (s, 2H, 
B3); 8.70 (d, J 8.0 Hz, 2H, A3); 7.93 (td, J 8.0, 1.7 Hz, 2H, A4); 7.75 (m, 4H, 
C2 and C3); 7.41 (ddd, J 7.4, 4.7, 1.3 Hz, 2H, A5). 
 
6.1.8  4'-(4-Ethynylphenyl)-2,2':6',2"-terpyridine 77 
 
Ligand 6 (0.307 g, 0.792 mmol), [(Ph3P)2PdCl2] (0.0362 g, 0.0516 
mmol), PPh3 (0.0104 g, 0.0534 mmol) and CuI (0.0218 g, 0.115 mmol) were 
stirred in NEt3 (30 ml) for 1 hour, during which the reaction was heated to 73 
°C and cooled back to 40 °C. Ethynyl TMS (0.055 ml, 3.96 mmol) was added 
and the reaction was stirred at 40 °C for 5 days. The solvent was removed 
and chromatographed using an alumina column with CH2Cl2 as the eluent. A 
brown solid was obtained. This solid was then stirred with K2CO3 (1.05 g, 
excess) for 1 day. Water and CH2Cl2 were added and the CH2Cl2 layer was 
extracted and dried with MgSO4. The solvent was evaporated to give the solid 
product. The 1H NMR spectrum agreed well with that published in the 
literature (0.18 g, 0.540 mmol, 79 %). 
 
1H NMR (CDCl3, 250 MHz): δ/ppm 8.78 (s, 2H, B3); 8.77 (d, J 5.4 Hz, 2H, A6); 
8.71 (d, J 8.0 Hz, 2H, A3); 7.94 (td, J 7.4, 1.7 Hz, 2H, A4); 7.80 (m, 4H, C2 
and C3); 7.41 (dd, J 7.4, 4.7 Hz, 2H, A5); 3.22 (s, 1H, C≡CH). 
 
6.1.9  4'-(3-Bromophenyl)- 2,2':6',2"-terpyridine 88 
 
2-Acetylpyridine (4.0 ml, 35.7 mmol) was added to a solution of 3-
bromobenzaldehyde (2.1 ml, 17.9 mmol) in EtOH (100 ml) and stirred. 
Ground KOH pellets (2.07 g, 36.9 mmol) and aqueous NH3 (25 %) (56 ml) 
were added and the reaction stirred at room temperature for 4 hours. The 
solid that precipitated was collected by filtration and recrystallised from 
CH2Cl2/MeOH. The 1H NMR spectrum agreed well with that published in the 
literature (4.97 g, 12.8 mmol, 71 %). 
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1H NMR (CDCl3, 500 MHz): δ/ppm 8.66 (d, J 5.6 Hz, 2H, A6); 8.59 (s, 2H, 
B3); 8.58 (dt, J 8.1, 1.0 Hz, 2H, A3); 8.00 (t, J 1.5 Hz, 1H, C2); 7.84 (td, J 8.1, 
1.5 Hz, 2H, A4); 7.78 (ddd, J 7.8, 1,7, 1.0 Hz, 1H, C4/C6); 7.53 (ddd, J 8.0, 
1.9, 1.0 Hz, 1H, C4/C6); 7.33 (m, 3H, A5 and C5). 
 
6.1.10 4'-(3-Ethynylphenyl)-2,2':6',2"-terpyridine 9 
 
Ligand 8 (0.686 g, 1.77 mmol), [(Ph3P)2PdCl2] (0.0836 g, 0.119 mmol), 
PPh3 (0.0339 g, 0.129 mmol) and CuI (0.0447 g, 0.235 mmol) in NEt3 (50 ml) 
were heated to 70 °C and cooled back to 40 °C over 1 hour. Ethynyl TMS 
(1.22 ml, 8.81 mmol) was added and the reaction stirred for 5 days. The 
mixture was filtered through Celite and the solvent removed from the filtrate. 
The solid obtained was purified with column chromatography using 1 % 
acetone in CH2Cl2 over an alumina column. The single terpyridine fraction 
was identified by spotting a small amount of the eluent onto an alumina 
covered TLC plate which was then dipped in an aqueous solution of 
FeCl2.4H2O. If the spot showed up purple the fraction contained a tpy ligand. 
This fraction was collected and the solvent removed. K2CO3 (1.9 g, excess) 
was added as well as MeOH (15 ml) and THF (15 ml) and the reaction stirred 
overnight. Water (30 ml) and CH2Cl2 (30 ml) were added and the organic 
layer was extracted. It was dried over Na2SO4 and the solvent was removed 
to yield a brown solid. This was purified by column chromatography with 1 % 
acetone in CH2Cl2 over alumina. The terpyridine fraction was identified as 
above and collected, and the solvent removed. Due to its poor solubility it was 
not possible to purify this compound in order to obtain an elemental analysis 
(0.265 g, 0.795 mmol, 45 %). 
 
1H NMR ((CD3)2SO, 500 MHz): δ/ppm 8.77 (dq, J 4.7, 0.9 Hz, 2H, A6); 8.68 
(s, 2H, B3); 8.66 (dt, J 8.0, 1.0 Hz, 2H, A3); 8.06 (t, J 1.8 Hz, 1H, C2); 8.04 
(td, J 7.6, 1.8 Hz, 2H, A4); 7.93 (dq, J 7.8, 0.9 Hz, 1H, C6); 7.74 (dq, J 8.0, 0.9 
Hz, 1H, C4); 7.55 (t, J 8.0 Hz, 1H, C5); 7.54 (td, J 4.7, 1.1 Hz, 2H, A5);  4.34 
(s, 1H, C≡CH). 
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13C NMR ((CD3)2SO, 125 MHz): δ/ppm 155.7 (A2/B2); 154.7 (A2/B2); 149.3 
(A6); 148.0 (C1); 140.0 (B4); 137.5 (A5); 132.2 (C4); 131.5 (C5); 129.5 (C2); 
126.1 (C6); 124.6 (A4); 122.6 (C3); 120.9 (A3); 118.1 (B3); 82.9 (C≡CH); 81.6 
(C≡CH). 
 
MALDI: M/z 395 [M + K + Na]+. 
 
IR (solid, cm-1): 3153w, 3060w, 3019w, 1605w, 1583s, 1566s, 1539s, 1466s, 
1440.73m, 1414m, 1381s, 1263m, 1231w, 1175w, 1124m, 1094w, 1078m, 
1038s 989s, 960w, 914w, 876s, 845m, 775s. 
 
UV/VIS λmax/nm (1.20x10-5 mol dm-3 CH2Cl2) 212 (ε/dm3 mol-1 cm-1 46000), 
231 (38000), 315 (8000). 
 
Melting Point: 142.0-148.3 °C. 
 
6.1.11 4'-[1,1,1-Tris(2-propyn-1-oxymethyl)methoxy]-
2,2':6',2"-terpyridine 12 
 
4'-[1,1,1-Tris(hydroxymethyl)methoxy]-2,2':6',2"-terpyridine9 (0.194 g, 
0.528 mmol) and ground KOH (0.299 g, 5.33 mmol) lin DMSO (3 ml) were 
stirred at room temperature for 30 minutes until the mixture became a white 
suspension. 3-Bromoprop-1-yne (80 % in toluene) (0.59 ml, 5.28 mmol) was 
added and the reaction stirred at room temperature for 4 days. The reaction 
mixture was then poured into water (100 ml) and extracted with CH2Cl2 (30 
ml) until both layers were no longer cloudy. The solvent was removed from 
the organic layer. The product was purified by column chromatography on 
alumina using 5 % MeOH in CHCl3 as the eluent. The first fraction contained 
the product, and was collected as a yellow oil (0.0583 g, 0.121 mmol, 23 %). 
The second fraction was found to be the bis-alkyne complex (0.0180 g, 
0.0406 mmol, 17 %). 
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1H NMR (CDCl3, 500 MHz): δ/ppm 8.69 (dq, J 4.8, 0.9 Hz, 2H, A6); 8.62 (dt, J 
7.9, 0.9 Hz, 2H, A3); 8.03 (s, 2H, B3); 7.85 (td, J 7.6, 1.8 Hz, 2H, A4); 7.33 
(ddd, J 7.4, 4.8, 1.2 Hz, 2H, A5); 4.27 (s, 2H, a); 4.13 (d, J 2.4 Hz, 6H, c); 3.68 
(s, 6H, b); 2.41 (t, J 2.4 Hz, 3H, C≡CH). 
 
13C NMR (CDCl3, 125 MHz): δ/ppm 167.2 (B4); 156.7 (A2/B2); 155.9 (A2/B2); 
148.9 (A6); 137.1 (A4); 123.8 (A5); 121.3 (A3); 107.6 (B3); 79.8 (C≡CH); 74.3 
(C≡CH); 68.5 (b); 66.9 (a); 58.7 (c); 44.8 (C(CH2)4). 
 
6.2 Platinahomoditopic Ligands 
 
6.2.1  Pt(1-H)2(PEt3)210 
 
Ligand 12 (0.108 g, 0.376 mmol) and trans-PtI2(PEt3)2 (0.128 g, 0.186 
mmol) and CuI (0.0050 g, 0.0263 mmol) in NEt3 (5 ml) were stirred for 2 hours 
at room temperature. The white precipitate formed was collected by filtration. 
It was separated by column chromatography on alumina using 
CH2Cl2/acetone 4:1 as the eluent and recrystallised from hexane/CH2Cl2 
(0.113 g, 0.113 mmol, 71 %).  
 
1H NMR (CDCl3, 500 MHz): δ/ppm 8.65 (dm, J 4.0 Hz, 4H, A6);  8.58 (dt, J 
8.0, 1.0 Hz, 4H, A3);  8.06 (s, 4H, B3); 7.82 (td, J 7.6, 1.8 Hz, 4H, A4); 7.30 
(ddd, J 7.5, 5.2, 1.2 Hz, 4H, A5); 4.96 (s, 4H, a); 1.83 (ddq, JHH 7.5, JPH 4.2, 
JP’H 3.8 Hz,  12H, y); 0.88 (dt + ddt, JHH 7.5, JPH 15.5, JPtH 120 Hz, 18H, z). 
 
13C NMR (CDCl3 125 MHz): δ/ppm 166.6 (B4); 156.6 (A2/B2); 156.2 (A2/B2); 
148.8 (A6); 136.6 (A4); 123.5 (A5); 121.1 (A3); 108.1 (B3); 104.8 (t+d, JPC 
14.4, JPtC 963 Hz, C≡CPt); 101.2 (s+d, JPtC 270 Hz, C≡CPt); 58.7 (s+d, JPtC 18 
Hz, a); 15.8 (t+dt, JPC 17.4 Hz, JPtC 35 Hz, y); 8.0 (s+d, JPtC 20 Hz, z).  
 
31P NMR (CDCl3 202 MHz): δ/ppm 10.8 (s+d, J 2352 Hz). 
 
195Pt NMR CDCl3 107 MHz): δ/ppm -4873 (t, J 2353 Hz). 
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MALDI: M/z 1003 [M]+.  
 
IR (solid, cm-1): 29620w, 2924w, 2870w, 21210m, 1736w, 1558s, 1443m, 
1404m, 1335m, 1258m, 1188m, 1088w, 1011s, 972m, 864m, 787m, 733s, 
617m, 563w, 525w. 
 
UV/VIS λmax/nm (1.88x10-5 mol dm-3 CH2Cl2) 246 (ε/dm3 mol-1 cm-1 68900), 
278 (69550). 
 
Fluorescence (CH2Cl2, 1.88x10-5 mol dm-3): 450 nm on excitation at 292 nm. 
 
Elemental analysis: Calc. C 57.422 %, H 5.421 %, N 8.371 %; Calc. +H2O C 
56.41 %, H 5.52 %, N 8.22 %; Found C 56.69/56.85 %, H 5.40/5.46 %, N 
8.23/8.19 %. 
 
6.2.2  Pt(1-H)2(PnBu3)211 
 
Ligand 12 (0.1350 g, 0.4699 mmol) and trans-PtI2(PnBu3)2 (0.2067 g, 
0.2422 mmol) and CuI (cat.) in NEt3 (5 ml) were stirred for 2 hours at room 
temperature. The white precipitate formed was collected by filtration. The 
product was purified by recrystallisation from hexane/CH2Cl2 (0.186 g, 0.159 
mmol, 68 %).  
 
1H NMR (CDCl3 500 MHz): δ/ppm 8.65 (ddd, J 4.8, 1.8, 1.0 Hz, 4H, A6);  8.58 
(dt, J 8.6, 1.0 Hz, 4H, A3);  8.05 (s, 4H, B3); 7.82 (td, J 7.6, 1.8 Hz, 4H, A4); 
7.30 (ddd, J 7.6, 4.8, 1.0 Hz, 4H, A5); 4.94 (s, 4H, CH2O); 1.85 (m, 12H, w); 
1.34 (m, 12H, x); 1.24 (q, J 7.2 Hz, 12H, y); 0.77 (t, J 7.2 Hz, 18H, z). 
 
13C NMR (CDCl3 100 MHz): δ/ppm 167.1 (B4); 157.0 (A2/B2); 156.6 (A2/B2); 
149.3 (A6); 137.2 (A4); 124.1 (A5); 121.7 (A3); 108.7 (B3); 104.9 (t, JPC 14.3 
Hz, C≡CPt); 100.4 (s+d, JPtC 270 Hz, C≡CPt); 58.7 (a); 26.5 (x/y); 24.1 (x/y);  
23.4 (t, JPC 17 Hz, w); 13.7 (z).  
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31P NMR (CDCl3 162 MHz): δ/ppm -0.4 (s+d, JPPt 2340 Hz).  
 
195Pt NMR (CDCl3 107 MHz) : δ/ppm -4843 (t, JPPt 2329 Hz). 
 
MALDI: M/z 1174 [M]+.  
 
IR (solid, cm-1): 2947m, 2924m, 2856m, 2123m, 1582s, 1560s, 1466m, 
1423m, 1404m, 1377w, 1337m, 1258w, 1184s, 1090m, 1064w, 1049w, 
1009s, 989s, 970s, 903m, 866m, 791s, 746s, 746m, 733m, 692m, 660m, 
609s.  
 
UV/VIS λmax/nm (3.75x10-5 mol dm-3 CH2Cl2) 254 (ε/dm3 mol-1 cm-1 19100), 
279 (20700). 
 
Fluorescence (CH2Cl2, 3.75x10-5mol dm-3):  emission at 452 nm on excitation 
at 322 nm. 
 
Elemental analysis: Calc. C 61.47 %, H 6.71 %, N 7.17 %; Calc. +3H2O C 
58.76 %, H 6.90 %, N 6.85 %; Found C 58.89/59.22 %, H 6.30/6.36 %, N 
6.66/6.78 %. 
 
6.2.3  Pt(1-H)2(PPh3)211 
 
 Ligand 12 (0.0789 g, 0.275 mmol), trans-PtI2(PPh3)2 (0.0409 g, 0.0449 
mmol) and CuI (0.0020 g, 0.0110 mmol) in CH2Cl2 (7 ml) and NEt3 (7 ml) were 
stirred for 5 days at room temperature.  The green precipitate was removed 
by filtration. It was chromatographed over alumina with CH2Cl2/acetone (99:1) 
as the eluent. The second fraction was isolated as a white crystalline solid 
(0.0283 g, 0.0219 mmol, 49 %). 
 
1H NMR (C6D6, 400 MHz): δ/ppm 8.74 (dt, J 7.9, 1.0 Hz, 4H, A3);  8.38 (ddd, J 
4.7, 1.8, 1.0 Hz, 4H, A6);  8.33 (s, 4H, B3); 7.85 (m, 12H, Ph); 7.30 (td, J 7.6, 
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1.8 Hz, 4H, A4); 6.95 (m, 18H, Ph); 6.70 (ddd, J 7.6, 4.8, 1.0 Hz, 4H, A5); 
4.18 (s, 4H, a).  
  
13C NMR (C6D6, 100 MHz): δ/ppm 167.4 (B4); 157.2 (A2/B2); 157.0 (A2/B2); 
149.3 (A6); 136.3 (A4); 135.5 (t, JPC 6.3 Hz, x); 131.6 (t, JPC 28.8 Hz, w); 
130.3 (y, z); 123.4 (A5); 121.2 (A3); 109.0 (B3); 108.2 (Calkyne); 105.2 (Calkyne); 
58.8 (a).  
 
31P NMR (C6D6 162 MHz): δ/ppm 20.2 (s+d, JPPt 2635 Hz). 
 
195Pt NMR (C6D6 107 MHz): δ/ppm -4921 (t, JPPt 2625 Hz). 
 
MALDI: M/z 1292 [M]+.  
 
IR (solid, cm-1): 3047w, 2920w, 2858w, 2131m, 1580s, 1560s, 1433m, 
1406m, 1329m, 1259w, 1184m, 1090m, 1014s, 989m, 972m, 883m, 862.12w, 
791w, 692s. 
 
UV/VIS λmax/nm (1.30x10-5 mol dm-3 CHCl3) 246 (ε/dm3 mol-1 cm-1 70500), 278 
(66700), 302 (36600). 
 
Fluorescence (CHCl3, 1.30x10-5 mol dm-3):  emission at 455 nm on excitation 
at 325 nm. 
 
Elemental analysis: Calc. C 66.92 %, H 4.21 %, N 6.50 %; Calc. +C6D6 C 
68.06 %, H 3.95 %, N 6.11 %; Found C 68.03/67.83 %, H 4.45/4.53 %, N 
6.31/6.38 %. 
  
6.2.4  PtI(5-H)(PEt3)25 
 
 Ligand  5 (0.0492 g, 0.131 mmol) and CuI (0.0004 g, 0.002 mmol) were 
added to THF (1.5 ml). The suspension was added to a solution of PtI2(PEt3)2 
(0.0479 g, 0.0699 mmol) in DMF (1.5 ml) and NEt3 (3 ml). The reaction was 
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stirred at room temperature for 4 days. Water was added to separate the 
product as a sticky oil. The product was purified by chromatography over 
alumina using CH2Cl2/acetone (99:1) as the eluent. The second fraction was 
collected and after removal of the solvent the product was isolated as a white 
oil (0.133 g, 0.0143 mmol, 20.5 %). 
 
1H NMR (CDCl3, 500 MHz): δ/ppm 8.72 (d, J 4.7 Hz, 2H, A6); 8.66 (d, J 8.0 
Hz, 2H, A3); 8.08 (s, 2H, B3); 7.89 (td, J 7.8, 1.8 Hz, 2H, A4); 7.37 (ddd, J 7.4, 
4.8, 1.0 Hz, 2H, A5); 4.44 (t, J 4.6 Hz, 2H, a); 4.29 (t, JPH 1.7 Hz, 2H, e); 3.98 
(t, J 4.8 Hz, 2H, b); 3.77 (m, 2H, c); 3.73 (m, 2H, d); 2.18 (m, 12H, y); 1.15 (m, 
18H, z). 
 
13C NMR (CDCl3, 125 MHz): δ/ppm 167.0 (B4); 157.1 (A2/B2); 156.0 (A2/B2); 
149.0 (A6); 136.8 (A4); 123.9 (A5); 121.4 (A3); 107.4 (B3); 94.9 (C≡CPt); 71.0 
(c); 69.4 (b); 68.3 (d); 67.9 (a); 61.2 (e); 16.5 (y); 8.3 (z). 
 
31P NMR (CDCl3 202 MHz): δ/ppm 8.8 (s+d, J 2323 Hz). 
 
195Pt NMR (CDCl3 107 MHz): δ/ppm -4936 (t, JPPt 2354 Hz). 
 
MALDI: M/z 957 [M + Na]+, [M – I]+.  
 
IR (solid, cm-1): 3055w, 2924m, 2878m, 2129w, 1728w, 1566s, 1450s, 1412s, 
1350m, 1258m, 1204m, 1126m, 1095s, 1034s, 995w, 872w, 795w, 632w, 
540s. 
 
UV/VIS λmax/nm (4.80x10-5 mol dm-3 CH2Cl2) 239 (ε/dm3 mol-1 cm-1 48000), 
276 (40400). 
 
6.2.5  Pt(5-H)2(PEt3)25 
 
Ligand 55 (0.139 g, 0.396 mmol), PtI2(PEt3)2 (0.0454 g, 0.0663 mmol) 
and CuI (0.0028 g, 0.0147 mmol) in CH2Cl2 (20 ml) and NEt3 (20 ml) were 
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stirred for 5 days at room temperature. The precipitate was removed by 
filtration. The solvent was removed from the filtrate and the resulting solid 
separated by column chromatography over alumina using CH2Cl2:acetone 
99:1 as the eluent. The second fraction was collected as a white oil (0.0281 g, 
0.0248 mmol, 36 %). 
 
1H NMR (CDCl3, 500 MHz): δ/ppm 8.67 (dm, J 5.0 Hz, 4H, A6);  8.52 (dm, J 
8.0 Hz, 4H, A3);  8.03 (s, 4H, B3); 7.84 (td, J 4.9, 1.8 Hz, 4H, A4); 7.33 (ddd, J 
3.5, 6.0, 1.2 Hz, 4H, A5); 4.39 (t, J 4.6 Hz, 4H, a); 4.26 (t, J 1.4 Hz, 4H, e); 
3.93 (dd, J 3.8, 4.8 Hz, 4H, b); 3.74 (m, 8H, c and d); 2.03 (m, 12H, y); 1.10 
(m, 18H, z). 
 
13C NMR (CDCl3 125 MHz): δ/ppm 167.0 (B4); 157.1 (A2/B2); 156.1 (A2/B2);  
149.0 (A6);  136.8 (A4);  123.8 (A5); 121.3 (A3); 107.4 (B3); 103.2 (C≡CPt); 
101.4 (t, JPC 14.5 Hz, C≡CPt); 71.0 (c); 69.4 (b); 67.9 (d);  67.8 (a);  60.9 (e); 
16.1 (t, JPC 17.5 Hz, y); 8.2 (z).  
 
31P NMR (CDCl3 202 MHz): δ/ppm 7.9 (s+d, J 2379 Hz). 
 
195Pt NMR (CDCl3 107 MHz): δ/ppm -4875 (t, J 2366 Hz). 
 
MALDI: M/z 1181 [M]+, 945 [M-2(PEt3)]+. 
 
IR (solid, cm-1):  2959m, 2920m, 2874m, 2853m, 2114m, 1727w, 1676s, 
1582s, 1562s, 1468m, 1441m, 1406s, 1379w, 1346m, 1278w, 1252w, 1204m, 
1134m, 1090s, 1057m, 1036s, 991m, 968m, 870m,795s, 758m, 735s, 698w, 
660m, 635m, 621m. 
 
UV/VIS λmax/nm (3.89x10-5 mol dm-3 CH2Cl2) 242 (ε/dm3 mol-1 cm-1 27450), 
277 (27200), 308 (10300). 
 
Fluorescence (CHCl3, 3.89x10-5 mol dm-3):  emission at 440 nm on excitation 
at 300 nm. 
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6.2.6  Pt(7-H)2(PEt3)2 
 
 Ligand 77 (0.103 g, 0.310 mmol) and CuI (0.0013 g, 0.0068 mmol) in 
THF (15 ml) and a solution of PtI2(PEt3)2 (0.0220 g, 0.0321 mmol) in DMF (3 
ml) and NEt3 (3 ml) were sonicated for 1 hour then stirred at room 
temperature for 4 days. The orange solution was poured into water (50 ml) 
and the precipitate formed was collected by filtration. The precipitate was 
washed with CH2Cl2 to give a yellow solution and a small amount of insoluble 
orange solid. The yellow solution was dried over Na2SO4 and the solvent was 
removed to yield an off-white solid. This was then separated using column 
chromatography over alumina, with CH2Cl2 as the eluent. Tpy fractions were 
identified by spotting a small amount of eluent on an alumina covered TLC 
plate then dipping this in an aqueous solution of FeCl2.4H2O. Fractions 
showing up purple after this test contained tpy. The second tpy-containing 
fraction was collected. The solvent was removed to give a yellow solid. Due to 
the low solubility as well as decomposition of the complex it was not possible 
to obtain a 13C NMR spectrum well enough resolved to assign the signals 
(0.0279 g, 0.025 mmol, 79 %). 
 
1H NMR (CDCl3, 500 MHz): δ/ppm 8.73 (m, 8H, A6 and B3); 8.67 (dt, J 7.9, 
1.0 Hz, 4H, A3); 7.88 (td, J 5.9, 1.7 Hz, 4H, A5); 7.81 (d, J 8.5 Hz, 4H, 
C2/C3); 7.41 (d, J 4.7 Hz, 4H, C2/C3); 7.38 (ddd, J 3.6, 8.1, 1.1 Hz, 4H, A4); 
2.23 (m, 12H, y); 1.28 (m, 18H, z). 
 
13C NMR (CDCl3, 125 MHz): δ/ppm 156.3, 155.8, 150.1, 149.2, 149.1, 136.9, 
134.7, 131.4, 126.9, 123.8, 121.4, 118.5, 110.7, 109.6, 16.4 (s+d, J 0.04 Hz), 
8.4.   
 
31P NMR (CDCl3, 202 MHz): δ/ppm 11.6 (s+d, J 2357 Hz). 
 
195Pt NMR (CDCl3, 107 MHz): δ/ppm -4839 (t, J 4.7 Hz). 
 
MALDI: M/z  450 [M-2(tpy-ph)]+. 
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IR (solid, cm-1): 2098m, 1582m, 1504m, 1458m, 1381m, 1242w, 1211w, 
1180w, 1034m, 895m, 833s, 795s, 733s, 617m, 579w.  
 
UV/VIS λmax/nm (9.12x10-5 mol dm-3 CH2Cl2) 291 (ε/dm3 mol-1 cm-1 16700). 
 
Fluorescence (CH2Cl2, 9.12x10-6 mol dm-3): 396 nm on excitation at 300 nm. 
 
6.2.7  Pt(7-H)2(PnBu3)2 
 
 Ligand 77 (0.0826 g, 0.284 mmol), PtI2(PnBu3)2 (0.121 g, 0.141 mmol) 
and CuI (0.0054 g, 0.0282 mmol) in NEt3 (5 ml) were stirred at room 
temperature for 1 hour. The precipitate was removed by filtration and the 
solvent was removed from the filtrate. Purification by both chromatography 
and recrystallisation was unsuccessful and resulted in the decomposition so 
the product was characterised as crude (0.0899 g, 0.0711 mmol, 50 %). Due 
to the poor solubility of the product it was not possible to obtain a well 
resolved 13C NMR spectrum. 
 
1H NMR (C6D6, 400 MHz): δ/ppm 9.18 (s, 4H, B3); 8.78 (d, J 7.9, 4H, A3); 
8.61 (d, J 3.9 Hz, 4H, A6); 7.65 (d, J 8.3 Hz, 4H, C2/C3); 7.57 (d, J 8.3 Hz, 
4H, C2/C3); 7.36 (td, J 7.6, 1.7 Hz, 4H, A4); 6.69 (ddd, J 7.4, 4.8, 1.0 Hz, 4H, 
A5); 2.19 (m, 12H, w); 1.73 (m, 12H, x); 1.48 (septuplet, J 7.4 Hz, 12H, y); 
0.96 (t, J 7.4 Hz, 18H, z). 
 
31P NMR (C6D6, 162 MHz): δ/ppm 0.9 (s+d, J 2365 Hz). 
  
MALDI: M/z 1266 [M]+. 
 
IR (solid, cm-1): 2947m, 2924m, 2862m, 2098s, 1975w, 1898w, 1697w, 
1581s, 1504s, 1466s, 1381s, 1265w, 1211w, 1180w, 1072m, 1034m, 964w, 
895m, 833s.  
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UV/VIS λmax/nm (1.11x10-5 mol dm-3 CH2Cl2) 233 (ε/dm3 mol-1 cm-1 73250), 
285 (67900), 348 (61500). 
 
Fluorescence (CH2Cl2, 1.11x10-5 mol dm-3): 416 nm on excitation at 348 nm. 
 
6.3 Gold(I) Complexes 
 
6.3.1  Au(1-H)(PnBu3) 
 
Ligand 12 (0.219 g, 0.763 mmol) and AuCl(PnBu3)12 (0.330 g, 0.750 
mmol) and CuI (0.0147 g, 0.0772 mmol) in NEt3 (10 ml) were stirred for 4 
hours at room temperature. The solvent was removed from the reaction 
mixture and the product was separated by column chromatography on 
alumina using CH2Cl2/acetone 99:1 as the eluent. The only fraction was 
collected and the solvent was removed (0.233 g, 0.340 mmol, 45 %). 
 
1H NMR (CDCl3, 400 MHz): δ/ppm 8.65 (ddd, J 4.7, 1.8, 0.8 Hz, 2H, A6);  8.54 
(dt, J 7.9, 0.9 Hz, 2H, A3);  8.04 (s, 2H, B3); 7.79 (td, J 7.6, 2.0 Hz, 2H, A4); 
7.26 (ddd, J 5.1, 7.6, 1.0 Hz, 2H, A5); 5.01 (s, 2H, a); 1.67 (m, 6H, w); 1.48 
(m, 6H, x); 1.38 (septuplet, J 7.6 Hz, 6H, y); 0.87 (t, J 7.6 Hz, 9H, z). 
 
13C NMR (CDCl3 100 MHz): δ/ppm 166.9 (B4); 157.4 (A2/B2); 156.7 (A2/B2); 
149.4 (A6); 137.0 (A4); 124.0 (A5); 121.7 (A3); 108.20 (B3); 108.0 (C≡CAu); 
97.2 (C≡CAu); 57.7 (a); 27.6 (y); 25.9 (d, JPC 32.2 Hz, w); 24.6 (d, JPC 14.6 
Hz, x); 14.0 (z). 
 
31P NMR (CDCl3 162 MHz): δ/ppm 25.7 (s). 
 
MALDI: M/z 686 [M]+. 
 
IR (cm-1, solid): 2955w, 2924w, 2862w, 2361w, 2130w, 1376w, 1558m, 
1450m, 1404m, 1335m, 1188m, 1088m, 1018s, 879w, 795m, 741m, 6178w, 
563w, 525w. 
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UV/VIS λmax/nm (CH2Cl2) 247, 277. 
 
Fluorescence: no fluorescence observed. 
 
6.3.2  (Au(1-H))2(dppe) 
 
(AuCl)2(dppe)13 (0.405 g, 0.447 mmol), ligand 12 (0.270 g, 0.934 mmol) 
and CuI (0.0094 g, 0.0494 mmol) in NEt3 (12 ml) and CH2Cl2 (12 ml) were 
stirred at room temperature for 4 days. The precipitate formed was collected 
by filtration and purified by column chromatography over alumina, using 
CH2Cl2/acetone 90:10 as the eluent. The single tpy fraction (no other fractions 
were present) was identified by spotting a small amount of the eluent onto an 
alumina covered TLC plate which was then dipped in aqueous FeCl2.4H2O 
solution, the resulting purple colour confirming the presence of a tpy moiety. 
The solvent was removed (0.253 g, 0.185 mmol, 40 %).  
 
1H NMR (CDCl3, 400 MHz): δ/ppm 8.63 (ddd, J 4.8, 1.8, 0.8 Hz, 4H, A6); 8.55 
(dt, J 8.1, 1.0 Hz, 4H, A3); 8.06 (s, 4H, B3); 7.78 (td, J 7.6, 1.8 Hz, 4H, A4); 
7.56 (q, J 6.6 Hz, 8H, PPh2); 7.34 (m, 12H, PPh2); 7.25 (ddd, J 7.6, 4.8, 1.0 
Hz, 4H, A5); 5.00 (s, 4H, a); 1.94 (s, 4H, b). 
 
13C NMR (CDCl3 100 MHz): δ/ppm 166.4 (B4); 157.0 (A2/B2); 156.2 (A2/B2); 
149.0 (A6); 136.7 (A4); 133.3 (x/y/z); 132.2 (x/y/z); 129.5 (x/y/z); 128.5 (w); 
123.9 (A5); 121.3 (A3); 107.8 (B3); 107.5 (Au-C≡C); 97.0 (Au-C≡C); 57.1 (a); 
23.7 (b). 
 
31P NMR (CDCl3 162 MHz): δ/ppm 36.5 (s). 
 
MALDI: M/z 1388.38 [M + Na]+, 1406 [M + K]+.  
 
IR (solid, cm-1): 3055w, 2924m, 285m, 1697w, 1558s, 1435s, 1404s, 1335s, 
1258m, 1188s, 1103m, 1018s, 879s, 795m, 725s, 687s.  
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UV/VIS λmax/nm (4.62x10-5 mol dm-3 CH2Cl2) 233 (ε/dm3 mol-1 cm-1 55500), 
253 (sh) (37900), 277 (30400). 
 
Fluorescence: no fluorescence observed. 
 
6.3.3  (AuPnBu3)3(12-3H) 
 
 Ligand 12 (0.161 g, 0.335 mmol), CuI (0.0094 g, 0.0494 mmol) and 
ClAu(PnBu3) (0.462 g, 0.0133 mmol) were stirred in NEt3 (5 ml) and CH2Cl2 (5 
ml) for 2 days. The precipitate which formed was collected by filtration. It was 
purified by column chromatography on alumina using 1 % acetone in CH2Cl2 
as the eluent. The single tpy fraction was eluted first and was identified by 
spotting a small amount of the eluent onto an alumina covered TLC plate and 
then dipping this in an aqueous solution of FeCl2.4H2O, the tpy fraction giving 
a purple colour and non-tpy fractions staying colourless. The solvent was 
removed from the tpy fraction to yield a white oil (0.0453 g, 0.0270 mmol, 8 
%). NMR chemical shifts were assigned based on comparison with ligand 12. 
 
1H NMR (CDCl3, 400 MHz): δ/ppm 8.66 (dq, J 4.8, 0.9 Hz, 2H, A6); 8.56 (dt, J 
7.9, 1.0 Hz, 2H, A3); 7.98 (s, 2H, B3); 7.79 (d, J 7.5, 1.8 Hz, 2H, A4); 7.26 
(ddd, J 7.5, 4.8, 1.2 Hz, 2H, A5); 4.30 (s, 2H, a); 4.23 (s, 6H, c); 3.71 (s, 6H, 
b); 1.67 (m, 18H, w); 1.51 (m, 18H, x); 1.47 (septuplet, J 7.3 Hz, 18H, y); 0.88 
(t, J 7.3 Hz, 27H, z). 
 
13C NMR (CDCl3 100 MHz): δ/ppm 167.4 (B4); 156.6 (A2/B2); 156.4 (A2/B2); 
148.9 (A6); 136.5 (A4); 123.3 (A5); 121.1 (A3); 107.8 (B3); 100.1 (d, JPC 25.9 
Hz, C≡CAu); 69.3 (b); 68.0 (a); 60.0 (c); 44.9 (C(CH2)4); 27.1 (y); 25.4 (d, JPC 
32.3 Hz, w); 24.2 (d, JPC 14.4 Hz, x); 13.6 (z). 
 
31P NMR (CDCl3 162 MHz): δ/ppm 25.8 (s). 
 
MALDI: M/z 1678 [M]+.  
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IR (solid, cm-1): 2955m, 2924m, 2862m, 2361w, 2129w, 1713m, 1566m, 
1443m, 1404m, 1350m, 1204m, 1088s, 1026m, 988w, 910w, 795m, 733w, 
640s, 617s, 517m, 463m. 
 
UV/VIS λmax/nm (2.39x10-5 mol dm-3 CH2Cl2) 249 (ε/dm3 mol-1 cm-1 106200), 
278 (72700).  
 
Fluorescence: no fluorescence observed. 
 
6.4  Iron 2,2':6',2"-Terpyridine Complexes and Macrocycles  
 
6.4.1  [Fe(4)2][PF6]2 
 
Ligand 4 (0.0299 g, 0.0887 mmol) and FeCl2.4H2O (0.0095 g, 0.0477 
mmol) were added to MeOH (5 ml) and stirred for 30 minutes at room 
temperature. Aqueous NH4PF6 was added and the precipitated product was 
collected by filtration. No purification was necessary (0.0431 g, 0.0422 mmol, 
95 %). 
 
1H NMR (CD3CN 400 MHz): δ/ppm 8.49 (s, 4H, B3); 8.44 (d, J 8.0 Hz, 4H, 
A3); 7.86 (t, J 7.6 Hz, 4H, A4); 7.16 (d, J 5.2 Hz, 4H, A6); 7.07 (t, J 6.8 Hz, 
4H, A5); 4.76 (m, 4H, a); 4.10 (m, 4H, b); 3.73 (s, 8H, c and d); 2.84 (br, OH). 
 
13C NMR (CD3CN 100 MHz): δ/ppm 168.8 (B4); 161.7 (A2/B2); 158.9 (A2/B2), 
154.3 (A6); 139.3 (A4); 128.1 (A5); 124.5 (A3); 112.3 (B3); 73.7 (c/d); 71.0 
(a); 69.8 (b); 62.0 (c/d). 
 
MALDI: M/z 979 [M - 2PF6 + matrix + Na]+, 617 [M - 2PF6 - 4 + matrix]+, 338 [4 
+ H]+. 
 
IR (solid, cm-1): 2924w, 2878w, 1668w, 1614m, 1551w, 1495w, 1474m, 
1441m, 1424m, 1354m, 1300w, 1252w, 1216m, 1161w, 1128m, 1117m, 
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1059m, 1045m, 966w, 924w, 825s, 787s, 754s, 739s, 727m, 698m, 663m, 
652m, 639w, 615w, 590m, 554m. 
UV/VIS λmax/nm (2.06x10-5 mol dm-3 CH3CN) 207 (ε/dm3 mol-1 cm-1 57800), 
244 (52500), 272 (53500), 315 (40350), 555 (10700). 
 
6.4.2  [Fe(5)2][PF6]2 
 
 Ligand 5 (0.0198 g, 0.0563 mmol) and FeCl2.4H2O (0.0056 g, 0.0282 
mmol) in MeOH (10 ml) were stirred for 1 hour at room temperature. Aqueous 
NH4PF6 was added and the precipitate collected by filtration. The product was 
recrystallised from various solvent combinations (Et2O/CH3CN, 
CH3CN/toluene and CH2Cl2/hexane) (0.0275 g, 0.0251 mmol, 89 %) (total 
from all recrystallisations). 
 
1H NMR (CD3CN, 500 MHz): δ/ppm 8.48 (s, 4H, B3); 8.43 (d, J 8.0 Hz, 4H, 
A3); 7.86 (td, J 8.0, 1.5 Hz, 4H, A4); 7.16 (ddd, J 5.5, 1.5, 0.9 Hz, 4H, A6); 
7.06 (ddd, J 7.0, 5.5, 1.3 Hz, 4H, A5); 4.74 (m, 4H, a); 4.21 (d, J 2.0 Hz, 4H, 
e); 4.09 (m, 4H, b); 3.82 (m, 4H, d); 3.73 (m, 4H, c); 2.71 (t, J 2.5 Hz, C≡CH). 
 
13C NMR (CDCl3 125 MHz): δ/ppm 169.7 (B4); 161.7 (A2/B2); 158.9 (A2/B2); 
154.3 (A6); 139.3 (A4); 128.0 (A5); 124.4 (A3); 112.4 (B3); 80.8 (C≡CH); 75.7 
(C≡CH); 71.3 (d); 70.9 (a); 69.9 (c); 69.8 (b); 58.7 (e). 
 
ESMS: M/z 951 [M – PF6]+, 403 [M – 2PF6]2+. 
 
IR (cm-1, solid): 2930w, 2876w, 1714.60w, 1614m, 1562w, 1551w, 1474m, 
1441m, 1423m, 1352m, 1288w, 1250w, 1215m, 1161w, 1130w, 1115w, 
1092w, 1059m, 1043m, 966 w, 825s, 789s, 754s, 729s, 698m, 663m, 652m. 
 
UV/VIS λmax/nm (5.72x10-5 mol dm-3 CH3CN) 281 (ε/dm3 mol-1 cm-1 7600), 313 
(14000), 354(sh) (2000), 552 (4050). 
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6.4.3  [Fe2{Pt(1-H)2(PEt3)2}2][PF6]410,11 
 
Pt(1-H)2(PEt3)2 (0.0129 g, 0.0128 mmol) and FeCl2.4H2O (0.0025 g, 
0.0128 mmol) in MeOH (3 ml) were stirred for half an hour at room 
temperature. Aqueous NH4PF6 was added and the precipitate formed was 
collected by filtration. The purple solid was recrystallised from CH2Cl2/hexane 
(0.0124 g, 0.00459 mmol, 72 %). 
 
1H NMR (CD3CN, 400 MHz): δ/ppm 8.56 (s, 8H, B3);  8.27 (d, J 7.6 Hz, 8H, 
A3); 7.79 (td, J 7.2, 1.9 Hz, 8H, A4);  6.93-6.96 (m, 16H, A5 and A6); 5.35 (s, 
8H, a); 2.03 (m, 24H, y); 0.96 (m, JP-H 8, JP’-H 8, JH-H 8 Hz, 36H, z). 
 
13C NMR (CDCl3 125 MHz): δ/ppm 163.1; 161.1; 159.0; 153.9; 139.4; 127.9; 
124.3; 118.3; 113.2; 61.7; 17.1 (t, J 17.6 Hz, 12C,); 8.8. 
 
31P NMR (CD3CN 162 MHz): δ/ppm 12.0 (s+d, JPPt 2334 Hz); -144.6 (septet, 
JPF 707 Hz). 
 
195Pt NMR (CD3CN 107 MHz): δ/ppm -4875 (t, J 2332 Hz). 
 
ESMS: M/z 1086 [M-2PF6 -2PEt3]2+, 755 [M-3PF6]3+. 
 
IR (solid, cm-1): 3661w, 3119w, 3043w, 2961w, 2120w, 1610m, 1549w, 
1474m, 1441m, 1421m, 1377m, 1340m, 1298w, 1256w, 1200s, 1159w, 
1117w, 1040m, 1007m, 970m, 878m, 829s, 787s, 752s, 729s, 673s, 650s, 
586s, 555s. 
 
UV/VIS λmax/nm (7.41x10-5 mol dm-3 CH3CN) 245 (ε/dm3 mol-1 cm-1 99600), 
272 (116400), 312 (81900), 557 (23350). 
 
Fluorescence: no observed fluorescence. 
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Elemental analysis: Calc. C 44.03 %, H 4.23 %, N 5.98 %; Found C 43.01 %, 
H 4.68 %, N 5.58 %. 
 
6.4.4  [Fe2{Pt(1-H)2(PnBu3)2}2][PF6]411 
 
Pt(1-H)2(PnBu3)2 (0.1055 g, 0.0900 mmol) and FeCl2.4H2O (0.0180 g, 
0.0905 mmol) in MeOH (20 ml) were stirred for half an hour at room 
temperature. Aqueous NH4PF6 was added and the precipitate formed was 
collected by filtration (0.105 g, 0.0346 mmol, 95 %).  
 
1H NMR (CD3CN, 500 MHz): δ/ppm 8.49 (s, 8H, B3); 8.27 (d, J 7.5 Hz, 8H, 
A6); 7.86 (t, J 7.5 Hz, 8H, A3); 6.99 (m, 8H, A5); 6.93 (m, 8H, a6); 5.32 (s, 8H, 
a); 1.94 (overlaps with solvent, w); 1.47 (m, 24H, x); 1.25 (septet, J 7.5 Hz, 
24H, y); 0.60 (t, J 7.5 Hz, 36H, z). 
 
31P NMR (CDCl3 162 MHz): δ/ppm 3.0 (s+d, JPPt 2315 Hz); -144.6 (septet, J 
707 Hz). 
 
ESMS: M/z 1373 [M - 2PF6]2+. 
 
IR (solid, cm-1): 2953w, 2926w, 2868w, 2116w, 1609m, 1472m, 1421m, 
1377w, 1339m, 1298w, 1256w, 1196m, 1163w, 1092w, 1040w, 1003w, 966m, 
875.62w, 829s, 787s, 752m, 727w. 
 
UV/VIS λmax/nm (2.64-5 mol dm-3 CH3CN) 246 (ε/dm3 mol-1 cm-1 67200), 271 
(78500), 313 (49300), 558 (13000). 
 
Fluorescence: no observed fluorescence. 
 
6.4.5  [Fen{Pt(1-H)2(PPh3)2}n][PF6]2n11 
 
Pt(1-H)2(PPh3)2 (0.0307 g, 0.0238 mmol) and FeCl2.4H2O (0.0048 g, 
0.0241 mmol) in MeOH (5 ml) were stirred for half an hour at room 
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temperature. Aqueous NH4PF6 was added and the precipitate formed was 
collected by filtration (0.0346 g). Since the product was an inseparable 
mixture it was not possible to characterise it fully. 
 
31P NMR (CDCl3 162 MHz): δ/ppm 18.5 (s+d, J 2611 Hz), 18.0 (s+d, J 2605 
Hz), -144.6 (septet, J 706 Hz). 
 
ESMS: M/z 793 [M - 3PF6 - 6Ph]3+. 
 
IR (solid, cm-1): 3047w, 2908w, 2851w, 2122w, 1609m, 1549w, 1472m, 
1435m, 1421m, 1377w, 1337m, 1298w, 1248w, 1196m, 1161m, 1095m, 
1007m, 876w, 829s, 787s, 743s, 690s, 617s. 
 
Fluorescence: no fluorescence observed. 
 
6.4.6  [Fe{Pt(5-H)2(PEt3)2}][PF6]25 
  
Pt(5-H)2(PEt3)2 (0.0182 g, 0.0154 mmol) and FeCl2.4H2O (0.0039 g, 
0.0196 mmol) were added to MeOH (2 ml) and stirred at room temperature for 
30 minutes. Aqueous NH4PF6 was added and the precipitate was collected by 
filtration. Thin layer chromatography showed that there were two purple 
fractions as well as some purple material remaining on the baseline. Attempts 
to separate the products were however unsuccessful and the product was 
partly characterised as a component of a mixture. 
 
1H NMR (CD3CN, 500 MHz): δ/ppm 8.63 (s, 4H, B3); 8.39 (d, J 8.0 Hz, 4H, 
A3); 8.01 (t, J 7.2 Hz, 4H, A4); 7.15 (m, 4H, A5); 7.07 (m, 4H, A6); 4.92 (m, 
4H, a); 4.12 (m, 4H, e); 4.04 (m, 4H, b); 3.65 (t, J 6.2 Hz, 4H, d); 1.66 (m, 
12H, y); 0.72 (m, 18H, z). 
 
31P NMR (CDCl3 162 MHz): δ/ppm 8.8 (s+d, JPPt 2313 Hz), -144.6 (septet, JPF 
707 Hz). 
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ESMS: M/z 617 [M - 2PF6]2+. 
 
MALDI: M/z 1457 [M - 2PF6 + matrix]+. 
 
6.4.7  [Fe{Au(1-H)(PnBu3)}2][PF6]2 
 
 Au(1-H)(PnBu3) (0.132 g, 0.192 mmol) and FeCl2.4H2O (0.0191 g, 
0.0961 mmol) in MeOH (20 ml) and CH2Cl2 (10 ml) were stirred for 30 minutes 
at room temperature. Some of the solvent was removed and aqueous NH4PF6 
was added. The precipitate was collected by filtration. Purification was 
attempted by chromatography on alumina using a mixture of CH3CN, 
saturated aqueous KNO3 and water in a 7:1:0.5 ratio as the eluent. The first 
band was collected (0.0952 g, 0.0554 mmol, 70 %). The product was still a 
mixture however, and a brown decomposition product was observed after a 
short time in solution, therefore it was not possible to obtain well resolved 1H 
and 13C NMR spectra. 
 
31P NMR (CD3CN 162 MHz): δ/ppm 36.3 (s); 25.2(br); -144.6 (septet, J 706 
Hz) 
 
ESMS: M/z 1442 [M – PnBu3 - PF6]+; 913 [Fe(1)2 - PF6]+.  
 
IR (solid, cm-1): 3279w, 3086w, 2924m, 2862m, 2129w, 1278w, 1612m, 
1558w, 1469m, 1420m, 1381w, 1350m, 1296w, 1250w, 1204m, 1165w, 
1095w, 1041w, 1011w, 980w, 825s, 787s, 748m, 717m, 663m, 617w, 555s. 
 
UV/VIS λmax/nm (1.75x10-5 mol dm-3 CH3CN) 243 (ε/dm3 mol-1 cm-1 30100), 
273 (29600), 283(sh), 315 (22600), 556 (6700). 
 
Fluorescence: no fluorescence observed. 
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6.4.8  [Fen{(Au(1-H))2(dppe)}n][PF6]2n 
 
(Au(1-H))2(dppe) (0.1141 g, 0.0836 mmol) and FeCl2.4H2O (0.0165 g, 
0.0830 mmol) in MeOH (15 ml) were stirred at room temperature for 30  
minutes. Aqueous NH4PF6 was added and the precipitate was collected by 
filtration. Attempts to separate the three products were unsuccessful and 
attempts to grow crystals of the product resulted in a change in the 31P NMR 
chemical shifts. 
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Crystal Data for Ligand 1 
Formula C18H13N3O1 
Formula weight 287.32 
Crystal system Triclinic 
Space group P -1 
a, b, c, [Å] 3.95720(10), 12.1228(4), 14.6442(4) 
α, β, γ [◦] 87.7010(19), 83.9528(19), 
82.9919(17) 
V [Å3] 693.12(3) 
Z 2 
D (calc) [gcm-3] 1.377 
µ (MoKα) [mm-1] 0.088 
F(000) 300 
Crystal size [mm] 0.14 x 0.14 x 0.16 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 3 (30) 
Total number of reflections 8003 
Number of unique reflections 4065 
Observed data [I>3.0 σ(I)] 2496 
Refinement 
Number of reflections 2496 
Number of parameters 200 
R1 0.0376 
R1 (all data) 0.0630 
wR2 0.0437 
wR2 (all data) 0.0780 
Goodness of fit (GOF) 1.1079 
Min. and Max. residual electron 
density [e Å-3] 
-0.18, 0.28 
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Crystal Data for Ligand 2 
Formula C20H17N3O1 
Formula weight 315.37 
Crystal system Orthorhombic 
Space group P n a 21 
a, b, c, [Å] 21.6358(4), 5.84320(10), 12.7032(2) 
V [Å3] 1605.97(5) 
Z 4 
D (calc) [gcm-3] 1.304 
µ (MoKα) [mm-1] 0.083 
F(000) 664 
Crystal size [mm] 0.12 x 0.18 x 0.38 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1 (28) 
Total number of reflections 12986 
Number of unique reflections 2011 
Observed data [I>0.5 σ(I)] 1748 
Refinement 
Number of reflections 1748 
Number of parameters 217 
R1 0.0351 
R1 (all data) 0.0416 
wR2 0.0328 
wR2 (all data) 0.0342 
Goodness of fit (GOF) 1.0949 
Min. and Max. residual electron 
density [e Å-3] 
-0.12, 0.20 
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Crystal Data for Ligand 3a 
Formula C21H19N3O1 
Formula weight 329.40 
Crystal system Monoclinic 
Space group P 21/n 
a, b, c, [Å] 5.6534(2), 25.5246(9), 12.1459(3) 
β [◦]  94.310(2)  
V [Å3] 1747.71(10) 
Z 4 
D (calc) [gcm-3] 1.252 
µ (MoKα) [mm-1] 0.079 
F(000) 696 
Crystal size [mm] 0.07 x 0.12 x 0.34 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1 (27) 
Total number of reflections 12169 
Number of unique reflections 3981 
Observed data [I>1.0 σ(I)] 2472 
Refinement 
Number of reflections 2472 
Number of parameters 226 
R1 0.0595 
R1 (all data) 0.0974 
wR2 0.0698 
wR2 (all data) 0.2981 
Goodness of fit (GOF) 0.9646 
Min. and Max. residual electron 
density [e Å-3] 
-0.17, 0.82 
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Crystal Data for Ligand 3b 
Formula C21H19N3O1 
Formula weight 329.40 
Crystal system Monoclinic 
Space group C2/c 
a, b, c, [Å] 35.6129(12), 5.4646(2), 20.5952(7) 
β [◦] 120.439(2) 
V [Å3] 3455.6(2) 
Z 8 
D (calc) [gcm-3] 1.266 
µ (MoKα) [mm-1] 0.080 
F(000) 1392 
Crystal size [mm] 0.04 x 0.16 x 0.54 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1 (30) 
Total number of reflections 48465 
Number of unique reflections 5038 
Observed data [I>3.0 σ(I)] 2605 
Refinement 
Number of reflections 2605 
Number of parameters 226 
R1 0.0504 
R1 (all data) 0.1034 
wR2 0.0326 
wR2 (all data) 0.0443 
Goodness of fit (GOF) 1.2421 
Min. and Max. residual electron 
density [e Å-3] 
-0.22, 1.02 
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Crystal Data for Ligand 5 
Formula C22H21N3O3 
Formula weight 375.43 
Crystal system Monoclinic 
Space group C 2/c 
a, b, c, [Å] 36.842(36), 5.040(4), 20.626(16) 
β [◦]  101.23(10)  
V [Å3] 3756.2(57) 
Z 8 
D (calc) [gcm-3] 1.328 
µ (MoKα) [mm-1] 0.090 
F(000) 1584  
Crystal size [mm] 0.06 x 0.31 x 0.35 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1 (27) 
Total number of reflections 30509 
Number of unique reflections 4317 
Observed data [I>2.0 σ(I)] 2565 
Refinement 
Number of reflections 2565 
Number of parameters 254 
R1 0.0565 
R1 (all data) 0.0576 
wR2 0.0497 
wR2 (all data) 0.0503 
Goodness of fit (GOF) 1.0740 
Min. and Max. residual electron 
density [e Å-3] 
-0.24, 0.22 
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Crystal Data for Pt(1-H)2(PnBu3)2 
Formula C60H78N6O2P2Pt1 
Formula weight 1172.36 
Crystal system Triclinic 
Space group P -1 
a, b, c, [Å] 9.39830(10), 10.99710(10), 
13.79160(10) 
α, β, γ [◦] 100.6520(6), 99.7287(6), 91.2631(6) 
V [Å3] 1378.62(2) 
Z 1 
D (calc) [gcm-3] 1.412 
µ (MoKα) [mm-1] 2.651 
F(000) 604 
Crystal size [mm] 0.04 x 0.16 x 0.28 
Data Collection 
Temperature [K] 123 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 3 (28) 
Total number of reflections 13016 
Number of unique reflections 6560 
Observed data [I>3.0 σ(I)] 6490 
Refinement 
Number of reflections 6490 
Number of parameters 322 
R1 0.0203 
R1 (all data) 0.0206 
wR2 0.0228 
wR2 (all data) 0.0229 
Goodness of fit (GOF) 1.0943 
Min. and Max. residual electron 
density [e Å-3] 
-1.20, 1.11 
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Crystal Data for Pt(1-H)2(PPh3)2.2C6H6 
Formula C84H66N6O2P2Pt1 
Formula weight 1448.52 
Crystal system Triclinic 
Space group P -1 
a, b, c, [Å] 9.3237(5), 13.3692(7), 15.5613(7) 
 
α, β, γ [◦] 104.458(3), 104.998(3), 107.061(2) 
V [Å3] 1676.16(16) 
Z 1 
D (calc) [gcm-3] 1.435 
µ (MoKα) [mm-1] 2.196 
F(000) 736 
Crystal size [mm] 0.25 x 0.27 x 0.48 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 2.933 (27.456) 
Total number of reflections 12703 
Number of unique reflections 7414 
R (int) 0.042 
Observed data [I>3.0 σ(I)] 6362 
Refinement 
Number of reflections 6362 
Number of parameters 430 
R1 0.0431 
R1 (all data) 0.0511 
wR2 0.0475 
wR2 (all data) 0.0520 
Goodness of fit (GOF) 1.1209 
Min. and Max. residual electron 
density [e Å-3] 
-1.48, 2.02 
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Crystal Data for [Cu2(PPh3)2(μ-I)(μ-7)]I 
Formula C59H45Cu2I2N3P2 
Formula weight 1238.87 
Crystal system Orthorhombic 
Space group C 2 2 21 
a, b, c, [Å] 18.4993(2), 26.7904(4), 10.46600(10)
V [Å3] 5186.99(11) 
Z 4 
D (calc) [gcm-3] 1.586 
µ (MoKα) [mm-1] 2.113 
F(000) 2456  
Crystal size [mm] 0.02 x 0.16 x 0.33 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1 (27) 
Total number of reflections 39838 
Number of unique reflections 5950 
Observed data [I>3.0 σ(I)] 5133 
Refinement 
Number of reflections 5133 
Number of parameters 314 
R1 0.0330 
R1 (all data) 0.0384 
wR2 0.0397 
wR2 (all data) 0.0422 
Goodness of fit (GOF) 1.0751 
Min. and Max. residual electron 
density [e Å-3] 
-2.63, 2.64 
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Crystal Data for Au(1-H)(PnBu3) 
Formula C30H39Au1N3O1P1 
Formula weight 685.60 
Crystal system Triclinic 
Space group P -1 
a, b, c, [Å] 11.1882(2), 11.3401(2), 14.3037(2) 
α, β, γ [◦] 92.6970(9), 110.5440(7), 116.1495(8)
V [Å3] 1480.86(5) 
Z 2 
D (calc) [gcm-3] 1.537 
µ (MoKα) [mm-1] 5.047 
F(000) 684 
Crystal size [mm] 0.12 x 0.22 x 0.23 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1.566 (29.988) 
Total number of reflections 17126 
Number of unique reflections 8610 
Observed data [I>2.0 σ(I)] 6366 
Refinement 
Number of reflections 6366 
Number of parameters 325 
R1 0.0315 
R1 (all data) 0.0498 
wR2 0.0491 
wR2 (all data) 0.0592 
Goodness of fit (GOF) 0.9678  
Min. and Max. residual electron 
density [e Å-3] 
-2.19, 1.67 
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Crystal Data for (AuPnBu3)3(12 – 3H) 
Formula C65H105Au3N3O4P3 
Formula weight 1676.39 
Crystal system Monoclinic 
Space group P 21/c 
a, b, c, [Å] 14.5969(4), 17.5045(3), 27.8698(6) 
 β  [◦]  98.7409(9)  
V [Å3] 7038.3(3) 
Z 4 
D (calc) [gcm-3] 1.582 
µ (MoKα) [mm-1] 6.350 
F(000) 3320 
Crystal size [mm] 0.04 x 0.07 x 0.21 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 2.958 (26.002) 
Total number of reflections 27178 
Number of unique reflections 13775 
Observed data [I>2.0 σ(I)] 7109 
Refinement 
Number of reflections 7109 
Number of parameters 703 
R1 0.0866 
R1 (all data) 0.1538 
wR2 0.0830 
wR2 (all data) 0.1152 
Goodness of fit (GOF) 1.0481 
Min. and Max. residual electron 
density [e Å-3] 
-2.08, 5.25 
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Crystal Data for [Au3Cl2(dppm)2][PF6] 
Formula C50H44Au3Cl2F6P5 
Formula weight 1575.56 
Crystal system Triclinic 
Space group P -1 
a, b, c, [Å] 9.67400(10), 15.4549(2), 18.9003(3) 
α, β, γ [◦] 105.9872(8), 101.5928(7), 
101.6696(8) 
V [Å3] 2559.58(6) 
Z 2 
D (calc) [gcm-3] 2.044 
µ (MoKα) [mm-1] 8.893 
F(000) 1488 
Crystal size [mm] 0.09 x 0.09 x 0.11 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1.165 (27.865) 
Total number of reflections 23737  
Number of unique reflections 12197 
Observed data [I>3.0 σ(I)] 8452 
Refinement 
Number of reflections 8452 
Number of parameters 650 
R1 0.0361 
R1 (all data) 0.0548 
wR2 0.0408 
wR2 (all data) 0.0578 
Goodness of fit (GOF) 1.1149  
Min. and Max. residual electron 
density [e Å-3] 
-4.00, 2.84 
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Crystal Data for (Au(1-H))2(dppe).4CHCl3 
Formula C66H52Au2Cl12N6O2P2 
Formula weight 1842.49 
Crystal system Triclinic 
Space group P -1 
a, b, c, [Å] 8.7136(3), 13.3106(4), 15.9758(4) 
α, β, γ [◦] 110.0374(18), 91.133(2), 95.8007(16)
V [Å3] 1728.92(9) 
Z 1 
D (calc) [gcm-3] 1.770 
µ (MoKα) [mm-1] 4.797  
F(000) 898 
Crystal size [mm] 0.02 x 0.05 x 0.37 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1.359 (27.491) 
Total number of reflections 14873 
Number of unique reflections 7916 
Observed data [I>3.0 σ(I)] 5094 
Refinement 
Number of reflections 5094 
Number of parameters 442 
R1 0.0325 
R1 (all data) 0.0626 
wR2 0.0359 
wR2 (all data) 0.0574 
Goodness of fit (GOF) 1.1116 
Min. and Max. residual electron 
density [e Å-3] 
-0.72, 0.79 
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Crystal Data for (AuCl)2(dppf) 
Formula C34H28Au2Cl2Fe1P2 
Formula weight 1019.23 
Crystal system Triclinic 
Space group P -1 
a, b, c, [Å] 8.62730(10), 9.04010(10), 
10.37150(10) 
α, β, γ [◦] 80.9701(7), 86.0279(7), 81.6056(7) 
V [Å3] 789.417(14) 
Z 1 
D (calc) [gcm-3] 2.144 
µ (MoKα) [mm-1] 10.017 
F(000) 480 
Crystal size [mm] 0.03 x 0.08 x 0.15 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1.990 (30.004) 
Total number of reflections 9181 
Number of unique reflections 4616 
Observed data [I>2.0 σ(I)] 4217 
Refinement 
Number of reflections 4592 
Number of parameters 188 
R1 0.0233 
R1 (all data) 0.0258 
wR2 0.0595 
wR2 (all data) 0.0604 
Goodness of fit (GOF) 0.9738 
Min. and Max. residual electron 
density [e Å-3] 
-1.28, 1.50 
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Crystal Data for [Fe(5)2][PF6]2 
Formula C44H42F12Fe1N6O6P2 
Formula weight 1096.62 
Crystal system Orthorhombic 
Space group P 21 21 21 
a, b, c, [Å] 8.691(2), 38.232(5), 13.7060(15) 
V [Å3] 4554.3(13) 
Z 4 
D (calc) [gcm-3] 1.599  
µ (MoKα) [mm-1] 0.507 
F(000) 2240 
Crystal size [mm] 0.05 x 0.12 x 0.34 
Data Collection 
Temperature [K] 173 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 1.578 (26.836) 
Total number of reflections 45472 
Number of unique reflections 9428 
Observed data [I>3.0 σ(I)] 8139 
Refinement 
Number of reflections 8139 
Number of parameters 641 
R1 0.0399 
R1 (all data) 0.0460 
wR2 0.0432 
wR2 (all data) 0.0441 
Goodness of fit (GOF) 1.0536 
Min. and Max. residual electron 
density [e Å-3] 
-0.40, 0.41 
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Crystal Data for [Fe2{Pt(1-H)2(PEt3)2}2][PF6]4.C6H5CH3.4MeCN 
Formula C55.5H64F12Fe1N8O2P4Pt1 
Formula weight 1477.98 
Crystal system Monoclinic 
Space group P 21/n 
a, b, c, [Å] 13.8860(2), 18.4187(2), 24.1365(3) 
α, β, γ [◦] 90, 94.6196(7), 90 
V [Å3] 6153.15(13) 
Z 4 
D (calc) [gcm-3] 1.595 
µ (MoKα) [mm-1] 2.694 
F(000) 2964 
Crystal size [mm] 0.10 x 0.13 x 0.20 
Data Collection 
Temperature [K] 123 
Radiation [Å] MoKα, 0.71073 
θ Min (Max) [◦] 2.943 (27.875) 
Total number of reflections 55770 
Number of unique reflections 14640 
Observed data [I>2.0 σ(I)] 9363 
Refinement 
Number of reflections 9363 
Number of parameters 901 
R1 0.0318 
R1 (all data) 0.0582 
wR2 0.0346 
wR2 (all data) 0.0391 
Goodness of fit (GOF) 1.0070 
Min. and Max. residual electron 
density [e Å-3] 
-0.66, 0.98 
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